Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same

Abstract
The present disclosure relates to novel macrocyclic compounds and libraries thereof containing heteroaryl moieties that are useful as research tools for drug discovery efforts. The present disclosure also relates to methods of preparing these compounds and libraries and methods of using these libraries, such as in high throughput screening. In particular, these libraries are useful for evaluation of bioactivity at existing and newly identified pharmacologically relevant targets, including G protein-coupled receptors, nuclear receptors, enzymes, ion channels, transporters, transcription factors, protein-protein interactions and nucleic acid-protein interactions. As such, these libraries can be applied to the search for new pharmaceutical agents for the treatment and prevention of a range of medical conditions.
Description
FIELD OF THE DISCLOSURE

The present document relates to the field of medicinal chemistry. More particularly, it relates to novel macrocyclic compounds and libraries thereof containing heteroaryl moieties that are useful as research tools for drug discovery efforts. The present disclosure also relates to methods of preparing these compounds and libraries and methods of using these libraries, such as in high throughput screening. In particular, these libraries are useful for evaluation of bioactivity at existing and newly identified pharmacologically relevant targets, including G protein-coupled receptors, nuclear receptors, enzymes, ion channels, transporters, transcription factors, protein-protein interactions and nucleic acid-protein interactions. As such, these libraries can be applied to the search for new pharmaceutical agents for the treatment and prevention of a range of medical conditions.


BACKGROUND OF THE DISCLOSURE

From its start in the 1990's, high throughput screening (HTS) of chemical compound libraries has become an essential part of the drug discovery process with the successful generation of many lead molecules, clinical candidates and marketed pharmaceuticals (Curr. Opin. Chem. Biol. 2001, 5, 273-284; Curr. Opin. Chem. Biol. 2003, 7, 308-325; J. Biomol. Screen. 2006, 11, 864-869; Drug Disc. Today 2006, 11, 277-279; Nat. Rev. Drug Disc. 2011, 10, 188-195). Current collections of molecules for HTS, however, often are overpopulated by compounds related to known pharmaceutical agents, with a continuing need to expand chemical diversity and improve the content of screening collections (Curr. Opin. Chem. Biol. 2010, 14, 289-298; Drug Disc. Today 2013, 18, 298-304). Indeed, the diversity of molecular structures available in the library collections utilized for HTS has been identified as an area that needs to be dramatically improved (Curr. Opin. Chem. Biol. 2010, 14, 289-298; Biochem. Pharmacol. 2009, 78, 217-223; Curr. Med. Chem. 2009, 16, 4374-4381). Whereas the initial efforts at building screening libraries focused primarily on numbers of compounds, the focus has shifted to providing higher quality molecules (Fut. Med. Chem. 2014, 6, 497-502) that permit more complete sampling of “chemical space”. Fortunately, given the estimated vastness of this space (J. Chem. Info. Model. 2007, 47, 342-353), significant opportunity exists for finding and exploring new or underexplored compound classes for desirable biological activity.


As an additional consideration, HTS has traditionally varied considerably in success rate depending on the type of target being interrogated, with certain target classes identified as being particularly challenging, for example protein-protein interactions (PPI). To address such intractable targets, a wider range of compounds and chemotypes will need to be explored. This situation has been exacerbated as advances in genomics and proteomics have led to the identification and characterization of large numbers of new potential pharmacological targets (Nat. Rev. Drug Disc. 2002, 1, 727-730; Drug Disc. Today 2005, 10, 1607-1610; Nat. Biotechnol. 2006, 24, 805-815), many of which fall into these difficult classes.


Recently, macrocycles have been identified as an underexplored class of biologically relevant synthetic molecules that possess properties amenable to these more difficult targets (Nat. Rev. Drug Disc. 2008, 7, 608-624; J. Med. Chem. 2011, 54, 1961-2004; Fut. Med. Chem. 2012, 4, 1409-1438; Molecules 2013, 18, 6230-6268; J. Med. Chem. 2014, 57, 278-295; Curr. Pharm. Design 2016, 22, 4086-4093). Although such structures are widespread in natural products, considerable challenges of synthetic accessibility have to date limited their presence in screening collections.


The interest in macrocycles originates in part from their ability to bridge the gap between traditional small molecules and biomolecules such as proteins, nucleotides and antibodies. They are considered to fill an intermediate chemical space between these two broad classes, but possessing favorable features of each: the high potency and exceptional selectivity of biomolecules with the ease of manufacturing and formulation, favorable drug-like properties and attractive cost-of-goods of small molecules. Hence, macrocycles provide a novel approach to addressing targets on which existing screening collections have not proven effective.


Indeed, macrocycles display dense functionality in a rather compact structural framework, but still occupy a sufficiently large topological surface area to enable interaction at the disparate binding sites often present in PPI and other difficult targets. In addition, macrocycles possess defined conformations, which can preorganize interacting functionality into appropriate regions of three-dimensional space, thereby permitting high selectivity and potency to be achieved even in early stage hits. Interestingly, spatial or shape diversity in the design of libraries has been identified as an important factor for broad biological activity (J. Chem. Info. Comput. Sci. 2003, 43, 987-1003).


Although cyclic peptide libraries of both synthetic and biosynthetic origin have been prepared and studied in some depth (J. Comput. Aided. Mol. Des. 2002, 16, 415-430; Curr. Opin. Struct. Biol. 2013, 23, 571-580), libraries of macrocyclic non-peptidic or semi-peptidic structures remain more problematic to construct and their bioactivity only perfunctorily investigated (J. Med. Chem. 2011, 54, 1961-2004; Macrocycles in Drug Discovery, J. Levin, ed., RSC Publishing, 2015, pp 398-486, ISBN 978-1-84973-701-2).


Thiazoles, oxazoles and, to a lesser extent, imidazoles have been found to be common structural features of natural products, particularly those of marine origin (Marine Drugs. 2010, 8, 2755-2780; Nat. Prod. Rep. 2011, 28, 1143-1191; Nat. Prod. Rep. 2013, 30, 869-915). In fact, many such products contain multiple azole rings. In addition, compounds containing the thiazole ring have been found to have significant pharmacological and therapeutic impact (Curr. Top. Med. Chem. 2016, 16, 284-2862). Further, the imidazole ring, partly from its presence in the natural amino acid histidine, plays a vital role in many biological interactions due to its unique combination of basic and aromatic character (Curr. Med. Chem. 2006, 13, 1-23; Med. Chem. Res. 2011, 20, 1119-1140).


However, the incorporation of these heteroaromatic components into the ring backbone of synthetic macrocycles and libraries, as well as assessment of bioactivity for the resulting molecules, have not been widely explored (Org. Lett. 2003, 5, 4567-4570; J. Med. Chem. 2009, 52, 7014-7028; J. Org. Chem. 2010, 75, 7939-7941; Intl. Pat. Appl. Publ. WO 2012/062777; Tetrahedron 2012, 68, 1029-1051; Chem. Biodivers. 2012, 9, 2473-2484; J. Org. Chem. 2012, 77, 11079-11090; Chem. Rec. 2013, 13, 539-548; Proc. Natl. Acad. Sci. USA 2013, 110, E3753-E3760; ACS Comb. Sci. 2014, 16, 71-77).


Hence, the macrocyclic compounds and libraries of the disclosure, which include these heteroaryl moieties, provide distinct structural scaffolds from those previously known. In that manner, they satisfy a significant need in the art for novel compounds and libraries that are useful in the search for new therapeutic agents for the prevention or treatment of a wide variety of disease states.


SUMMARY OF THE DISCLOSURE

According to one aspect, there are provided libraries of two or more macrocyclic compounds of formulas (Ia), (Ib), (Ic), (Id) and (Ie) and their salts as defined in the present disclosure.


According to another aspect, there are provided libraries comprising from two (2) to over ten thousand (10,000 macrocyclic compounds.


According to other aspects, there are provided libraries comprising discrete macrocyclic compounds and libraries comprising mixtures of macrocyclic compounds.


According to an additional aspect, it was found that such libraries can be useful for the identification of macrocyclic compounds that modulate a biological target.


According to still other aspects, there are provided libraries dissolved in a solvent and libraries distributed in one or more multiple sample holders.


According to yet another aspect, there are provided kits comprising the libraries as defined in the present disclosure and one or more multiple sample holders.


According to a further aspect, there are provided macrocyclic compounds and their pharmaceutically acceptable salts as defined in the present disclosure.


According to one more aspect, there is provided a process for preparing macrocyclic compounds and libraries thereof as defined in the present disclosure.


It was found that such libraries of macrocyclic compounds are useful as research tools in drug discovery efforts for new therapeutic agents to treat or prevent a range of diseases.


BRIEF DESCRIPTION OF THE SCHEMES

Further features and advantages of the disclosure will become more readily apparent from the following description of specific embodiments as illustrated by way of examples in the schemes found in the last few pages of the description wherein:


Scheme 1 shows a general synthetic scheme for the synthesis of macrocyclic compounds for the libraries of the present disclosure.


Scheme 2 shows a synthetic scheme for a representative library of macrocyclic compounds of formula (Ib) of the present disclosure.


Scheme 3 shows a synthetic scheme for a representative library of macrocyclic compounds of formula (Ic) of the present disclosure.


Scheme 4 shows a synthetic scheme for a representative library of macrocyclic compounds of formula (Ia) of the present disclosure.


Scheme 5 shows a synthetic scheme for a representative library of macrocyclic compounds of formula (Ie) of the present disclosure.


Scheme 6 shows a synthetic scheme for another representative library of macrocyclic compounds of formula (Ie) of the present disclosure.


Scheme 7 shows a synthetic scheme for a third representative library of macrocyclic compounds of formula (Ie) of the present disclosure.


Scheme 8 shows a synthetic scheme for a representative library of macrocyclic compounds of formula (Id) of the present disclosure.







DETAILED DESCRIPTION OF THE DISCLOSURE

The inventors have discovered new macrocyclic compounds, specifically incorporating heteroaryl components in the ring skeleton, and libraries thereof that are useful as research tools for the discovery of new pharmaceutical agents for a range of diseases. In particular, they include oxazole, thiazole and imidazole rings. Processes for preparing these compounds and libraries have also been developed and comprise part of this disclosure.


Therefore, in a first aspect, the disclosure relates to libraries comprising at least two macrocyclic compounds selected from the group consisting of compounds of formula (Ia), formula (Ib), formula (Ic), formula (Id), formula (Ie) and salts thereof:




embedded image


wherein:

    • Q1, Q2, Q3, Q4, Q5, Q6, Q7, Q8 and Q8 are independently selected from the group consisting of CH2 or C═O, wherein in formula (Id) at least one of Q4, Q5 and Q6 is CH2 and wherein in formula (Ie) at least one of Q7, Q8 and Q9 is CH2;
    • X1, X5, X12, X13, X14, X15, X17, X18 and X19 are, when Q1, Q2, Q3, Q4, Q5, Q6, Q7, Q8 and Q9, respectively, are C═O, independently selected from the group consisting of O and NR20a, where R20a is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, sulfonyl and C1-C6 alkyl substituted with hydroxy, alkoxy, amino, mercapto, carboxy, carboxyalkyl, carboxyaryl, amido, amidino, guanidino, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl or C4-C14 heteroaryl;
    • when X1, X12, X13, X14, X15, X17, X18 or X19 are NR20a, X1, X12, X13, X14, X15, X17, X18 and X19 can also form an optionally substituted four, five, six or seven-membered ring together with, respectively, R1, R11, R13, R14, R15, R17, R18 and R19;
    • when Q1, Q2, Q3, Q4, Q5, Q6, Q7, Q8 and Q9, are CH2, X1, X5, X12, X13, X14, X15, X17, X18 and X19, respectively, can also be independently selected from the group consisting of S(O)q1 and NR20b, where q1 is 0-2; and R20b is selected from the group consisting of formyl, acyl, amino acyl, amido, amidino, carboxyalkyl, carboxyaryl and sulfonamido, and that X5 can also be N and form, together with B, an optionally substituted four, five, six or seven-membered ring;
    • X2, X3, X7, X8, X9, X11 and X16 are independently selected from the group consisting of O and NR21, where R21 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, sulfonyl and C1-C6 alkyl substituted with hydroxy, alkoxy, amino, mercapto, carboxy, carboxyalkyl, carboxyaryl, amido, amidino, guanidino, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl or C4-C14 heteroaryl, when X2, X7, X8, X9 or X16 are NR21, X2, X7, X8, X9 and X16 can also form an optionally substituted four, five, six or seven-membered ring together with, respectively, R2, R6, R7, R10 and R16, and wherein X3 and X8 can also independently be N and form, together with A and D, respectively, an optionally substituted four, five, six or seven-membered ring;
    • X4, X6 and X10 are independently selected from the group consisting of O, S(O)q2 and NR22, where q2 is 0-2 and R22 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, formyl, acyl, amino acyl, carboxyalkyl, carboxyaryl, amido, amidino, sulfonyl, sulfonamido and C1-C6 alkyl substituted with hydroxy, alkoxy, amino, mercapto, carboxy, carboxyalkyl, carboxyaryl, amido, amidino, guanidino, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl or C4-C14 heteroaryl, when X4 or X6 are NR22, X4 and X6 can also form an optionally substituted four, five, six or seven-membered ring together with, respectively, R4 and R5;
    • Z1, Z3, Z5, Z7 and Z9 are independently selected from the group consisting of O, S and NR23 where R23 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, formyl, acyl, amino acyl, carboxyalkyl, carboxyaryl, amido, amidino, sulfonyl, sulfonamido and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl, or C4-C14 heteroaryl;
    • Z2, Z4, Z6, Z8 and Z10 are independently selected from the group consisting of N, N+—O and CR24 where R24 is selected from the group consisting of hydrogen, halogen, amino, nitro, carboxy, carboxyalkyl, carboxyaryl, trifluoromethyl, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl;
    • R1, R2, R4, R5, R6, R7, R9, R10, R11, R13, R14, R15, R16, R17, R18 and R19 are independently selected from the group consisting of:




embedded image




    • where (#) indicates the site of bonding of the group to the remainder of the structure; p1, p2, p3, p4 and p5 are independently 0-5; p6 and p7 are independently 0-6;

    • W1 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, formyl, acyl, amino acyl, amido, carboxyalkyl, carboxyaryl, amidino, sulfonyl, sulfonamido and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl or C4-C14 heteroaryl;

    • W2 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, acyl, amino acyl and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl or C4-C14 heteroaryl;

    • W3 and W8 are independently selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl or C4-C14 heteroaryl;

    • W4 is selected from the group consisting of hydrogen, halogen, trifluoromethyl, hydroxy and methyl;

    • W5 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, formyl, acyl, carboxyalkyl, carboxyaryl, amido, amidino, sulfonyl, sulfonamido and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl or C4-C14 heteroaryl;

    • W6 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, acyl, carboxyalkyl, carboxyaryl, amido and sulfonyl; and

    • W7 is selected from the group consisting of hydrogen, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, sulfonyl and C1-C8 alkyl substituted with C3-C15 cycloalkyl, C6-C15 aryl or C4-C14 heteroaryl;

    • wherein R1, R11, R13, R14, R15, R17, R18 and R19, when X1, X12, X13, X14, X15, X17, X18 or X19 are NR20a, can also form an optionally substituted four, five, six or seven-membered ring together with NR20a,

    • wherein R2, R6, R7, R10 and R16, when X2, X7, X8, X9 or X16, respectively, are NR21, can also form an optionally substituted four, five, six or seven-membered ring together with NR21,

    • wherein R4 and R5, when X4 or X6, respectively, are NR22, can also form an optionally substituted four, five, six or seven-membered ring together with NR22;

    • R3, R8 and R12 are independently selected from the group consisting of hydrogen, C1-C6 alkyl and C6-C15 aryl; and A, B and D are independently selected from the group consisting of:







embedded image




    • when X3, X5, or X8 is N, A, B and D, respectively, can also be independently selected from the group consisting of:







embedded image




    • wherein n1a is 0-5; n1b and n1c are independently 1-3; n2, n3, n4, n5, n6, n7, n10 and n13 are independently 0-4; n8, n9, n11 and n12 are independently 0-4, wherein the sum of n8 and n9 is at least 2 and the sum of n11 and n12 is at least 2;

    • X20 is selected from O, NR26, CH═CH and C≡C, where R26 is selected from the group consisting of hydrogen, C1-C4 alkyl, acyl and sulfonyl;

    • X21, X22, X23, X24, X25 and X26 are independently selected from the group consisting of (CH2)m1, O, S(O)q3 and NR27, where m1 is 0-4, q3 is 0-2 and R27 is selected from the group consisting of hydrogen, C1-C4 alkyl, acyl and sulfonyl;

    • Z11, Z12, Z13, Z14, Z15, Z16, Z17, Z18, Z19, Z20, Z21 and Z22 are independently selected from the group consisting of N, N+—O and CR28, where R28 is selected from hydrogen, hydroxy, alkoxy, amino, amido, amidino, guanidino, halogen, cyano, nitro, carboxy, carboxyalkyl, carboxyaryl, trifluoromethyl, C1-C20 alkyl, C3-C15 cycloalkyl, C2-C14 heterocycle, C6-C15 aryl, C4-C14 heteroaryl, wherein in the group of Z11, Z12, Z13 and Z14, three or less within that group are N; wherein in the group of Z15, Z16, Z17 and Z18, three or less within that group are N; and wherein in the group of Z19, Z20, Z21 and Z22, three or less within that group are N; and

    • (X) indicates the site or sites of bonding to X3 of formula (Ia) for A, to X5 of formula (Ib) for B, and to X11 of formula (Ic) for D, and (C) indicates the site of bonding to CHR3 of formula (Ia) for A, to CHR8 of formula (Ib) for B and to CHR12 of formula (Ic) for D.





In one embodiment, the libraries of the present disclosure may be comprised of at least two macrocyclic compounds selected from only one of formula (Ia), formula (Ib), formula (Ic), formula (Id) and formula (Ie), from two of said formulas, from three of said formulas, from four of said formula or from all five of said formulas.


In further embodiments, the libraries of the present disclosure may comprise as few as two (2) to more than ten thousand (10,000) such macrocyclic compounds.


In another embodiment, A in formula (Ia), B in formula (Ib) and D in formula (Ic) are independently selected from the group consisting of:




embedded image




    • where (X) indicates the site of bonding to X3 of formula (Ia) for A, to X5 of formula (Ib) for B, and to X11 of formula (Ic) for D, and (C) indicates the site of bonding to CHR3 of formula (Ia) for A, to CHR8 of formula (Ib) for B and to CHR12 of formula (Ic) for D.





In an additional embodiment, Z1, Z3, Z5, Z7 and Z9 are independently selected from the group consisting of O and S; and Z2, Z4, Z6, Z8 and Z10 are CH.


In other embodiments, Z11, Z12, Z13, Z14, Z15, Z16, Z17, Z18, Z19, Z20, Z21 and Z22 are independently CR27 and R27 is selected from the group consisting of hydrogen or halogen.


In still a further embodiment, R1, R2, R4, R5, R6, R7, R9, R10, R11, R13, R14, R15, R16, R17, R18 and R19 are independently selected from the group consisting of:




embedded image




    • where (#) indicates the site of bonding of the group to the remainder of the structure.





In yet another embodiment, R3, R8 and R12 are independently selected from the group consisting of hydrogen, methyl or phenyl.


In more embodiments, X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12, X13, X14, X15, X16, X17, X18 and X19 are independently selected from selected from the group consisting of NH and NCH3.


In a further embodiment, X21, X22, X23, X24, X25 and X26 are independently selected from selected from the group consisting of CH2, CH2CH2, O, NH and NCH3.


In an additional embodiment, the library is comprised of macrocyclic compounds selected from those with structures 1-1334 as defined herein.


In yet an another embodiment, the library is comprised of macrocyclic compounds selected from those with structures 1335-1467 as defined herein.


In a preferred embodiment, the library can be synthesized as discrete individual macrocyclic compounds utilizing techniques as described herein.


In still another embodiment, the library is synthesized as mixtures of at least two macrocyclic compounds.


In further embodiments, the macrocyclic compounds in the library are provided as solids (powders, salts, crystals, amorphous material and so on), syrups or oils as they are obtained from the preparation methods described in the disclosure.


In a different embodiment, the macrocyclic compounds in the library are provided dissolved in an appropriate organic, aqueous or mixed solvent, solvent system or buffer.


In a preferred embodiment, the organic solvent used to dissolve the macrocyclic compounds in the library is DMSO. The resulting concentration of the compound in DMSO may be between 0.001 and 100 mM.


In an embodiment relating to the use of the libraries, the macrocyclic compounds are distributed into at least one multiple sample holder, such as a microtiter plate or a miniaturized chip. For most uses, this distribution is done in an array format compatible with the automated systems used in HTS.


In a related embodiment, this distribution may be done as single, discrete compounds in each sample of the at least one multiple sample holder or as mixtures in each sample of the at least one multiple sample holder.


In a further embodiment, at least one multiple sample holder is a microtiter plate containing 96, 384, 1536, 3456, 6144 or 9600 wells, which are the sizes typically used in HTS, although other numbers of wells may be utilized for specialized assays or equipment.


In another aspect, the disclosure relates to kits comprising a library of macrocyclic compounds as described herein and at least one multiple sample holder.


In an embodiment, the one multiple sample holder in the kit is a microtiter plate containing 96, 384, 1536, 3456, 6144 or 9600 wells or a miniaturized chip.


In other embodiments, the library in the kit is distributed as individual compounds in each sample of the at least one multiple sample holder or as more than one compound in each sample of the at least one multiple sample holder


In an additional aspect, the disclosure relates to macrocyclic compounds represented by formula (Ia), formula (Ib), formula (Ic), formula (Id) and formula (Ie) and salts thereof.


In a particular embodiment, macrocyclic compounds with structures 1-1334 as defined in the disclosure and their pharmaceutically acceptable salts are provided.


In another particular embodiment, macrocyclic compounds with structures 1335-1467 as defined in the disclosure and their pharmaceutically acceptable salts are provided.


In a further aspect, the disclosure relates to methods of using the libraries of macrocyclic compounds of formula (Ia), formula (Ib), formula (Ic), formula (Id) and formula (Ie) and their salts for the identification of specific compounds that modulate a biological target by contacting the compounds of the libraries with said target. This is most often done using HTS assays, but may also be done in low or medium throughput assays. The libraries of the disclosure may be tested in these assays in whole or in part and may be tested separately or at the same time as tests of other compounds and libraries.


In an embodiment, the biological target is selected from any known class of pharmacological targets, including enzymes, G protein-coupled receptors (GPCR), nuclear receptors, ion channels, transporters, transcription factors, protein-protein interactions and nucleic acid-protein interactions. Enzymes include, but are not limited to, proteases, kinases, esterases, amidases, dehydrogenases, endonucleases, hydrolases, lipases, phosphatases, convertases, synthetases and transferases. Since HTS assays have been developed for all of these target classes, the nature of the target is not a limiting factor in the use of the libraries of the present disclosure. Further, given this level of experience, it is within the scope of those skilled in the art to develop such assays for new targets that are identified and characterized for use in drug discovery programs.


In a further embodiment, the modulation in the method of using the libraries is agonism, antagonism, inverse agonism, activation, inhibition or partial variants of each of these types of activities as may be of interest depending on the specific target and the associated disease state.


In other embodiments, the modulation and biological target being investigated in the method of using the libraries may have relevance for the treatment and prevention of a broad range of medical conditions. As such, the libraries of the present disclosure have wide applicability to the discovery of new pharmaceutical agents.


In a further embodiment, there is provided the use of the libraries according to the present disclosure or at least one compound according the present disclosure for identification of compounds that modulate a biological target. For example, the identification is conducted in a high throughput fashion. For example, the biological target is an enzyme, a G protein-coupled receptor, a nuclear receptor, an ion channel, a transporter, a transcription factor, a protein-protein interaction or a nucleic acid-protein interaction. For example, the modulation is agonism, antagonism, activation, inhibition or inverse agonism.


In an additional aspect, the disclosure provides a process for preparing the macrocyclic compounds of formula (Ia), formula (Ib), formula (Ic), formula (Id) and formula (Ie) and libraries of such macrocyclic compounds.


In a particular embodiment, the process involves the following steps:

    • synthesis of the individual multifunctional, protected building blocks;
    • assembly of from three to six building blocks in a sequential manner with cycles of selective deprotection of a reactive functionality followed by attachment, wherein one of the building blocks contains an oxazole, thiazole or imidazole ring;
    • selective deprotection of two reactive functional groups of the assembled building block structure followed by cyclization;
    • removal of all remaining protecting groups from the cyclized products; and
    • optionally, purification.


In another embodiment applicable to libraries, the process further comprises distribution of the final macrocycle compounds into a format suitable for screening.


In an additional embodiment, one or more of the above steps are performed on the solid phase. In particular, the assembly of the building blocks is preferentially conducted on the solid phase.


In further embodiments, the attachment of each individual building block is performed using a reaction independently selected from amide bond formation, reductive amination, Mitsunobu reaction and its variants, such as the Fukuyama-Mitsunobu reaction, and nucleophilic substitution.


Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs.


The term “alkyl” refers to straight or branched chain saturated or partially unsaturated hydrocarbon groups having from 1 to 20 carbon atoms, in some instances 1 to 8 carbon atoms. Examples of alkyl groups include, but are not limited to, methyl, ethyl, isopropyl, tert-butyl, 3-hexenyl, and 2-butynyl. By “unsaturated” is meant the presence of 1, 2 or 3 double or triple bonds, or a combination of the two. Such alkyl groups may also be optionally substituted as described below.


When a subscript is used with reference to an alkyl or other hydrocarbon group defined herein, the subscript refers to the number of carbon atoms that the group may contain. For example, “C2-C4 alkyl” indicates an alkyl group with 2, 3 or 4 carbon atoms.


The term “cycloalkyl” refers to saturated or partially unsaturated cyclic hydrocarbon groups having from 3 to 15 carbon atoms in the ring, in some instances 3 to 7, and to alkyl groups containing said cyclic hydrocarbon groups. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclopropylmethyl, cyclopentyl, cyclohexyl, 2-(cyclohexyl)ethyl, cycloheptyl, and cyclohexenyl. Cycloalkyl as defined herein also includes groups with multiple carbon rings, each of which may be saturated or partially unsaturated, for example decalinyl, [2.2.1]-bicycloheptanyl or adamantanyl. All such cycloalkyl groups may also be optionally substituted as described below.


The term “aromatic” refers to an unsaturated cyclic hydrocarbon group having a conjugated pi electron system that contains 4n+2 electrons where n is an integer greater than or equal to 1. Aromatic molecules are typically stable and are depicted as a planar ring of atoms with resonance structures that consist of alternating double and single bonds, for example benzene or naphthalene.


The term “aryl” refers to an aromatic group in a single or fused carbocyclic ring system having from 6 to 15 ring atoms, in some instances 6 to 10, and to alkyl groups containing said aromatic groups. Examples of aryl groups include, but are not limited to, phenyl, 1-naphthyl, 2-naphthyl and benzyl. Aryl as defined herein also includes groups with multiple aryl rings which may be fused, as in naphthyl and anthracenyl, or unfused, as in biphenyl and terphenyl. Aryl also refers to bicyclic or tricyclic carbon rings, where one of the rings is aromatic and the others of which may be saturated, partially unsaturated or aromatic, for example, indanyl or tetrahydronaphthyl (tetralinyl). All such aryl groups may also be optionally substituted as described below.


The term “heterocycle” or “heterocyclic” refers to non-aromatic saturated or partially unsaturated rings or ring systems having from 3 to 15 atoms, in some instances 3 to 7, with at least one heteroatom in at least one of the rings, said heteroatom being selected from O, S or N. Each ring of the heterocyclic group can contain one or two O atoms, one or two S atoms, one to four N atoms, provided that the total number of heteroatoms in each ring is four or less and each ring contains at least one carbon atom. The fused rings completing the heterocyclic groups may contain only carbon atoms and may be saturated or partially unsaturated. The N and S atoms may optionally be oxidized and the N atoms may optionally be quaternized. Examples of non-aromatic heterocycle groups include, in a non-limitative manner, pyrrolidinyl, tetrahydrofuranyl, morpholinyl, thiomorpholinyl, piperidinyl, piperazinyl, thiazolidinyl, isothiazolidinyl, and imidazolidinyl. All such heterocyclic groups may also be optionally substituted as described below.


The term “heteroaryl” refers to an aromatic group in a single or fused ring system having from 5 to 15 ring atoms, in some instances 5 to 10, which have at least one heteroatom in at least one of the rings, said heteroatom being selected from O, S or N. Each ring of the heteroaryl group can contain one or two O atoms, one or two S atoms, one to four N atoms, provided that the total number of heteroatoms in each ring is four or less and each ring contains at least one carbon atom. The fused rings completing the bicyclic or tricyclic groups may contain only carbon atoms and may be saturated, partially unsaturated or aromatic. In structures where the lone pair of electrons of a nitrogen atom is not involved in completing the aromatic pi electron system, the N atoms may optionally be quaternized or oxidized to the N-oxide. Heteroaryl also refers to alkyl groups containing said cyclic groups. Examples of monocyclic heteroaryl groups include, but are not limited to pyrrolyl, pyrazolyl, pyrazolinyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, isothiazolyl, furanyl, thienyl, oxadiazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl. Examples of bicyclic heteroaryl groups include, but are not limited to indolyl, benzothiazolyl, benzoxazolyl, benzothienyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, benzopyranyl, indolizinyl, benzofuranyl, isobenzofuranyl, chromonyl, coumarinyl, benzopyranyl, cinnolinyl, quinoxalinyl, indazolyl, purinyl, pyrrolopyridinyl, furopyridinyl, thienopyridinyl, dihydroisoindolyl, and tetrahydroquinolinyl. Examples of tricyclic heteroaryl groups include, but are not limited to carbazolyl, benzindolyl, phenanthrollinyl, acridinyl, phenanthridinyl, and xanthenyl. All such heteroaryl groups may also be optionally substituted as described below.


The term “alkoxy” or “alkoxyl” refers to the group —ORa, wherein Ra is alkyl, cycloalkyl or heterocyclic. Examples include, but are not limited to methoxy, ethoxy, tert-butoxy, cyclohexyloxy and tetrahydropyranyloxy.


The term “aryloxy” refers to the group —ORb wherein Rb is aryl or heteroaryl. Examples include, but are not limited to phenoxy, benzyloxy and 2-naphthyloxy.


The term “acyl” refers to the group —C(═O)—Rc wherein Rc is alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl. Examples include, but are not limited to, acetyl, benzoyl and furoyl.


The term “amino acyl” indicates an acyl group that is derived from an amino acid as later defined.


The term “amino” refers to an —NRdRe group wherein Rd and Re are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclic, aryl and heteroaryl. Alternatively, Rd and Re together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The term “amido” refers to the group —C(═O)—NRfRg wherein Rf and Rg are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclic, aryl and heteroaryl. Alternatively, Rf and Rg together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The term “amidino” refers to the group —C(═NRh)NRiRj wherein Rh is selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclic, aryl and heteroaryl; and Ri and Rj are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclic, aryl and heteroaryl. Alternatively, Ri and Rj together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The term “carboxyalkyl” refers to the group —CO2Rk, wherein Rk is alkyl, cycloalkyl or heterocyclic.


The term “carboxyaryl” refers to the group —CO2Rm, wherein Rm is aryl or heteroaryl.


The term “oxo” refers to the bivalent group ═O, which is substituted in place of two hydrogen atoms on the same carbon to form a carbonyl group.


The term “mercapto” refers to the group —SRn wherein Rn is hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl.


The term “sulfinyl” refers to the group —S(═O)Rp wherein Rp is alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl.


The term “sulfonyl” refers to the group —S(═O)2—Rq1 wherein Rq1 is alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl.


The term “aminosulfonyl” refers to the group —NRq2—S(═O)2—Rq3 wherein Rq2 is hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl; and Rq3 is alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl.


The term “sulfonamido” refers to the group —S(═O)2—NRrRs wherein Rr and Rs are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl. Alternatively, Rr and Rs together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The term “carbamoyl” refers to a group of the formula —N(Rt)—C(═O)—ORu wherein Rt is selected from hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl; and Ru is selected from alkyl, cycloalkyl, heterocylic, aryl or heteroaryl.


The term “guanidino” refers to a group of the formula —N(Rv)—C(═NRw)—NRxRy wherein Rv, Rw, Rx and Ry are independently selected from hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl. Alternatively, Rx and Ry together form a heterocyclic ring or 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The term “ureido” refers to a group of the formula —N(Rz)—C(═O)—NRaaRbb wherein Rz, Raa and Rbb are independently selected from hydrogen, alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl. Alternatively, Raa and Rbb together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N.


The expression “optionally substituted” is intended to indicate that the specified group is unsubstituted or substituted by one or more suitable substituents, unless the optional substituents are expressly specified, in which case the term indicates that the group is unsubstituted or substituted with the specified substituents. As defined above, various groups may be unsubstituted or substituted (i.e., they are optionally substituted) unless indicated otherwise herein (e.g., by indicating that the specified group is unsubstituted).


The term “substituted” when used with the terms alkyl, cycloalkyl, heterocyclic, aryl and heteroaryl refers to an alkyl, cycloalkyl, heterocyclic, aryl or heteroaryl group having one or more of the hydrogen atoms of the group replaced by substituents independently selected from unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, halo, oxo, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino, ureido and groups of the formulas —NRccC(═O)Rdd, —NReeC(═NRff) Rgg, —OC(═O)NRhhRii, —OC(═O)Rjj, OC(═O)ORkk, —NRmmSO2Rnn, or —NRppSO2NRqqRrr wherein Roc, Rdd, Ree, Rff, Rgg, Rhh, Rii, Rjj, Rmm, Rpp, Rqq and Rrr are independently selected from hydrogen, unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl or unsubstituted heteroaryl; and wherein Rkk and Rnn are independently selected from unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl or unsubstituted heteroaryl. Alternatively, Rgg and Rhh, Rjj and Rkk or Rpp and Rqq together form a heterocyclic ring of 3 to 8 members, optionally substituted with unsubstituted alkyl, unsubstituted cycloalkyl, unsubstituted heterocyclic, unsubstituted aryl, unsubstituted heteroaryl, hydroxy, alkoxy, aryloxy, acyl, amino, amido, carboxy, carboxyalkyl, carboxyaryl, mercapto, sulfinyl, sulfonyl, sulfonamido, amidino, carbamoyl, guanidino or ureido, and optionally containing one to three additional heteroatoms selected from O, S or N. In addition, the term “substituted” for aryl and heteroaryl groups includes as an option having one of the hydrogen atoms of the group replaced by cyano, nitro or trifluoromethyl.


A substitution is made provided that any atom's normal valency is not exceeded and that the substitution results in a stable compound. Generally, when a substituted form of a group is present, such substituted group is preferably not further substituted or, if substituted, the substituent comprises only a limited number of substituted groups, in some instances 1, 2, 3 or 4 such substituents.


When any variable occurs more than one time in any constituent or in any formula herein, its definition on each occurrence is independent of its definition at every other occurrence. Also, combinations of substituents and/or variables are permissible only if such combinations result in stable compounds.


A “stable compound” or “stable structure” refers to a compound that is sufficiently robust to survive isolation to a useful degree of purity and formulation into an efficacious therapeutic agent.


The term “amino acid” refers to the common natural (genetically encoded) or synthetic amino acids and common derivatives thereof, known to those skilled in the art. When applied to amino acids, “standard” or “proteinogenic” refers to the genetically encoded 20 amino acids in their natural configuration. Similarly, when applied to amino acids, “non-standard,” “unnatural” or “unusual” refers to the wide selection of non-natural, rare or synthetic amino acids such as those described by Hunt, S. in Chemistry and Biochemistry of the Amino Acids, Barrett, G. C., ed., Chapman and Hall: New York, 1985.


The term “amino acid side chain” refers to any side chain from a standard or unnatural amino acid, and is denoted RAA. For example, the side chain of alanine is methyl, the side chain of valine is isopropyl and the side chain of tryptophan is 3 indolylmethyl.


The term “activator” refers to a compound that increases the normal activity of a protein, receptor, enzyme, interaction, or the like.


The term “agonist” refers to a compound that duplicates at least some of the effect of the endogenous ligand of a protein, receptor, enzyme, interaction, or the like.


The term “antagonist” refers to a compound that reduces at least some of the effect of the endogenous ligand of a protein, receptor, enzyme, interaction, or the like.


The term “inhibitor” refers to a compound that reduces the normal activity of a protein, receptor, enzyme, interaction, or the like.


The term “inverse agonist” refers to a compound that reduces the activity of a constitutively-active receptor below its basal level.


The term “library” refers to a collection of chemical compounds.


The term “modulator” refers to a compound that imparts an effect on a biological or chemical process or mechanism. For example, a modulator may increase, facilitate, upregulate, activate, inhibit, decrease, block, prevent, delay, desensitize, deactivate, down regulate, or the like, a biological or chemical process or mechanism. Accordingly, a modulator can be an “agonist” or an “antagonist.” Exemplary biological processes or mechanisms affected by a modulator include, but are not limited to, enzyme binding, receptor binding and hormone release or secretion. Exemplary chemical processes or mechanisms affected by a modulator include, but are not limited to, catalysis and hydrolysis.


The term “peptide” refers to a chemical compound comprising at least two amino acids covalently bonded together using amide bonds.


The term “peptidomimetic” refers to a chemical compound designed to mimic a peptide, but which contains structural differences through the addition or replacement of one of more functional groups of the peptide in order to modulate its activity or other properties, such as solubility, metabolic stability, oral bioavailability, lipophilicity, permeability, etc. This can include replacement of the peptide bond, side chain modifications, truncations, additions of functional groups, etc. When the chemical structure is not derived from the peptide, but mimics its activity, it is often referred to as a “non-peptide peptidomimetic.”


The term “peptide bond” refers to the amide [—C(═O)—NH—] functionality with which individual amino acids are typically covalently bonded to each other in a peptide.


The term “protecting group” refers to any chemical compound that may be used to prevent a potentially reactive functional group, such as an amine, a hydroxyl or a carboxyl, on a molecule from undergoing a chemical reaction while chemical change occurs elsewhere in the molecule. A number of such protecting groups are known to those skilled in the art and examples can be found in Protective Groups in Organic Synthesis, T. W. Greene and P. G. Wuts, eds., John Wiley & Sons, New York, 4th edition, 2006, 1082 pp, ISBN 9780471697541. Examples of amino protecting groups include, but are not limited to, phthalimido, trichloroacetyl, benzyloxycarbonyl, tert butoxycarbonyl, and adamantyl-oxycarbonyl. In some embodiments, amino protecting groups are carbamate amino protecting groups, which are defined as an amino protecting group that when bound to an amino group forms a carbamate. In other embodiments, amino carbamate protecting groups are allyloxycarbonyl (Alloc), benzyloxycarbonyl (Cbz), 9 fluorenylmethoxycarbonyl (Fmoc), tert-butoxycarbonyl (Boc) and α,α dimethyl-3,5 dimethoxybenzyloxycarbonyl (Ddz). For a recent discussion of newer nitrogen protecting groups see: Tetrahedron 2000, 56, 2339-2358. Examples of hydroxyl protecting groups include, but are not limited to, acetyl, tert-butyldimethylsilyl (TBDMS), trityl (Trt), tert-butyl, and tetrahydropyranyl (THP). Examples of carboxyl protecting groups include, but are not limited to, methyl ester, tert-butyl ester, benzyl ester, trimethylsilylethyl ester, and 2,2,2-trichloroethyl ester. A protecting group is herein designated as PG, with a subscript if more than one is present in the same molecule.


The term “solid phase chemistry” refers to the conduct of chemical reactions where one component of the reaction is covalently bonded to a polymeric material (solid support as defined below). Reaction methods for performing chemistry on solid phase have become more widely known and established outside the traditional fields of peptide and oligonucleotide chemistry (Solid-Phase Synthesis: A Practical Guide, F. Albericio, ed., CRC Press, 2000, 848 pp, ISBN: 978-0824703592; Organic Synthesis on Solid Phase, 2nd edition, Florencio Zaragoza Dorwald, Wiley-VCH, 2002, 530 pp, ISBN: 3-527-30603-X; Solid-Phase Organic Synthesis: Concepts, Strategies, and Applications, P. H. Toy, Y. Lam, eds., Wiley, 2012, 568 pp, ISBN: 978-0470599143).


The term “solid support,” “solid phase” or “resin” refers to a mechanically and chemically stable polymeric matrix utilized to conduct solid phase chemistry. This is denoted by “Resin,” “P—” or the following symbol:




embedded image


Examples of appropriate polymer materials include, but are not limited to, polystyrene, polyethylene, polyethylene glycol (PEG, including, but not limited to, ChemMatrix® (Matrix Innovation, Quebec, Quebec, Canada; J. Comb. Chem. 2006, 8, 213-220)), polyethylene glycol grafted or covalently bonded to polystyrene (also termed PEG-polystyrene, TentaGel™, Rapp, W.; Zhang, L.; Bayer, E. In Innovations and Perspectives in Solid Phase Synthesis. Peptides, Polypeptides and Oligonucleotides; Epton, R., ed.; SPCC Ltd.: Birmingham, UK; p 205), polyacrylate (CLEAR™), polyacrylamide, polyurethane, PEGA [polyethyleneglycol poly(N,N dimethyl-acrylamide) co-polymer, Tetrahedron Lett. 1992, 33, 3077-3080], cellulose, etc. These materials can optionally contain additional chemical agents to form cross-linked bonds to mechanically stabilize the structure, for example polystyrene cross-linked with divinylbenezene (DVB, usually 0.1-5%, preferably 0.5-2%). This solid support can include as non-limiting examples aminomethyl polystyrene, hydroxymethyl polystyrene, benzhydrylamine polystyrene (BHA), methylbenzhydrylamine (MBHA) polystyrene, and other polymeric backbones containing free chemical functional groups, most typically, NH2 or —OH, for further derivatization or reaction. The term is also meant to include “Ultraresins” with a high proportion (“loading”) of these functional groups such as those prepared from polyethyleneimines and cross-linking molecules (J. Comb. Chem. 2004, 6, 340-349). At the conclusion of the synthesis, resins are typically discarded, although they have been shown to be able to be recycled (Tetrahedron Lett. 1975, 16, 3055).


In general, the materials used as resins are insoluble polymers, but certain polymers have differential solubility depending on solvent and can also be employed for solid phase chemistry. For example, polyethylene glycol can be utilized in this manner since it is soluble in many organic solvents in which chemical reactions can be conducted, but it is insoluble in others, such as diethyl ether. Hence, reactions can be conducted homogeneously in solution, then the product on the polymer precipitated through the addition of diethyl ether and processed as a solid. This has been termed “liquid-phase” chemistry.


The term “linker” when used in reference to solid phase chemistry refers to a chemical group that is bonded covalently to a solid support and is attached between the support and the substrate typically in order to permit the release (cleavage) of the substrate from the solid support. However, it can also be used to impart stability to the bond to the solid support or merely as a spacer element. Many solid supports are available commercially with linkers already attached.


Abbreviations used for amino acids and designation of peptides follow the rules of the IUPAC-IUB Commission of Biochemical Nomenclature in J. Biol. Chem. 1972, 247, 977-983. This document has been updated: Biochem. J., 1984, 219, 345-373; Eur. J. Biochem., 1984, 138, 9-37; 1985, 152, 1; Int. J. Pept. Prot. Res., 1984, 24, following p 84; J. Biol. Chem., 1985, 260, 14-42; Pure Appl. Chem. 1984, 56, 595-624; Amino Acids and Peptides, 1985, 16, 387-410; and in Biochemical Nomenclature and Related Documents, 2nd edition, Portland Press, 1992, pp 39-67. Extensions to the rules were published in the JCBN/NC-IUB Newsletter 1985, 1986, 1989; see Biochemical Nomenclature and Related Documents, 2nd edition, Portland Press, 1992, pp 68-69.


The expression “compound(s) and/or composition(s) of the present disclosure” as used in the present document refers to compounds of formulas (Ia), (Ib), (Ic), (Id) and (Ie) presented in the disclosure, isomers thereof, such as stereoisomers (for example, enantiomers, diastereoisomers, including racemic mixtures) or tautomers, or to pharmaceutically acceptable salts, solvates, hydrates and/or prodrugs of these compounds, isomers of these latter compounds, or racemic mixtures of these latter compounds, and/or to composition(s) made with such compound(s) as previously indicated in the present disclosure. The expression “compound(s) of the present disclosure” also refers to mixtures of the various compounds or variants mentioned in the present paragraph.


It is to be clear that the present disclosure includes isomers, racemic mixtures, pharmaceutically acceptable salts, solvates, hydrates and prodrugs of compounds described therein and mixtures comprising at least two of such entities.


The macrocyclic compounds comprising the libraries of the disclosure may have at least one asymmetric center. Where the compounds according to the present document possess more than one asymmetric center, they may exist as diastereomers. It is to be understood that all such isomers and mixtures thereof in any proportion are encompassed within the scope of the present disclosure. It is to be understood that while the stereochemistry of the compounds of the present disclosure may be as provided for in any given compound listed herein, such compounds of the disclosure may also contain certain amounts (for example less than 30%, less than 20%, less than 10%, or less than 5%) of compounds of the present disclosure having alternate stereochemistry.


The expression “pharmaceutically acceptable” means compatible with the treatment of subjects such as animals or humans.


The expression “pharmaceutically acceptable salt” means an acid addition salt or basic addition salt which is suitable for or compatible with the treatment of subjects such as animals or humans.


The expression “pharmaceutically acceptable acid addition salt” as used herein means any non-toxic organic or inorganic salt of any compound of the present disclosure, or any of its intermediates. Illustrative inorganic acids which form suitable salts include hydrochloric, hydrobromic, sulfuric and phosphoric acids, as well as metal salts such as sodium monohydrogen orthophosphate and potassium hydrogen sulfate. Illustrative organic acids that form suitable salts include mono-, di-, and tricarboxylic acids such as glycolic, lactic, pyruvic, malonic, succinic, glutaric, fumaric, malic, tartaric, citric, ascorbic, maleic, benzoic, phenylacetic, cinnamic and salicylic acids, as well as sulfonic acids such as p-toluenesulfonic and methanesulfonic acids. Either the mono or di-acid salts can be formed, and such salts may exist in either a hydrated, solvated or substantially anhydrous form. In general, the acid addition salts of the compounds of the present disclosure are more soluble in water and various hydrophilic organic solvents, and generally demonstrate higher melting points in comparison to their free base forms. The selection of the appropriate salt will be known to one skilled in the art. Other non-pharmaceutically acceptable salts, e.g. oxalates, may be used, for example, in the isolation of the compounds of the present disclosure, for laboratory use, or for subsequent conversion to a pharmaceutically acceptable acid addition salt.


The term “pharmaceutically acceptable basic addition salt” as used herein means any non-toxic organic or inorganic base addition salt of any acid compound of the disclosure, or any of its intermediates. Acidic compounds of the disclosure that may form a basic addition salt include, for example, where CO2H is a functional group. Illustrative inorganic bases which form suitable salts include lithium, sodium, potassium, calcium, magnesium or barium hydroxide. Illustrative organic bases which form suitable salts include aliphatic, alicyclic or aromatic organic amines such as methylamine, trimethylamine and picoline or ammonia. The selection of the appropriate salt will be known to a person skilled in the art. Other non-pharmaceutically acceptable basic addition salts, may be used, for example, in the isolation of the compounds of the disclosure, for laboratory use, or for subsequent conversion to a pharmaceutically acceptable acid addition salt.


The formation of a desired compound salt is achieved using standard techniques. For example, the neutral compound is treated with an acid or base in a suitable solvent and the formed salt is isolated by filtration, extraction or any other suitable method.


The formation of a desired compound salt is achieved using standard techniques. For example, the neutral compound is treated with an acid or base in a suitable solvent and the formed salt is isolated by filtration, extraction or any other suitable method.


The term “solvate” as used herein means a compound of the present disclosure, wherein molecules of a suitable solvent are incorporated in the crystal lattice. A suitable solvent is physiologically tolerable at the dosage administered. Examples of suitable solvents are ethanol, water and the like. When water is the solvent, the molecule is referred to as a “hydrate”. The formation of solvates of the compounds of the present disclosure will vary depending on the compound and the solvate. In general, solvates are formed by dissolving the compound in the appropriate solvent and isolating the solvate by cooling or using an antisolvent. The solvate is typically dried or azeotroped under ambient conditions.


The terms “appropriate” and “suitable” mean that the selection of the particular group or conditions would depend on the specific synthetic manipulation to be performed and the identity of the molecule but the selection would be well within the skill of a person trained in the art. All process steps described herein are to be conducted under conditions suitable to provide the product shown. A person skilled in the art would understand that all reaction conditions, including, for example, reaction solvent, reaction time, reaction temperature, reaction pressure, reactant ratio and whether or not the reaction should be performed under an anhydrous or inert atmosphere, can be varied to optimize the yield of the desired product and it is within their skill to do so.


28 Compounds of the present disclosure include prodrugs. In general, such prodrugs will be functional derivatives of these compounds which are readily convertible in vivo into the compound from which it is notionally derived. Prodrugs of the compounds of the present disclosure may be conventional esters formed with available hydroxy, or amino group. For example, an available OH or nitrogen in a compound of the present disclosure may be acylated using an activated acid in the presence of a base, and optionally, in inert solvent (e.g. an acid chloride in pyridine). Some common esters which have been utilized as prodrugs are phenyl esters, aliphatic (C8-C24) esters, acyloxymethyl esters, carbamates and amino acid esters. In certain instances, the prodrugs of the compounds of the present disclosure are those in which one or more of the hydroxy groups in the compounds is masked as groups which can be converted to hydroxy groups in vivo. Conventional procedures for the selection and preparation of suitable prodrugs are described, for example, in “Design of Prodrugs” ed. H. Bundgaard, Elsevier, 1985.


Compounds of the present disclosure include radiolabeled forms, for example, compounds labeled by incorporation within the structure 2H, 3H, 14C, 15N, or a radioactive halogen such as 125I. A radiolabeled compound of the compounds of the present disclosure may be prepared using standard methods known in the art.


The term “subject” as used herein includes all members of the animal kingdom including human.


The expression a “therapeutically effective amount”, “effective amount” or a “sufficient amount” of a compound or composition of the present disclosure is a quantity sufficient to, when administered to the subject, including a mammal, for example a human, effect beneficial or desired results, including clinical results, and, as such, an “effective amount” or synonym thereto depends upon the context in which it is being applied. For example, in the context of treating cancer, for example, it is an amount of the compound or composition sufficient to achieve such treatment of the cancer as compared to the response obtained without administration of the compound or composition. The amount of a given compound or composition of the present disclosure that will correspond to an effective amount will vary depending upon various factors, such as the given drug or compound, the pharmaceutical formulation, the route of administration, the type of disease or disorder, the identity of the subject or host being treated, and the like, but can nevertheless be routinely determined by one skilled in the art. Also, as used herein, a “therapeutically effective amount”, “effective amount” or a “sufficient amount” of a compound or composition of the present disclosure is an amount which inhibits, suppresses or reduces a cancer (e.g., as determined by clinical symptoms or the amount of cancerous cells) in a subject as compared to a control.


As used herein, and as well understood in the art, “treatment” or “treating” is an approach for obtaining beneficial or desired results, including clinical results. Beneficial or desired clinical results can include, but are not limited to, alleviation or amelioration of one or more symptoms or conditions, diminishment of extent of disease, stabilized (i.e. not worsening) state of disease, preventing spread of disease, delay or slowing of disease progression, amelioration or palliation of the disease state, and remission (whether partial or total), whether detectable or undetectable. “Treatment” or “treating” can also mean prolonging survival as compared to expected survival if not receiving treatment.


“Palliating” a disease or disorder, means that the extent and/or undesirable clinical manifestations of a disorder or a disease state are lessened and/or time course of the progression is slowed or lengthened, as compared to not treating the disorder.


The expression “derivative thereof” as used herein when referring to a compound means a derivative of the compound that has a similar reactivity and that could be used as an alternative to the compound in order to obtain the same desired result.


In understanding the scope of the present disclosure, the term “comprising” and its derivatives, as used herein, are intended to be open ended terms that specify the presence of the stated features, elements, components, groups, integers, and/or steps, but do not exclude the presence of other unstated features, elements, components, groups, integers and/or steps. The foregoing also applies to words having similar meanings such as the terms, “including”, “having” and their derivatives. Finally, terms of degree such as “substantially”, “about” and “approximately” as used herein mean a reasonable amount of deviation of the modified term such that the end result is not significantly changed. These terms of degree should be construed as including a deviation of at least ±5% of the modified term if this deviation would not negate the meaning of the word it modifies.


Further features and advantages of the macrocyclic compounds and libraries of the present disclosure will become more readily apparent from the following description of synthetic methods, analytical procedures and methods of use.


1. Synthetic Methods


A. General Synthetic Information


37 Reagents and solvents were of reagent quality or better and were used as obtained from various commercial suppliers unless otherwise noted. For certain reagents, a source may be indicated if the number of suppliers is limited. Solvents, such as DMF, DCM, DME and THF, are of DriSolv®, OmniSolv® (EMD Millipore, Darmstadt, Germany), or an equivalent synthesis grade quality except for (i) deprotection, (ii) resin capping reactions and (iii) washing. NMP used for coupling reactions is of analytical grade. DMF was adequately degassed by placing under vacuum for a minimum of 30 min prior to use. Ether refers to diethyl ether. Amino acids, Boc-, Fmoc- and Alloc-protected and side chain-protected derivatives, including those of N-methyl and unnatural amino acids, were obtained from commercial suppliers, including AAPPTec (Louisville, Ky., USA), Advanced ChemTech (part of CreoSalus, Louisville, Ky.), AstaTech (Bristol, Pa., USA), Bachem (Bubendorf, Switzerland), Chem-Impex International (Wood Dale, Ill., USA), Iris Biotech (Marktredwitz, Germany), Novabiochem (EMD Millipore), PepTech (Bedford, Mass., USA), or synthesized through standard methodologies known to those in the art. Amino alcohols were obtained commercially or synthesized from the corresponding amino acids or amino esters using established procedures from the literature (for example Tet. Lett. 1992, 33, 5517-5518; J. Org. Chem. 1993, 58, 3568-3571; Lett. Pept. Sci. 2003, 10, 79-82; Ind. J. Chem. 2006, 45B, 1880-1886; Synth. Comm. 2011, 41, 1276-1281). Hydroxy acids were obtained from commercial suppliers or synthesized from the corresponding amino acids as described in the literature (Tetrahedron 1989, 45, 1639-1646; Tetrahedron 1990, 46, 6623-6632; J. Org. Chem. 1992, 57, 6239-6256; J. Am. Chem. Soc. 1999, 121, 6197-6205; Org. Lett. 2004, 6, 497-500; Chem. Comm. 2015, 51, 2828-2831). The synthesis of thiazole, imidazole and oxazole-containing amino acids are carried out as described in the literature (J. Pept. Sci. 1999, 5, 392-398; Org. Lett. 2006, 8, 2417-2420; ACS Comb. Sci. 2014, 16, 1-4; ACS Comb. Sci. 2014, 16, 39-45) and in Examples 1I, 1M, 1N, 1O, 1P and 1Q. Resins for solid phase synthesis were obtained from commercial suppliers, including AAPTech, Novabiochem and Rapp Polymere (Tubingen, Germany). Analytical TLC was performed on pre-coated plates of silica gel, for example 60F254 (0.25 mm thickness) containing a fluorescent indicator.


NMR spectra were recorded on a Bruker 400 MHz or 500 MHz spectrometer and are referenced internally with respect to the residual proton signals of the solvent. Additional structural information or insight about the conformation of the molecules in solution can be obtained utilizing appropriate two-dimensional NMR techniques known to those skilled in the art.


HPLC analyses were performed on a Waters Alliance system running at 1 mL/min using a Zorbax SB-C18 (4.6 mm×30 mm, 2.5 μm), an Xterra MS C18 column (4.6 mm×50 mm, 3.5 μm), or comparable. A Waters 996 PDA provided UV data for purity assessment. Data was captured and processed utilizing the instrument software package. MS spectra were recorded on a Waters ZQ or Platform II system.


Preparative HPLC purifications were performed on deprotected macrocycles using the following instrumentation configuration (or comparable): Waters 2767 Sample Manager, Waters 2545 Binary Gradient Module, Waters 515 HPLC Pumps (2), Waters Flow Splitter, 30-100 mL, 5000:1, Waters 2996 Photodiode Detector, Waters Micromass ZQ., on an Atlantis Prep C18 OBD (19×100 mm, 5 μm), an XTerra MS C18 column (19×100 mm, 5 μm). The mass spectrometer, HPLC, and mass-directed fraction collection are controlled via MassLynx software version 4.0 with FractionLynx. Fractions shown by MS analysis to contain the desired pure product were evaporated under reduced pressure, usually on a centrifugal evaporator system [Genevac (SP Scientific), SpeedVac™ (Thermo Scientific, Savant) or comparable] or, alternatively, lyophilized. Compounds were then analyzed by LC-MS-UV analysis for purity assessment and identity confirmation. Automated medium pressure chromatographic purifications were performed on a Biotage Isolera system with disposable silica or C18 cartridges. Solid phase extraction was performed utilizing PoraPak™ (Sigma-Aldrich (Supelco), St. Louis, Mo., USA), SiliaSep™, SiliaPrep™ and SiliaPrepX™ (SiliCycle, Quebec, Quebec, Canada) or comparable columns, cartridges, plates or media as appropriate for the compound being purified.


The expression “concentrated/evaporated/removed under reduced pressure or in vacuo” indicates evaporation utilizing a rotary evaporator under either water aspirator pressure or the stronger vacuum provided by a mechanical oil vacuum pump as appropriate for the solvent being removed or, for multiple samples simultaneously, evaporation of solvent utilizing a centrifugal evaporator system. “Flash chromatography” refers to the method described as such in the literature (J. Org. Chem. 1978, 43, 2923.) and is applied to chromatography on silica gel (230-400 mesh, EMD Millipore or equivalent) used to remove impurities, some of which may be close in Rf to the desired material.


The majority of the synthetic procedures described herein are for the solid phase (i.e. on resin), since this is more appropriate for creating the libraries of the present disclosure, but it will be appreciated by those in the art that these same transformations can also be modified to be applicable to traditional solution phase processes as well. The major modifications are the substitution of a standard aqueous organic work-up process for the successive resin washing steps and the use of lower equivalents for reagents versus the solid phase.


The following synthetic methods will be referenced elsewhere in the disclosure by using the number 1 followed by the letter referring to the method or procedure, i.e. Method 1F for Fmoc deprotection.


B. General Methods for Synthesis of Libraries of Macrocyclic Compounds


Different synthetic strategies, including solution and solid phase techniques, are employed to prepare the libraries of macrocyclic compounds of the disclosure. An outline of the general strategy for the synthesis of the libraries of compounds of the disclosure is provided in Scheme 1. It will be appreciated by those skilled in the art that for the synthesis of larger libraries, the use of solid phase procedures typically will be preferable and more efficient. Further, the macrocyclic compounds can be made in mixtures or as discrete compounds. In either case, the utilization of specific strategies for tracking the synthesis can be advantageous, such as the use of tagging methodologies (i.e. radiofrequency, color-coding or specific chemical functionality, for a review, see J. Receptor Signal Transduction Res. 2001, 21, 409-445) and sequestration of resin containing a single compound using a polypropylene mesh “tea” bag (Proc. Natl. Acad. Sci. USA 1985, 82, 5131-5135) or flow-through capsule (MiniKan™, Biotechnol. Bioengineer. 2000, 71, 44-50), which permit the simultaneous transformation of multiple different individual compounds in the same reaction vessel. For mixtures, such tags can also be effectively used to facilitate “deconvolution” or the identification of the active structure(s) from a mixture that was found to be a hit during screening.


The construction of the macrocyclic compounds of the library involves the following phases: (i) synthesis of the individual multifunctional, appropriately protected, building blocks, including elements for interaction at biological targets and fragments for control and definition of conformation, as well as moieties that can perform both functions; (ii) assembly of the building blocks, typically in a sequential manner with cycles of selective deprotection and attachment, although this step could also be performed in a convergent manner, utilizing standard chemical transformations as well as those described in more detail in the General/Standard Procedures and Examples herein, such as amide bond formation, reductive amination, Mitsunobu reaction and its variants, and nucleophilic substitution reactions; (iii) selective deprotection of two functional groups followed by cyclization of the assembled linear compounds, which can involve one or more steps, to form the macrocyclic structures; (iv) optionally, selective removal of one or more protecting groups can be performed, then the macrocycle further reacted with one or more additional building blocks to extend the structure at the unprotected functional group(s); and (v) removal of all remaining protecting groups, if necessary, and, optionally, purification to provide the desired final macrocycles.


The assembly reactions require protection of functional groups to avoid side reactions. Even though amino acids are only one of the types of building blocks employed, the well-established strategies of peptide chemistry have utility for the macrocyclic compounds and libraries of the disclosure as well (Meth. Mol. Biol. 2005, 298, 3-24). In particular, these include the Fmoc/tBu strategy (Int. J. Pept. Prot. Res. 1990, 35, 161-214) and the Boc/Bzl strategy (Meth. Mol. Biol. 2013, 1047, 65-80), although those in the art will appreciate that other orthogonal strategies may be necessary, for example the use of allyl-based protecting groups, to enable selective reaction at a particular site in multi-functional building blocks.


For solid phase processes, the cyclization can be conducted with the linear precursor on the resin after the two reacting groups are selectively deprotected and the appropriate reagents for cyclization added. This is followed by cleavage from the resin, which may also cleave the side chain protecting groups with the use of appropriate conditions. However, it is also possible to cyclize concomitant with resin cleavage if a special linker that facilitates this so-called “cyclization-release” process (Comb. Chem. HTS 1998, 1, 185-214) is utilized. Alternatively, the assembled linear precursor can be cleaved from the resin and then cyclized in solution. This requires the use of a resin that permits removal of the bound substrate without concomitant protecting group deprotection. For Fmoc strategies, 2-chlorotrityl resin (Tetrahedron Lett. 1989, 30, 3943-3946; Tetrahedron Lett. 1989, 30, 3947-3950) and derivatives are effective for this purpose, while for Boc approaches, an oxime resin has been similarly utilized (J. Org. Chem. 1980, 45, 1295-1300). Alternatively, a resin can be used that is specially activated for facile cleavage only after precursor assembly, but is otherwise quite stable, termed a “safety-catch” linker or resin (Bioorg. Med. Chem. 2005, 13, 585-599). For cyclization in solution phase, the assembled linear precursor is selectively deprotected at the two reacting functional groups, then subjected to appropriate reaction conditions for cyclization.


Upon isolation and characterization, the library compounds can be stored individually in the form thus obtained (solids, syrups, liquids) or dissolved in an appropriate solvent, for example DMSO. If in solution, the compounds can also be distributed into an appropriate array format for ease of use in automated screening assays, such as in microplates or on miniaturized chips. Prior to use, the library compounds, as either solids or solutions, are typically stored at low temperature to ensure the integrity of the compounds is maintained over time. As an example, libraries are stored at or below −70° C. as 10 mM solutions in 100% DMSO, allowed to warm to ambient temperature and diluted with buffer, first to a working stock solution, then further to appropriate test concentrations for use in HTS or other assays.


C. General Methods for Solid Phase Chemistry


These methods can be equally well applied for the combinatorial synthesis of mixtures of compounds or the parallel synthesis of multiple individual compounds to provide the libraries of macrocyclic compounds of the present disclosure. In the event of combinatorial synthesis of mixtures, it is necessary to include some type of encoding or tracking mechanism in order to deconvolute the data obtained from HTS of the libraries so that the identity of the active compound obtained can be ascertained (Curr. Opin. Biotechnol. 1995, 6, 632-639; Curr. Opin. Drug Discov. Develop. 2002, 5, 580-593; Curr. Opin. Chem. Biol. 2003, 7, 374-379).


For solid phase chemistry, the solvent choice is important not just to solubilize reactants as in solution chemistry, but also to swell the resin to be able to access all the reactive sites thereon. Certain solvents interact differently with the polymer matrix depending on its nature and can affect this swelling property. As an example, polystyrene (with DVB cross-links) swells best in nonpolar solvents such as DCM and toluene, while shrinking when exposed to polar solvents like alcohols. In contrast, other resins such as PEG (for example, ChemMatrix) and PEG-grafted ones (for example, TentaGel), maintain their swelling even in polar solvents. For the reactions of the present disclosure, appropriate choices can be made by one skilled in the art. In general, polystyrene-DVB resins are employed with DMF, DCM and NMP common solvents. The volume of the reaction solvent required is generally 3-5 mL per 100 mg resin. When the term “appropriate amount of solvent” is used in the synthesis methods, it refers to this quantity. The recommended quantity of solvent roughly amounts to a 0.2 M solution of building blocks (amino acids, hydroxy acids, amino alcohols, diacids, diamines, and derivatives thereof, typically used at 5 eq relative to the initial loading of the resin). Reaction stoichiometry was determined based upon the “loading” (represents the number of active functional sites, provided by the supplier, typically as mmol/g) of the starting resin.


The reaction can be conducted in any appropriate vessel, for example round bottom flasks, solid phase reaction vessels equipped with a fritted filter and stopcock, or Teflon-capped jars. The vessel size should be such that there is adequate space for the solvent, and that there is sufficient room for the resin to be effectively agitated taking into account that certain resins can swell significantly when treated with organic solvents. The solvent/resin mixture should fill about 60% of the vessel. Agitations for solid phase chemistry could be performed manually or with an orbital shaker (for example, Thermo Scientific, Forma Models 416 or 430) at 150-200 rpm, except for those reactions where scale makes use of mild mechanical stirring more suitable to ensure adequate mixing, a factor which is generally accepted as important for a successful reaction on resin.


The volume of solvent used for the resin wash is a minimum of the same volume as used for the reaction, although more is generally used to ensure complete removal of excess reagents and other soluble residual by-products (minimally 0.05 mL/mg resin). Each of the resin washes specified in the General/Standard Procedures and Examples should be performed for a duration of at least 5 min with agitation (unless otherwise specified) in the order listed. The number of washings is denoted by “nx” together with the solvent or solution, where n is an integer. In the case of mixed solvent washing systems, they are listed together and denoted solvent 1/solvent 2. After washing, the expression “dried in the usual manner” and analogous expressions mean that the resin is dried first in a stream of air or nitrogen for 20 min-1 h, using the latter if there is concern over oxidation of the substrate on the resin, and subsequently under vacuum (oil pump usually) until full dryness is attained (minimum 2 h to overnight (o/n)).


The general and specific synthetic methods and procedures utilized for representative macrocyclic compounds disclosed and utilized herein are presented below. Although the methods described may indicate a specific protecting group, other suitable protection known in the art may also be employed.


D. General Procedure for Loading of First Building Block to Resin


Certain resins can be obtained with the first building block, in particular amino acid building blocks, already attached. For other cases on the solid support, the building blocks can be attached using methods known in the art. As an example, the following procedure is followed for 2-chlorotrityl chloride resin.


Prewash the resin with DCM (2×), then dry in the usual manner. In a suitable reaction vessel, dissolve Fmoc-BB1 (2 eq) in DCM (0.04 mL/mg resin) and add DIPEA (4 eq.), agitate briefly, then add the resin. Agitate o/n on an orbital shaker, remove the solvent, wash with DMF (2×), then, cap any remaining reactive sites using MeOH/DIPEA/DCM (2:1:17) (3×). The resin is then washed sequentially with DCM (1×), IPrOH (1×), DCM (2×), ether (1×), then dried in the usual manner.


In the case of solution phase chemistry, the first building block is typically used as a suitably protected derivative with one functional group free for subsequent reaction.


E. Standard Procedure for Monitoring the Progress of Reactions on the Solid Phase


Since methods usually employed for monitoring reaction progress (TLC, direct GC or HPLC) are not available for solid phase reactions, it is necessary to perform the following in order to determine the progress of such a transformation. A small amount of resin (a few beads is usually sufficient) is removed from the reaction vessel, then washed successively with DMF (2×), iPrOH (1×), DCM (2×), ether (1×), dried, then treated with 200 μL 20% hexafluoroisopropanol (HFIP)/DCM, for 10-20 min, and concentrated with a stream of air or nitrogen. To the crude residue obtained, add 200-400 μL MeOH (or use DMSO or THF to solubilize fully protected intermediate compounds), filter through a 45 μm HPLC filter, or a plug of cotton, and analyze the filtrate by HPLC or HPLC-MS.


F. General Procedure for Fmoc Deprotection


In an appropriate vessel, a solution of 20% piperidine (Pip) in DMF (0.04 mL/mg resin) was prepared. The resin was added to the solution and the mixture agitated for 30 min. The reaction solution was removed, then this treatment repeated. After this, the resin was washed sequentially with: DMF (2×), iPrOH (1×), DMF (1×), iPrOH (1×), DCM (2×), ether (1×), then the resin dried in the usual manner.


Note that when N-alkylated-amino acids are present in the BB1 position, to minimize the potential of diketopiperazine formation, 50% Pip/DMF is used for Fmoc-deprotection of BB2 and the procedure modified as follows: Add the solution to the resin and agitate for only 5-7 min, remove the solvent, add DMF, agitate quickly and remove the solvent, then resume the remaining washes as described above.


G General Procedure for Attachment of Amines to Acids


To an appropriate reaction vessel, add the acid building block (2.5-3.5 eq), coupling agent (2.5-3.5 eq) and NMP (0.04 mL/mg resin), followed by DIPEA (5-7 eq). Agitate the mixture vigorously for a few seconds and then add the amine-containing resin. Alternatively, separately prepare a solution of the coupling agent (3.5 eq) in NMP, then add this solution to the acid building block (2.5-3.5 eq) and agitate vigorously. Add DIPEA (5-7 eq), agitate a few seconds, then add the resin. HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) and DEPBT (3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one) are the typical coupling agents employed, although many other suitable ones are known and could also be utilized (Chem. Rev. 2011, 111, 6557-6602). Agitate the reaction mixture o/n, remove the solution and, if deprotection will be done immediately, wash the resin sequentially with: DMF (2×), iPrOH (1×), DMF (2×), then dry. If deprotection will not be performed immediately, wash sequentially with DMF (2×); iPrOH (1×); DMF (1×); iPrOH (1×), DCM (2×), ether (1×), then dry in the usual manner.


For attachment of BB3 and beyond, utilize 5 eq of acid building block and coupling agent with 10 eq of DIPEA. If the acid building block is one known to require repeated treatment for optimal results, for example N-alkylated and other hindered amino acids, use half of the indicated equivalents for each of the two treatments.


Although the above describes the amine on resin and the acid as the new building block added, it will be appreciated by those in the art that the reverse can also be performed in a similar manner, with the acid component on the solid phase and the amine being the added component.


In addition to the use of acids as building blocks, it is also possible to utilize Fmoc acid fluorides (formed from the acid using cyanuric fluoride, J. Am. Chem. Soc. 1990, 112, 9651-9652) and Fmoc acid chlorides (formed from the acid using triphosgene, J. Org. Chem. 1986, 51, 3732-3734) as alternatives for particularly difficult attachments.


H General Procedure for Oxidation of Alcohol Building Blocks to Aldehydes.


A number of different oxidation methods can be utilized to convert alcohols to aldehydes for use in the attachment of building blocks by reductive amination. The following lists the most appropriate methods for the compounds of the present disclosure, and the types of building blocks on which they are applied,

  • 1) MnO2 oxidation (see Example 1L for additional details) used for benzylic aldehydes.
  • 2) Swern oxidation (DMSO, oxalyl chloride) used for both benzylic and alkyl aldehydes. (Synthesis 1981, 165-185)




embedded image


  • 3) Pyridine.SO3 (see Example 1K for additional details) used for both benzylic and alkyl aldehydes.

  • 4) Dess-Martin Periodinane (DMP, 1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one) used for alkyl aldehydes (J. Am. Chem. Soc., 1991, 113, 7277-7287)





embedded image


The following are structures of representative aldehyde building blocks of the present disclosure formed by oxidation of the corresponding alcohols or prepared as described in the Examples.




embedded image


embedded image


The products are characterized by 1H NMR (using the aldehyde CHO as a diagnostic tool) and LC-MS.


I. General Procedure for Attachment of Building Blocks by Reductive Amination Using BAP


The N-protected aldehyde (1.5 eq) was dissolved in MeOH/DCM/TMOF (trimethyl orthoformate) (2:1:1) or MeOH/TMOF (3:1) (0.04 mL/mg resin) and the resulting solution added to the resin and agitated for 0.5-1 h. If solubility is a problem, THF can be substituted for DCM in the first solvent mixture. Add borane-pyridine complex (BAP, 3 eq) and agitate for 15 min, then carefully release built-up pressure and continue agitation o/n. If the reaction is not complete, add more BAP (2 eq) and agitate again o/n. After removal of the solvent, the resin was washed sequentially with DMF (2×), THF (1×), iPrOH (1×), DCM (1×), THF/MeOH (3:1, 1×), DCM/MeOH (3:1, 1×), DCM (2×), ether (1×), then dried in the usual manner.


For alkyl aldehydes, the quantity of reactants can be adjusted slightly to 1.4-1.5 eq of aldehyde and 2-3 eq of BAP in MeOH/DCM/TMOF (2:1:1). However, note that the reaction often does require up to 3 eq of reducing agent to go to completion with hindered amines. For benzylic aldehydes, add 3 eq of BAP in a mixture of 3:1 of MeOH/TMOF. If the reaction is not complete, add another 2 eq of BAP and agitate again o/n. Certain amino acids, such as Gly, undergo double alkylation easily (for such cases use Nos-Gly and attach the building block using Method 1L), while hindered amino acids such as Aib do not proceed to completion. In the latter instance, monitor reaction closely before proceeding to Fmoc deprotection and, if not complete, perform a second treatment.


J. General Procedure for Attachment of Building Blocks by Reductive Amination Using Sodium Triacetoxyborohydride


As an alternative method, found particularly useful for benzylic aldehydes, sodium triacetoxyborohydride can be employed in the reductive amination process as follows. Dissolve 1.5-3 eq of the aldehyde in DCM (0.4 mL/mg resin), add the amine-containing resin, then agitate for 2 h. To the mixture, add NaBH(OAc)3 (4-5 eq) and agitate o/n. Once the reaction is complete, remove the solvent, then wash the resin sequentially with DMF (2×), THF (1×), iPrOH (1×), DCM (1×), THF/MeOH (3:1, 1×), DCM/MeOH (3:1, 1×), DCM (2×), ether (1×) and dry in the usual manner. Please note that if the reductive amination is not complete, such as is often encountered with Pro or N-alkyl amino acids, additional aldehyde must be included as part of the second treatment.


K. General Procedure for Attachment of Building Blocks by Reductive Amination Using Sequential Sodium Cyanoborohydride and BAP Treatment


For certain benzylic aldehydes, a sequential Borch and BAP reduction process can be beneficial as described in the following. In the first step, the Fmoc-protected aldehyde (3 eq) in NMP/TMOF (1:1) containing 0.5% glacial acetic acid) (0.4 mL/mg resin) is added to the resin in an appropriate reaction vessel and agitate for 30 min. To the mixture, add NaBH3CN (10 eq), agitate for 10 min, then release pressure and continue agitation o/n. Remove the solvent and wash the resin sequentially with: DMF (2×), iPrOH (1×), DMF (1×), iPrOH (1×), DCM (2×), ether (1×). If in-process QC (Method 1E) shows incomplete reaction, proceed to suspend the resin in MeOH/DCM/TMOF (2:1:1), add BAP (2-3 eq) and agitate for 4 h. Remove the solvent and wash the resin sequentially with: DMF (2×), THF (1×), iPrOH (1×), DCM (1×), THF/MeOH (3:1, 1×), DCM/MeOH (3:1, 1×), DCM (2×), ether (1×), then dry in the usual manner. For building blocks containing a pyridine moiety, use MeOH/DCM (1:1), no TMOF, for the second treatment.


Reductive amination conditions and reagents for representative building blocks are as follows:













Aldehyde Building



Block(s)
Conditions and reagents







PG-S30
3 eq aldehyde, MeOH/DCM/TMOF 2:1:1, 3 eq



BAP


PG-S31, PG-S32
2-3 eq aldehyde, MeOH/DCM/TMOF 2:1:1, 3


and any amino
eq BAP


aldehyde derived


from an amino acid


PG-S37
1.5-2 eq aldehyde NaBH(OAc)3/DCM


PG-S38
1.5 eq aldehyde, MeOH/TMOF 3:1, 3 eq BAP,



followed by NaBH(OAc)3, or NaBH(OAc)3/DCM


PG-S43
1.5 eq aldehyde, MeOH/DCM/TMOF 2:1:1, 2



eq BAP


PG-S46
1.5 eq aldehyde, MeOH/TMOF 3:1, 3 eq. BAP



or NaBH(OAc)3


PG-S49
1.5 eq aldehyde, MeOH/DCM/TMOF 2:1:1, 2



eq BAP


Pyridine-containing
3 eq aldehyde, MeOH/DCM/TMOF (2:1:1), 2-3


building blocks
eq BAP









Although the above procedures for reductive amination describe the amine being the resin component and the aldehyde as the new building block added, it will be appreciated by those in the art that the reverse can also be performed in a similar manner, with the aldehyde component on the solid phase and the amine being the added component.


L. Standard Procedure for Building Block Attachment Using Mitsunobu Reaction.


Step 1L-1. Prepare a solution of HATU (5 eq), or other appropriate coupling agent, in NMP (0.04 mL/mg resin), monitoring the pH and adjusting to maintain around pH 8, then add to the nosyl-containing building block (5 eq, see Method 1M below) and agitate vigorously. To this solution, add DIPEA (10 eq), agitate briefly, then add to resin and agitate o/n. Use 50% of the indicated quantities if a repeat treatment is planned or anticipated. Upon completion, if the next step will be conducted immediately, wash the resin sequentially with DMF (2×), i-PrOH (1×), DMF (2×), then proceed. Otherwise, wash with DMF (2×); i-PrOH (1×); DMF (1×); DCM (2×), the last wash cycle can be alternatively done as DCM (1×), ether (1×), then dry the resin in the usual manner.


Step 1L-2.


Dissolve the reactant hydroxy component (alcohol, phenol) (5 eq) in THF (0.04 mL/mg resin, 0.2 M) and add PPh3-DIAD adduct (5 eq, see Method 10 below) and very briefly agitate (10-15 sec). Alternatively, prepare a solution of PPh3 (5 eq) and alcohol (5 eq) in THF, cool to 0° C. and add DIAD (5 eq) dropwise. Stir for 15 min at 0° C., add nosyl-containing resin and agitate o/n. Filter the resin and wash sequentially with: THF (2×), toluene (1×), EtOH (1×), toluene (1×), THF (1×), iPrOH (1×), THF (1×), THF/MeOH (3:1, 1×), DCM/MeOH (3:1, 1×), DCM (2×), then dry the resin in the usual manner. Note that the order of addition is important for best results.


The Mitsunobu reaction is used preferentially to attach the following building blocks (note that some may require a second treatment): PG-S7, PG-S8, PG-S9, PG-S10, PG-S13, PG-S15.


The above procedure describes the building block being attached as its 2-nitrobenzenesulfonyl-derivative (Nos, nosyl) and then Fukuyama-Mitsunobu reaction conditions (Tet. Lett. 1995, 36, 6373-6374) used for attachment of the next building block. However, the building block can also be attached as its Fmoc, Boc or other N-protected derivative. In those cases, that protection must first be removed using the appropriate method, then the nosyl group installed and the alkyation executed as described in Method 1P below. Other sulfonamides containing electron-withdrawing substituents can also be utilized for this transformation, including, but not limited to, the 4-nitro-benzenesulfonyl, 2,4-dinitrobenzenesulfonyl (Tet. Lett. 1997, 38, 5831-5834) and Bts (benzothiazolylsulfonyl) (J. Am. Chem. Soc. 1996, 118, 9796-9797; Bioorg. Med. Chem. Lett. 2008, 18, 4731-4735) groups.


Further, although the above procedure describes the nosylated amine being on the resin and the hydroxy/phenol-containing component being present on the new building block added, it will be appreciated by those in the art that the reverse arrangement can also be utilized in an analogous manner, with the hydroxy/phenol-containing component on the solid phase and the nosylated amine being present on the added building block.


M. Standard Procedure for Nosyl Protection.


The amine substrate was added to a solution of 2-nitro-benzenesulfonyl chloride (Nos-Cl, 4 eq) and 2,4,6-collidine (10 eq) in NMP (0.04 mL/mg resin), then the reaction agitate for 1-2 h. The solution was removed and the resin washed sequentially with: DMF (2×), iPrOH (1×), DMF (1×), iPrOH (1×), DMF (2×), iPrOH (1×), DCM (2×), ether (1×). For protection of primary amines, Nos-Cl (1 eq) and 2,4,6-collidine (2.5 eq) in NMP (0.04 mL/mg resin) were used with agitation for 30-45 min. With more hindered amines, a second treatment might be required.


N. Standard Procedure for Nosyl Deprotection


A solution of 2-mercaptoethanol (10 eq), DBU (1,8-diaza-bicyclo[5.4.0.]undec-7-ene, 5 eq) in NMP (0.04 mL/mg resin) was prepared and added to the resin, then the mixture agitated for 8-15 min. The longer reaction time will be required for more hindered substrates. The resin was filtered and washed with NMP, then the treatment repeated. The resin was again filtered and washed sequentially with: DMF (2×), iPrOH (1×), DMF (1×), iPrOH (1×), DMF (1×), DCM (1×), iPrOH (1×), DCM (2×), ether (1×).


O. Standard Procedure for the Synthesis of PPh3-DIAD Adduct.


This reagent was prepared in a manner essentially as described in WO 2004/111077. In a round bottom flask under nitrogen, DIAD (1 eq) was added dropwise to a solution of PPh3 (1 eq) in THF (0.4 M) at 0° C., then the reaction stirred for 30 min at that temperature. The solid precipitate was collected on a medium porosity glass-fritted filter, wash the solid with cold THF (DriSolv grade or equivalent) to remove any color, then with anhydrous ether. The resulting white powder was dried under vacuum and stored under nitrogen in the freezer. It is removed shortly before an intended use.


P. Standard Procedure for N-Alkylation




embedded image


If the building block is attached as its Fmoc (depicted), Boc or other N-protected derivative, first remove that protection using the appropriate deprotection method, and execute installation of the nosyl group using Method 1M. With the Nos group in place, use the procedure of Step 1K-2 above to alkylate the nitrogen under Fukuyama-Mitsunobu conditions (Tet. Lett. 1995, 36, 6373-6374). The nosyl group is then removed using Method 1N, then the next building block is added or, if the building block assembly is concluded, the precursor is cleaved from the resin (or the appropriate functionality on the first building block is deprotected if solution phase) and subjected to the macrocyclization reaction (Method 1R).


As an example utilized in the disclosure, certain N-methyl amino acids are not available commercially, while others are difficult to access or expensive. However, this procedure, using methanol (MeOH) as the alcohol components permits the installation of an N-methyl group on a nitrogen prior to its reaction with another building block.


Q. General Procedure for Cleavage from 2-Chlorotrityl Resin.


Add a solution of 20% HFIP (hexafluoro-2-propanol) in DCM (0.03 mL/mg resin) to the resin and agitate for 2 h. Filter the resin and wash it with 20% HFIP in DCM (0.01 mL/mg resin, 2×) and DCM (0.01 mL/mg resin, 1×). The filtrate is evaporated to dryness under vacuum.


R. General Procedure for Macrocyclization.


A solution of DEPBT (1.0-1.2 eq) and DIPEA (2.0-2.4 eq) in 25% NMP/THF (0.03 mL/mg original resin) is prepared and added to the residue from the previous step. In certain cases where compounds may be poorly soluble, dissolve the residue first in NMP, then add DEPBT and DIPEA in THF to the solution. The crude reaction mixture is filtered through one or more solid phase extraction (SPE) cartridges (for example PoraPak, PS-Trisamine, Si-Triamine, Si-Carbonate), then further purified by flash chromatography or preparative HPLC.


S. Standard Procedures for Final Protecting Group Deprotection


The method of deprotection depends on the nature of the protecting groups on the side chains of the macrocycle(s) being deprotected using the following guidelines.

  • 1) For removal of Boc and tBu groups only, the following mixtures are utilized: 50% TFA/3% triisopropylsilane (TIPS)/47% DCM or 50% TFA/45% DCM/5% H2O (2 mL/cpd), agitate for 2 h, then concentrate in vacuo. For building blocks containing a double bond, 50% TFA/45% DCM/5% H2O should be used as the cleavage solution to avoid reduction of the alkene.
  • 2) For removal of tBu esters/ethers and trityl groups, utilize 75% TFA/22% DCM/3% TIPS (2 mL/cpd), agitate for 2 h, then concentrate in vacuo. Alternatively, 75% 4N HCl/dioxane/20% DCM/5% H2O mixture can be employed, which works particularly well to ensure complete Ser(But) deprotection. Also, if the macrocycle does not contain Thr, Ser, His, Asn or Gin building block components, 75% TFA/20% DCM/5% H2O (2 mL/cpd) can be used as an alternative cleavage mixture.
  • 3) For removal of Pbf groups, use a mixture of 91% TFA/2% DCM/5% H2O/2% TIPS (2 mL/cpd), agitate for 2 h protected from ambient light, then concentrate in vacuo.
  • 4) Triethylsilane (TES) can also be used for the above deprotection procedures in place of TIPS, but should not be used with compounds containing Trp as it can reduce the indole moiety.


    T. Standard Procedure for Reactions of Side Chain Functionalities on Solid Phase


Using orthogonal protecting groups on side chains permits selective deprotection and reaction of the liberated group(s) in order to further diversify the library of macrocyclic compounds. Representative groups that can be derivatized with one or more of the procedures below are amines, alcohols, phenols and acids. This is typically performed while the structure is still bound to the resin and prior to cyclization. The following are representative types of transformations that have been performed:


1) With Acid Chlorides


Prepare a solution of acid chloride (3.5 eq) in THF, 2,4,6-collidine (5 eq) and add the substrate on resin, agitate at rt o/n. The reaction mixture becomes milky after about 5 min. After o/n, remove the solution and wash the resin with: DMF (2×), DCM (1×), iPrOH (1×), DMF (1×), DCM (2×), ether (1×), then dry in the usual manner.


2) With Sulfonyl Chlorides


Add the sulfonyl chloride (4 eq for aryl sulfonyl chlorides and 8 eq for alkyl sulfonyl chlorides) to the suspension of the resin and collidine (2.5× sulfonyl chloride eq) in NMP, then agitate for 1-2 h. Remove the solution, wash the resin sequentially with DMF (2×), iPrOH (1×), DMF (1×), DCM (2×), ether (1×), then dry the resin in the usual manner.


3) With Carboxylic Acids


To a solution of carboxylic acid (5 eq), DIPEA (10 eq), HATU (5 eq) in NMP, add the resin and agitate o/n. Remove the solution, wash the resin sequentially with DMF (2×), iPrOH (1×), DMF (1×), DCM (2×), ether (1×), then dry the resin in the usual manner.


4) Reductive Amination


The standard procedures (Methods 1I, 1J and 1K) described above are employed for reductive amination, except only 1 eq of the aldehyde is used to avoid double alkylation side products.


5) With Amines


Prepare a solution of 6-Cl-HOBt (1 eq), EDAC (3-(((ethylimino)-methylene)amino)-N,N-dimethylpropan-1-amine hydrochloride, 5 eq.), and DIPEA (1 eq) in NMP. Add the resin and agitate for 15 min. To this is added the amine (5 eq) and the reaction mixture agitated o/n. Remove the solutions and wash the resin sequentially with DMF (2×); iPrOH (1×); DMF (1×); DCM (2×), ether (1×), then dry in the usual manner.


U. Standard Procedure for Boc Protection


Di-tert-butyl dicarbonate (5 eq) was added to the amine substrate on resin and triethylamine (5 eq) in DCM (0.04 mL/mg resin), then the mixture agitated for 4 h. The solvent was removed and the resin washed sequentially with DMF (2×), iPrOH (1×), DMF (1×), DCM (2×), ether (1×), then dried the resin in the usual manner. An analogous method can be utilized in solution phase.


V. Standard Procedure for Boc Deprotection


The Boc-containing substrate on resin was treated with 25% TFA in DCM (0.04 mL/mg resin) and agitated for 30 min. The resin was washed sequentially with DMF (2×); iPrOH (1×); DMF (1×); DCM (2×), ether (1×), then dried in the usual manner.


W. Standard Procedures for Alloc Deprotection


Suspend the resin in DCM and bubble nitrogen gas through the mixture for 10 min, then add phenylsilane (PhSiH3) (10-24 eq) and bubble nitrogen through the suspension again for 5 min. Add Pd(PPh3)4 (0.1 eq) and maintain the nitrogen flow for a further 5 min, then agitate the reaction for 4 h protected from light. Remove the solvent and wash the resin sequentially with: DMF (2×), iPrOH (1×), DCM (1×), DMF (1×), 0.5% sodium diethylthiocarbamate in DMF (3×), DMF (1×), iPrOH (1×), DMF (1×), DCM (2×), ether (1×), then dry in the usual manner.


X. Standard Procedure for Ally Ester Deprotection


Bubble nitrogen through the resin in DCM for 5 min, then evacuate and flush with nitrogen (3×) and bubble nitrogen through for a further 5 min. Add phenylsilane (10-24 eq), bubble nitrogen for 5 min, then add Pd(PPh3)4 (0.1 eq) and keep bubbling nitrogen through for a further 5 min. Close the reaction vessel, and agitate for 5 h protected from light. Remove the solution and wash the resin sequentially with: DMF (2×); iPrOH (1×); DCM (1×); DMF (1×); 0.5% sodium diethylthiocarbamate in DMF (3×); DMF (1×); iPrOH (1×); DMF (1×); DCM (2×); ether (1×) and dry in the usual manner.


Y. Standard Procedure for Ally Ether Deprotection


Bubble nitrogen through the resin in DCM for 5 min, then evacuate and flush with nitrogen (3×) and bubble nitrogen through for a further 5 min. Add phenylsilane (24 eq), bubble nitrogen for 5 min, then add Pd(PPh3)4 (0.10-0.25 eq) and keep bubbling nitrogen through for a further 5 min, close the reaction vessel and agitate at rt for 16 h (o/n) protected from light. Remove the solution and wash the resin sequentially with: DMF (2×); iPrOH (1×); DCM (1×); DMF (1×); 0.5% sodium diethylthiocarbamate in DMF (3×); DMF (1×); iPrOH (1×); DMF (1×); DCM (2×); ether (1×), then dry in the usual manner.


2. Analytical Methods


The following methods for qualitative and quantitative analysis and characterization of the macrocyclic compounds comprising the libraries of the disclosure are routinely performed both for monitoring reaction progress as well as to assess the final products obtained. These analytical methods will be referenced elsewhere in the disclosure by using the number 2 followed by the letter referring to the method or procedure, i.e. Method 2B for preparative purification.


A. Standard HPLC Methods for Purity Analysis


Column: Zorbax SB-C18, 4.6 mm×30 mm, 2.5 μm


Solvent A: Water+0.1% TFA


Solvent B: CH3CN+0.1% TFA


UV Monitoring at λ=220, 254, 280 nm


Gradient Method A1


















Time (min)
Flow (mL/min)
% A
% B





















0
2
95
5



2.3
2
0
100



2.32
2
0
100



4
2
0
100










Gradient Method A2


















Time (min)
Flow (mL/min)
% A
% B





















0
2
95
5



0.5
2
95
5



5
2
0
100



7
2
0
100










The following methods are employed for preparative HPLC purification of the macrocyclic compounds comprising the libraries of the disclosure.


B. Standard HPLC Methods for Preparative Purification


Column: Atlantis Prep C18 OBD, 19 mm×100 mm, 5 μm


Solvent A: Aqueous Buffer (10 mM ammonium formate, pH 4)


Solvent B: MeOH


Gradient Method P1
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
89
11



2
30
89
11
6


8
30
2
98
6


9.7
30
2
98
6


10
30
50
50
6









Gradient Method P2
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
80
20



2
30
80
20
6


8
30
2
98
6


9.7
30
2
98
6


10
30
50
50
6









Gradient Method P3
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
70
30



2
30
70
30
6


8
30
2
98
6


9.7
30
2
98
6


10
30
50
50
6









Gradient Method P4
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
60
40



2
30
60
40
6


8
30
2
98
6


9.7
30
2
98
6


10
30
50
50
6









Gradient Method P5
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
89
11



2
30
89
11
6


12
30
2
98
6


14.7
30
2
98
6


15
30
70
30
6









Gradient Method P6
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
80
20



2
30
80
20
6


12
30
2
98
6


14.7
30
2
98
6


15
30
70
30
6









Gradient Method P7
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
89
11



2
30
89
11
6


11.7
30
2
98
6


12
30
89
11
6









Gradient Method P8
















Time (min)
Flow (mL/min)
% A
% B
Curve



















0
30
89
11



3
30
89
11
6


11.7
30
2
98
6


12
30
89
11
6











    • Typically, methods P5, P6, P7 and P8 are used if a sample requires additional purification after the initial purification run.

    • Note that lower flow rates (i.e. 20-25 mL/min) can be utilized with concomitant lengthening of the gradient run time.

    • The use of ammonium formate buffer results in the macrocyclic compounds, typically, being obtained as their formate salt forms.


      3. Methods of Use





The libraries of macrocyclic compounds of the present disclosure are useful for application in high throughput screening (HTS) on a wide variety of targets of therapeutic interest. The design and development of appropriate HTS assays for known, as well as newly identified, targets is a process well-established in the art (Methods Mol. Biol. 2009, 565, 1-32; Mol. Biotechnol. 2011, 47, 270-285) and such assays have been found to be applicable to the interrogation of targets from any pharmacological target class. These include G protein-coupled receptors (GPCR), nuclear receptors, enzymes, ion channels, transporters, protein-protein interactions and nucleic acid-protein interactions. Methods for HTS of these target classes are known to those skilled in the art (High Throughput Screening in Drug Discovery, J. Hüser, ed., Wiley-VCH, 2006, pp 343, ISBN 978-3-52731-283-2; High Throughput Screening: Methods and Protocols, 2nd edition, W. P. Janzen, P. Bernasconi, eds., Springer, 2009, pp 268, ISBN: 978-1-60327-257-5; Cell-Based Assays for High-Throughput Screening: Methods and Protocols, P. A. Clemons, N. J. Tolliday, B. K. Wagner, eds., Springer, 2009, pp 211, ISBN 978-1-60327-545-3). These methods can be utilized to identify modulators of any type, including agonists, activators, inhibitors, antagonists, and inverse agonists. The Examples describe representative HTS assays in which libraries of the present disclosure are useful. The targets include an enzyme, a G protein-coupled receptor and a protein-protein interaction. Prior to use, the libraries are typically stored at or below −70° C. as 10 mM stock solutions in 100% DMSO, then diluted to an appropriate test concentration, for example 10 μM in buffer.


The libraries of compounds of the present disclosure are thus used as research tools for the identification of bioactive hits from HTS that in turn serve to initiate drug discovery efforts directed towards new therapeutic agents for the prevention and treatment of a range of medical conditions. As used herein, “treatment” is not necessarily meant to imply cure or complete abolition of the disorder or symptoms associated therewith.


Further embodiments of the present disclosure will now be described with reference to the following Examples. It should be appreciated that these Examples are for the purposes of illustrating embodiments of the present disclosure, and do not limit the scope of the disclosure.


Example 1
Preparation of Building Blocks

Protected building blocks S1, S2, S3, S4, S5, S6, S7 and S8 were prepared by N-protection of the readily commercially available materials 2-aminoethanol, 2-methylaminoethanol, L-alaninol, L-leucinol, 3-aminopropan-1-ol, 4-aminobutan-1-ol, 5-aminopentan-1-ol, 6-aminohexan-1-ol, respectively, with methods and conditions known to those in the art, for example Boc2O and K2CO3 for N-Boc derivatives, and Fmoc-OSu (as shown in Example 1A) or Fmoc-Cl and base for N-Fmoc derivatives. Similarly, protected derivatives of S9, S11, S12, S13, S14, S15, S16, S23, S24 and S28 can be prepared directly from the commercially available starting materials indicated:

  • S9: 2-(2-aminoethoxy)ethanol (Alfa Aesar (Ward Hill, Mass.), Cat. No. L18897);
  • S11: 3-(Hydroxymethyl)azetidine (SynQuest Laboratories (Alachua, Fla.), Cat. No. 4H56-1-NX);
  • S12: 4-piperidinyl-methanol (Alfa Aesar Cat. No. 17964);
  • S13: [2-(Aminomethyl)phenyl]methanol (Ark Pharm (Libertyville, Ill.) Cat. No. AK138281, as HCl salt);
  • S14: [3-(Aminomethyl)phenyl]methanol (Combi-Blocks (San Diego, Calif.) Cat. No. QB-3285);
  • S15: 2-(2-aminoethyl)benzoic acid (Ark Pharm Cat. No. AK100976);
  • S16: 3-(2-aminoethyl)benzoic acid (Ark Pharm Cat. No. AK100975);
  • S23: 2-[2-(aminomethyl)phenylthio]benzyl alcohol (Aldrich (Milwaukee, Wis.), Cat. No. 346314);
  • S24: cis-4-aminocyclohexyl methanol (Enamine (Monmouth Junction, N.J.), Cat. No. EN300-105832);
  • S28: trans-4-aminocyclohexyl methanol (Enamine), Cat. No. EN300-106767);


Building blocks S10 and S21 were synthesized as described in the literature (J. Med. Chem. 2006, 49, 7190-7197, Supplementary Information; compounds 4g and 4b, respectively).


Structures of representative amino alcohol building blocks of the present disclosure, presented as their N-protected derivatives, the usual species utilized, are:




embedded image


embedded image


embedded image



A. Representative Procedure for Fmoc Protection




embedded image


Fmoc-OSu (38.6 g, 115 mmol) was added to a solution of [3-(amino-methyl)phenyl]methanol (S14) (16.5 g, 121 mmol) in THF (150 mL), water (75 mL) and sodium bicarbonate (20.3 g, 241 mmol) at room temperature (rt) and the reaction stirred overnight (o/n). At that point, a small sample was diluted with MeOH, acidified with a drop of HOAc, and analyzed by LC-MS, which showed the desired product with no Fmoc-OSu reagent. The reaction was acidified with 1M HCl, diluted with ethyl acetate (EtOAc), and stirred for 2 h. The white solid was filtered off, washed well with water, then EtOAc, and air dried for 3 h until a constant weight was attained. The product thus obtained, Fmoc-S14 (15.3 g), was found by LC-MS to be free of identifiable organic impurities. The aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with H2O (2×) and brine, then dried over anhydrous MgSO4. The dessicant was removed by filtration and the filtrate concentrated under reduced pressure to give additional amounts of the desired product as a white solid (34.1 g). The combined solids were triturated with ethyl acetate at reflux for a few minutes, then o/n at rt to give Fmoc-S14 in 88% yield (38.1 g).


B. Alternative Procedure for the Synthesis of Building Block S14




embedded image


Conversion of 3-bromobenzaldehyde (14-1) to the nitrile was accomplished through nucleophilic aromatic substitution with copper(I) cyanide. Subsequent reduction of both the carbonyl and nitrile with lithium aluminum hydride (LAH) provided the amino alcohol after appropriate work-up, which was then protected with Fmoc using standard conditions (Example 1A). The corresponding Boc derivative is accessed by substituting Boc2O and K2CO3 in the last step.


C. Standard Procedure for the Synthesis of Building Blocks S15 and S16




embedded image


Analogous procedures are utilized to access protected derivatives of S15 and S16 starting, respectively, from 2-(2-aminoethyl)benzoic acid (15-1, Ark Pharm, Cat. No. AK-32693) and 3-(2-aminoethyl)benzoic acid (16-1, Ark Pharm, Cat. No. AK-34290). The amine is protected with Boc (Method 1U) or Fmoc (Method 1W, Example 1A) in the standard manner to provide 15-2 and 16-2. The acid was then reduced to the alcohol through the mixed anhydride (see Example 1I) to yield PG-S15 and PG-S16.


D. Standard Procedure for the Synthesis of Protected Building Blocks S17 and S19




embedded image


An identical strategy is employed for the preparation of the protected building blocks of S17 and S19. The former begins from 2-(2-aminomethyl)-phenol (Combi-Blocks Cat. No. A-3525, as HCl salt), while the latter proceeds from 2-(2-aminoethyl)phenol (Ark Pharm Cat. No. 114741). The amine of each is protected with Boc in the usual manner (Boc2O, Na2CO3) to give 17-1 and 19-1, respectively. For each, the free phenol is then derivatized using a Mitsunobu reaction with triphenylphosphine and diisopropylazodicarboxylate (DIAD) along with the mono-t-butyldimethylsilyl (TBDMS) ether of ethylene glycol (17-A), followed by removal of the silyl protecting group with tetrabutylammonium fluoride (TBAF, 1 M in THF) to give Boc-S17 and Boc-S19. These can be converted into the corresponding Fmoc analogues through the deprotection-protection sequence shown.


As an alternative approach to these two molecules, the phenol can be alkylated via a substitution reaction utilizing base (for example K2CO3, NaH) and a suitable derivative of 17-A containing a leaving group (i.e. halide, mesylate, tosylate, triflate) in place of the hydroxyl, which can be prepared from 17-A using procedures known to those in the art.


E. Standard Procedure for the Synthesis of Protected Building Blocks S18 and S20




embedded image


An essentially identical strategy is utilized for the synthesis of the protected building blocks S18 and S20. The former starts from methyl salicylate (18-1), while the latter initiates from methyl 2-(2-hydroxyphenyl)acetate (20-1, Ark Pharm Cat. No. AK-76378). Reaction of the phenol of these two materials with Boc-2-aminoethanol (Boc-S1) under Mitsunobu conditions gives 18-2 and 20-2, respectively. Reduction of the ester group with diisobutylaluminum hydride (DIBAL) provides the Boc-protected target compounds. Conversion of the protecting group from Boc to Fmoc can be effected as already described to give Fmoc-S17 and Fmoc-S19.


F. Standard Procedure for the Synthesis of Building Block S22 and S27




embedded image


The two phenols of catechol (22-1) or resorcinol (27-1) were sequentially reacted under Mitsunobu conditions, first with 1 eq of the mono-protected diol 17-A, followed by 1 eq of an appropriate N-protected-2-amino-ethanol (PG-S1). Material that does not react fully can be extracted with aqueous base (hence, the PG chosen must be compatible with such conditions). Standard deprotection of the silyl ether with 1 M TBAF in THF provides PG-S22 and PG-S27. The N-protecting group can be interchanged as already described if necessary.


G. Standard Procedure for the Synthesis of Building Block S25




embedded image


To a solution of 3-hydroxybenzaldehyde (25-1, 100 mg, 0.819 mmol), Ph3P (215 mg, 0.819 mmol) and Fmoc-3-amino-1-propanol (Fmoc-S5, 256 mg, 0.860 mmol) in THF (30 mL) at rt was added dropwise DIAD (0.159 mL, 0.819 mmol). The mixture was stirred at rt for 2 d, then evaporated in vacuo and the residue purified by flash chromatography (hexanes:EtOAc: 95:5 to 50:50 over 14 min). Product-containing fractions were concentrated under reduced pressure to leave the desired coupled product, Fmoc-S45, as a white solid, 1H NMR and MS consistent with structure. Reduction of the aldehyde with sodium borohydride under standard conditions provided Fmoc-S25.


H. Standard Procedure for the Synthesis of Building Block S26




embedded image


In a manner analogous to that described above for PG-S22 and PG-S27, the two phenol moieties of 4-fluoro-catechol (26-1, Fluorochem Cat. No. 306910) were sequentially reacted under Mitsunobu conditions, first with 17-A, then with PG-S1. Although the initial conversion is regioselective for the phenol para to the fluorine substituent, the first reaction uses only a single equivalent of 17-A to minimize formation of side products. Standard deprotection of the silyl ether with 1 M TBAF in THF provides PG-S26.


I. Standard Procedure for the Synthesis of Oxazole Amino Acids




embedded image


The synthetic approach followed that described in the literature by Nefzi (ACS Comb. Sci. 2014, 16, 39-45) and shown above for a generic oxazole amino acid. Standard coupling of the Boc-protected amino acid I-1 with L-serine methyl ester provided the dipeptide (I-2). Cyclization to form the oxazole (I-3) was effected using the two step literature method through the intermediate oxazoline (Org. Lett. 2000, 2, 1165-1168). Subsequent cleavage of the methyl ester and acidification provided the oxazole amino acid (I-4). The Boc derivatives thus obtained could be converted to the corresponding Fmoc derivatives (I-5) using standard transformations. Representative compounds prepared using this methodology are shown below along with the overall yields from I-1 to I-5. 1H NMR and LC-MS were consistent with the indicated structures.




embedded image


An improved procedure (Org. Proc. Res. Develop. 2009, 13, 310-314) has been applied to the first step with better yields for certain derivatives as described for a representative amino acid substrate.




embedded image


To a solution of Boc-Ala (6 g, 31.7 mmol), H-Ser-OMe.HCl (5.08 g, 32.7 mmol), and 6-Cl-HOBt (1.613 g, 9.51 mmol) in EtOH (81 mL) was added DIPEA (11.60 ml, 66.6 mmol) and the mixture cooled in an ice-bath under nitrogen. EDC (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 6.69 g, 34.9 mmol) was added to the cold reaction mixture. The reaction was stirred for 1.5 h in the ice-bath, then for 1 h at rt after which it was heated to 40° C. for 16 h. LC/MS of a sample showed the desired product. The solvent was removed under reduced pressure, then EtOAc added to the residue followed by aqueous NaHCO3 (sat.). The organic layer was separated, washed with water, then with 1N HCl, followed by brine (2×), dried over MgSO4, filtered and concentrated leaving the product as a clear oil (7.66 g, 83%). This procedure in conjunction with the other steps in the standard process led to the following oxazole building blocks in the yields indicated. The corresponding enantiomers are accessed similarly starting from the appropriate Fmoc-D-amino acids.




embedded image



J. Representative Procedure for the Reduction of Acid Building Blocks to Alcohols




embedded image


As an example of the transformation of amino acid building blocks (J-1) to the corresponding amino alcohol (J-2) components, a solution of Fmoc-OX-1 (6.55 g, 15.6 mmol) in THF (100 mL) under nitrogen was cooled in an ice-salt bath, then isobutyl chloroformate (IBCF, 2.04 mL, 15.6 mmol) and 4-methylmorpholine (NMM, 1.71 mL, 15.6 mmol) added dropwise simultaneously via syringes over 5 min. The mixture was stirred at 0° C. for 30 min, then at rt for another 30 min. The white precipitate that formed was filtered into a 500 mL flask through a pre-washed Celite® pad and rinsed with anhydrous ether (71.4 mL). The flask was placed under nitrogen in an ice-bath, and a mixture of sodium borohydride (0.884 g, 23.4 mmol) in water (10 mL) added in one shot with the neck of the flask left open. Significant gas evolution was observed and the reaction mixture formed a suspension. More water (20 mL) was added, the ice-bath removed, and the reaction stirred rapidly with monitoring by LC-MS and TLC. After 1 h at ambient temperature, LC-MS analysis indicated that the reaction was complete. More water was then added and the organic layer extracted with EtOAc (2×150 mL). The combined organic layers were washed sequentially with 1 M citric acid, NaHCO3 (sat.), water, brine, and dried over anhydrous MgSO4. The mixture was filtered and the filtrate concentrated under reduced pressure to give Fmoc-OX-7 in 71.4% yield (4.52 g). The product was sufficiently pure to be used without further purification for subsequent reactions. Other non-limiting examples of the compounds from this transformation are shown below:




embedded image


embedded image


This same procedure can be utilized for the transformation of standard protected amino acid derivatives into the corresponding alcohols.


Alternatively, the N-protected amino acid ester can be reduced directly to the N-protected amino alcohol, for example with lithium borohydride or DIBAL, which can provide a more efficient route to these building blocks in certain cases.


K. Representative Procedure for the Oxidation of Alcohol Building Blocks to Aldehydes Using Pyridine Sulfur Trioxide Complex




embedded image


The following procedure is provided as an example of the transformation of amino alcohol building blocks such as K-1 to the corresponding amino aldehyde components (K-2) for use in a reductive amination attachment procedure. In a 250 mL round-bottomed flask was dissolved Fmoc-OX-7 (3.95 g, 9.72 mmol) in CH2Cl2 (46.3 mL) and DMSO (10 mL). Triethylamine (TEA, 5.42 mL, 38.9 mmol) was added and the solution cooled to 0° C. under nitrogen. Pyridine sulfur trioxide complex (pyr.SO3, 4.64 g, 29.2 mmol) was added as a solution in DMSO (15.8 mL) over 20 min and the reaction monitored by TLC and LC-MS until complete. After 4 h, the reaction was cooled to 0° C. in an ice-bath, EtOAc/ether (1:1, 150 mL) was added, and the organic layer washed with saturated NaHCO3 (1×150 mL). More water was added as necessary to dissolve any insoluble material. The aqueous layer was extracted with EtOAc/ether (1:1, 3×150 mL). The organic extracts were combined and washed sequentially with 1M KHSO4 (1×150 mL), saturated NH4Cl (2×120 mL), water (200 mL), brine (2×200 mL), dried over anhydrous MgSO4, filtered and the filtrate concentrated under reduced pressure to give Fmoc-OX-13 in 95% yield (3.72 g) as a clear semi-solid. The product thus obtained was acceptable for use in the further transformations without further purification. Other non-limiting examples of the compounds from this transformation, with selected yields, are shown below:




embedded image



L. Representative Procedure for the Oxidation of Building Blocks to Aldehydes with Manganese Dioxide




embedded image


Fmoc-S14 (38 g, 106 mmol) was suspended in DCM (151 mL) and THF (151 mL). Manganese dioxide (Strem (Newburyport, Mass., USA) Cat. No. 25-1360, 92 g, 1.06 mol) was added and the reaction agitated o/n on an orbital shaker at 200 rpm. A small sample was filtered through MgSO4 with THF and analyzed by LC-MS, which indicated 87% conversion. More MnO2 (23.0 g, 264 mmol) was added and the reaction agitated for 16 h more, at which time the reaction was found to have progressed to 90% conversion. Another quantity of MnO2 (23.0 g, 264 mmol) was added and agitation continued for another 16 h, after which LC-MS indicated complete reaction. The reaction mixture was filtered through MgSO4 with filter-paper on top, and the trapped solids rinsed with THF. The residual MnO2 was agitated with THF, filtered and washed with THF. The filtrate was passed again through MgSO4 and several layers of filter-paper and the filtrate was pale yellow with no MnO2. Evaporation of the filtrate under reduced pressure left a light yellow solid. The solid was triturated with ether, heated to reflux and allowed to cool slowly with stirring. After stirring for 4 h, the white solid that formed was filtered to give Fmoc-S37 as a white solid (28.6 g, 80 mmol, 76.0% yield). 1H-NMR and LC-MS were consistent with the expected product. The MnO2 was washed again with THF (300 mL) with agitation o/n, followed by filtration and concentration of the filtrate in vacuo to give 1.0 g of crude product which was combined with 2.0 g recovered from the mother liquor of the above trituration and this combined solid triturated with ether. A second crop of the desired product was isolated as an off white solid (1.60 g, 4.48 mmol, 4.2% additional yield).


M. Standard Procedures for the Synthesis of Oxazole and Thiazole Amino Acids




embedded image


Variations of the routes as described in the literature procedure (Org. Lett. 2006, 8, 2417-2420) permit both oxazole and thiazole-containing building blocks to be accessed from a common intermediate. In the first instance, the dipeptide (M-3), from standard coupling of an N-protected amino acid (AA) to carboxy-protected Thr, was oxidized to the ketone M-4, which underwent cyclodehydration to either the oxazole (M-5) or the thiazole (M-6) using the reagents indicated. In contrast, the AA-Ser dipeptide (M-3) was treated with Burgess reagent to effect cyclodehydration to the oxazoline (M-7), which could then be further oxidized to the oxazole (M-8). The two-step process proved to be more efficient with this substrate.


N. Standard Procedure for the Synthesis of Thiazole Amino Acids




embedded image


Step 1N-1.


Construction of protected thiazole building blocks (N4) was performed based upon the literature method (J. Pept. Sci. 1999, 5, 392-398) starting from the N-protected amino acid (N-1) and utilizing a Hantzsch cyclocondensation as the key step. To a stirred solution of N-1 (1 eq), pyridine (0.05 mL/eq) and di-t-butyl-dicarbonate (Boc2O, 1.3 eq) in an appropriate solvent (10-15 mL) was added ammonium hydrogen carbonate (1.25 eq) and the mixture stirred for 4-16 h. Upon completion, EtOAc or a mixture of CHCl3:1-propanol (9:1) was added and the organic layer washed with water and 5% H2SO4 (aq), then dried over anhydrous MgSO4. The solution was filtered, the filtrate evaporated in vacuo, and the resulting product triturated with ether. Alternatively, the reaction mixture was diluted with water (30-40 mL), then stirred until crystallization was completed. The solid amide (N-2) was collected by filtration, washed with water, dried in vacuo and recrystallized if necessary.


Step 1N-2.


Lawesson's reagent (0.75 mmol/mmol of N-2) and a solution of N-2 (1 eq) in dimethoxyethane (DME, 20 mL/mmol) was stirred at rt) until the starting material was consumed as indicated by TLC or HPLC. The solvent was evaporated in vacuo and the residue recrystallized from an appropriate solvent to yield the intermediate thioamide (N-3).


Step 1N-3.


In anhydrous EtOH (30 mL/mmol) were dissolved N-3 (1 eq), 3-bromo-2-oxo-propionic acid (bromopyruvic acid, 1.5 eq), and CaCO3 (5.5 eq) and the resulting mixture stirred under an inert atmosphere at rt for 24 h. Upon reaction completion, water and ethyl acetate were added and the organic layer washed sequentially with water and 5% H2SO4 (aq), then dried over anhydrous MgSO4. The solution was filtered, the filtrate evaporated in vacuo, and the resulting residue purified by crystallization from an appropriate solvent or solvent mixture to give the desired product (N-4).


The protected thiazole amino acids (N-4) can be converted to their corresponding alcohols and aldehydes in a manner similar to those described for the oxazole amino acids in Examples 1J and 1K.


O. Standard Procedure for the Synthesis of Trifunctional Thiazole Amino Acids




embedded image


An analogous strategy to that of Example 1N can be employed as illustrated to construct trifunctional thiazole building blocks from protected derivatives of Asn and Gin (ACS Comb. Sci. 2014, 16, 1-4). With the appropriate orthogonal protection strategy in place, these compounds can be subjected to attachment of the next building block or cyclization through any of the three reactive groups.


Step 1O-1.


The (bis)protected amino acid (0-1, 1 eq) is dissolved in THF (9 mL/mmol), then phosphorous pentasulfide (0.5 eq) added quickly. The reaction vessel is sealed and the mixture placed in a sonicating bath for 1-2 h until TLC indicates the conversion is complete. Ice is added to the bath to cool the exothermic reaction. The yellow precipitate that forms is separated by filtration and discarded. The filtrate is concentrated in vacuo and the residue purified by flash chromatography using 100% DCM or DCM followed by EtOAc to provide the desired thioamide (0-2) in 70-80% yield.


Step 1O-2.


To 0-2 (1 eq) in THF (3 mL/mmol) is added bromopyruvic acid (1.1 eq) and the reaction brought to reflux in a heating bath and maintained for 18 h. After cooling to rt, the solvent is removed in vacuo, then the residue dissolved in DCM and filtered through a pad of charcoal to remove the dark color. The filtrate is evaporated under reduced pressure and the crude product purified by flash chromatography. The product thus obtained is recrystallized to provide O-3 as a white solid in 50-55% yield.


P. Standard Procedure for the Synthesis of Thiazole and Imidazole Amino Acids




embedded image


Based upon the literature report (Org. Lett. 2006, 8, 2417-2420), similar processes can be employed to prepare thiazole and imidazole building blocks either in solution or on solid phase. Formation of the dipeptide (P-2, P-3) under standard conditions is followed by cyclodehydration to the thiazoline (P-4) or imidazoline (P-5) using bis(triphenyl)oxodiphosphonium trifluoro-methanesulfonate generated in situ from triphenylphosphine oxide and triflic anhydride. Oxidation with BrCCl3/DBU then provided the thiazole (P-6) or imidazole (P-7) products.


Q. Standard Procedure for the Synthesis of Imidazole Amino Acids




embedded image


The N-protected amino acid amide (Q-2) was prepared using well-established methodology from the corresponding ester (Q-1), then the imidazole amino acid ester (Q-5) synthesized based upon the literature method (J. Pept. Sci. 1999, 5, 392-398). Treatment with Meerwein's Reagent (triethyloxonium tetrafluoroborate) or the analogous hexafluorophosphate provides the O-alkylated intermediate (Q-3), an excess (1.3 eq) of which is reacted with L-2,3-diaminopropionic acid methyl ester (1 eq, as its HCl salt) in refluxing MeOH or CHCl3 (4 mL/mmol) to yield the imidazoline (Q-4). Oxidation of Q-4 is conducted by adding DBU (3 eq) in a mixture of CCl4 (5 mL/mmol), pyridine (3 mL/mmol) and acetonitrile (5 mL/mmol). After 3 h at rt, the solvent is removed in vacuo and the residue dissolved in EtOAc. The organic is extracted with 0.5 N HCl, then the aqueous phase back-extracted with EtOAc (2×). The combined organic phase is washed with brine, dried over anhydrous MgSO4. The dessicant is removed by filtration, the filtrate evaporated in vacuo, and the residue recrystallized. Cleavage of the methyl ester with a method compatible with the other protecting groups of Q-5 gives the imidazole amino acid Q-6.


The imidazole amino acids can be converted to their corresponding alcohols and aldehydes in a similar manner to those described for the oxazole amino acids (Examples 1J and 1K), although protection of the imidazole NH with a Boc, Trt or other appropriate removable moiety is required to minimize side reactions.


R. Standard Procedure for the Synthesis of Building Block S50




embedded image


Step S50-1.


To a solution of 2-hydroxybenzaldehyde (50-1, 10.0 g, 82 mmol) in MeOH (100 mL) at rt was added 7 N ammonium hydroxide (29.2 mL, 205 mmol) in MeOH. The solution turned yellow in color. The homogeneous solution was stirred at rt for 3 h at which time TLC showed a new, more polar product. Solid sodium borohydride (1.73 g, 45.7 mmol) was added to the reaction in small portions and stirring continued at rt for 2 h. The reaction was quenched with 10% NaOH, then the methanol evaporated in vacuo. The resulting aqueous solution was diluted with EtOAc (50 mL) and the layers separated. The organic layer was washed with 10% HCl (3×). The aqueous washes were combined with the original aqueous layer and the pH adjusted to 9 with 10% NaOH. A white solid formed, which was isolated by filtration, washed and dried in air. This material was treated with Boc2O (19.0 mL, 82.0 mmol) in DCM and stirred at rt for 24 h. The reaction mixture was diluted with water, extracted with EtOAc, the organic layers dried over MgSO4, filtered, then evaporated in vacuo to leave an oil that was purified by flash chromatography (hexanes:EtOAc, 9:1 to 1:1) to give 50-2 as a colorless oil (65% yield).




embedded image


Step S50-2.


To a solution of 50-2 (3.86 g, 17.29 mmol) and Alloc-S1 (3.76 g, 25.9 mmol) in THF (200 mL) at rt was added Ph3P (6.80 g, 25.9 mmol), then DIAD (5.04 mL, 25.9 mmol). The mixture was stirred at rt o/n at which point TLC indicated reaction completion. The solvent was evaporated in vacuo and the residue purified by flash chromatography (100 g silica, hexanes:EtOAc: 90:10 to 70:30 over 13 min) to give two fractions. The main fraction contained primarily the desired product, while the minor fraction was contaminated with a significant amount of solid hydrazine by-product. The minor fraction was triturated with an ether/hexane mixture, then filtered. The residue from concentration in vacuo of the mother liquors from this filtration were combined with the major fraction and subjected to a second flash chromatography (hexanes:EtOAc: 90:10 to 60:40 over 14 min) to give the diprotected product, Alloc-S50(Boc), as a colorless oil (46% yield). This was treated with 1% TFA to remove the Boc group, which provided Alloc-S50.


S. Alternative Procedure for the Synthesis of Building Block S50




embedded image


To 2-hydroxybenzaldehyde (50-1, 605 mg, 4.96 mmol) and (9H-fluoren-9-yl)methyl carbamate (593 mg, 2.48 mmol) in toluene (30 mL) was added TFA (0.955 mL, 12.4 mmol). The mixture was stirred at 80° C. for 2 d, then allowed to cool to rt, evaporated in vacuo and the residue purified by flash chromatography (hexanes:EtOAc: 95:5 to 50:50 over 14 min). Product-containing fractions were concentrated under reduced pressure to leave 50-3 as a solid, 1H NMR and LC-MS consistent with structure, 0.39 mg, estimated 46% yield.


As another alternative, 2-(aminomethyl) phenol is commercially available (Matrix Scientific Cat. No. 009264; Apollo Scientific Cat. No. OR12317; Oakwood Cat. No. 023454) and can be protected with Fmoc using standard methods (Method 1W, Example 1A).


Analogously as described for 50-2, 50-3 can be converted into Alloc-S50 by a reaction sequence involving Mitsunobu coupling followed by standard Fmoc deprotection (Method 1F).




embedded image



T. Standard Procedure for the Synthesis of Building Block S51




embedded image


To a solution of 2-(2-hydroxyphenyl)acetamide (50-1, Fluorochem Cat. No. 375417, 50.0 mg, 0.331 mmol), Ph3P (104 mg, 0.397 mmol) and Fmoc-2-aminoethanol (Fmoc-S1, 122 mg, 0.430 mmol) in THF (4 mL) at rt was added DIAD (0.077 ml, 0.397 mmol) dropwise. The mixture was stirred at rt overnight, then evaporated in vacuo and the residue purified by flash chroatography. The intermediate amide 51-2 was then treated with borane-dimethyl sulfide at 0° C. for 2 h, then quenched carefully with water, followed by dilute acid. The product Fmoc-S51 was isolated after standard work-up. Use of other appropriate nitrogen protecting groups on 2-aminoethanol provides alternative protected derivatives of S51.




embedded image


In a similar manner, various protected derivatives of S50 can be accessed starting from salicylamide (50-3) as an alternative route to these materials.


U. Standard Procedure for the Synthesis of Building Block S52




embedded image


Boc-L-phenylalaninamide ((S)-52-1), purchased from commercial suppliers or prepared from the unprotected precursor by treatment with Boc2O under standard conditions, was reduced with borane-dimethyl sulfide to give the mono-protected diamine (S)-S52(Boc). The primary amine was protected in the usual manner with an Alloc group, then the Boc group removed using standard conditions to yield Alloc-(S)-S52. The enantiomer was synthesized similarly from D-phenylalaninamide. Such a procedure is also applicable to the synthesis of other diamines from α-N-protected amino acid amides.


Example 2
Synthesis of a Representative Library of Macrocyclic Compounds of Formula (Ib)

The synthetic scheme presented in Scheme 2 was followed to prepare the library of macrocyclic compounds 1-289 on solid support. The oxazole amino acid (BB1) was loaded onto the resin (Method 1D), then the next two building blocks (BB2, BB3) sequentially coupled (Method 1G) after removal of the Fmoc protection (Method 1F) on the preceding building block. The final building block (BB4) was attached using reductive amination (Methods 1I or 1J) followed by selective N-terminal deprotection (Method 1F and macrocyclization (Method 1R). The side chain protecting groups were then removed (Method 1S) and the resulting crude product purified by preparative HPLC (Method 2B). The amounts of each macrocycle obtained, their HPLC purity and confirmation of their identity by mass spectrometry (MS) are provided in Table 1A. The individual structures of the compounds thus prepared are presented in Table 1B.
















TABLE 1A





Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
MS (M + H)






















1
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Ala
Fmoc-S33
6.7
100
557


2
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Ala
Fmoc-S33
5.9
100
534


3
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Ala
Fmoc-S33
6.0
100
557


4
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Ala
Fmoc-S33
6.9
97
534


5
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-S33
12.0
100
600


6
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-S33
10.7
98
577


7
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-S33
9.1
100
600


8
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-S33
10.1
100
577


9
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Asp(OBut)
Fmoc-S33
8.6
100
601


10
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Asp(OBut)
Fmoc-S33
9.8
100
578


11
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Asp(OBut)
Fmoc-S33
7.2
100
601


12
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Asp(OBut)
Fmoc-S33
6.4
100
578


13
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Ala
Fmoc-S33
6.5
100
557


14
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Ala
Fmoc-S33
6.8
100
534


15
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Ala
Fmoc-S33
5.0
100
557


16
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Ala
Fmoc-S33
5.7
100
534


17
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Asn(Trt)
Fmoc-S33
10.9
100
600


18
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Asn(Trt)
Fmoc-S33
13.5
97
577


19
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Asn(Trt)
Fmoc-S33
9.3
100
600


20
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Asn(Trt)
Fmoc-S33
9.7
100
577


21
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Asp(OBut)
Fmoc-S33
9.5
100
601


22
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Asp(OBut)
Fmoc-S33
13.9
100
578


23
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Asp(OBut)
Fmoc-S33
6.6
100
601


24
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Asp(OBut)
Fmoc-S33
6.2
100
578


25
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-His(Trt)
Fmoc-S33
11.7
98
623


26
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-His(Trt)
Fmoc-S33
11.4
98
600


27
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-His(Trt)
Fmoc-S33
8.3
100
623


28
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-His(Trt)
Fmoc-S33
8.2
100
600


29
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-S33
8.3
100
614


30
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-S33
7.0
100
591


31
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-S33
6.4
100
614


32
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-S33
7.2
100
591


33
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Nva
Fmoc-S33
7.9
100
585


34
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Nva
Fmoc-S33
6.1
100
562


35
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Nva
Fmoc-S33
6.4
100
585


36
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Nva
Fmoc-S33
6.7
100
562


37
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Phe
Fmoc-S33
12.5
100
633


38
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Phe
Fmoc-S33
10.4
100
610


39
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Phe
Fmoc-S33
7.2
100
633


40
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Phe
Fmoc-S33
11.4
100
610


41
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Pro
Fmoc-S33
12.3
100
583


42
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Pro
Fmoc-S33
11.9
100
560


43
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Pro
Fmoc-S33
10.3
99
583


44
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Pro
Fmoc-S33
9.6
100
560


45
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Ser(But)
Fmoc-S33
8.7
100
573


46
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Ser(But)
Fmoc-S33
8.5
100
550


47
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Ser(But)
Fmoc-S33
6.4
100
573


48
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Ser(But)
Fmoc-S33
6.4
100
550


49
Fmoc-OX-1
Fmoc-Ala
Fmoc-D-Trp(Boc)
Fmoc-S33
7.1
100
557


50
Fmoc-OX-1
Fmoc-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-S33
11.1
100
600


51
Fmoc-OX-1
Fmoc-D-Ala
Fmoc-D-Trp(Boc)
Fmoc-S33
8.1
100
557


52
Fmoc-OX-1
Fmoc-Dap(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
7.3
100
572


53
Fmoc-OX-1
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-S33
11.5
95
600


54
Fmoc-OX-1
Fmoc-D-Dap(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
8.5
100
572


55
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-D-Trp(Boc)
Fmoc-S33
11.0
96
614


56
Fmoc-OX-1
Fmoc-D-Glu(OBut)
Fmoc-D-Trp(Boc)
Fmoc-S33
8.8
97
615


57
Fmoc-OX-1
Fmoc-D-His(Trt)
Fmoc-D-Trp(Boc)
Fmoc-S33
8.5
100
623


58
Fmoc-OX-1
Fmoc-D-Ile
Fmoc-D-Trp(Boc)
Fmoc-S33
8.2
100
599


59
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
9.1
100
614


60
Fmoc-OX-1
Fmoc-D-Nva
Fmoc-D-Trp(Boc)
Fmoc-S33
8.6
100
585


61
Fmoc-OX-1
Fmoc-D-Phe
Fmoc-D-Trp(Boc)
Fmoc-S33
9.4
97
633


62
Fmoc-OX-1
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-S33
4.1
100
583


63
Fmoc-OX-1
Fmoc-D-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-S33
6.1
100
573


64
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
6.1
100
672


65
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Trp(Boc)
Fmoc-S33
9.1
96
649


66
Fmoc-OX-1
Fmoc-D-Val
Fmoc-D-Trp(Boc)
Fmoc-S33
8.4
100
585


67
Fmoc-OX-1
Fmoc-Glu(OBut)
Fmoc-D-Trp(Boc)
Fmoc-S33
7.4
100
615


68
Fmoc-OX-1
Fmoc-Sar
Fmoc-D-Trp(Boc)
Fmoc-S33
7.2
100
557


69
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-D-Trp(Boc)
Fmoc-S33
7.9
100
623


70
Fmoc-OX-1
Fmoc-Ile
Fmoc-D-Trp(Boc)
Fmoc-S33
7.0
100
599


71
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
7.2
97
614


72
Fmoc-OX-1
Fmoc-Nva
Fmoc-D-Trp(Boc)
Fmoc-S33
7.3
100
585


73
Fmoc-OX-1
Fmoc-Phe
Fmoc-D-Trp(Boc)
Fmoc-S33
9.1
100
633


74
Fmoc-OX-1
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-S33
5.1
100
583


75
Fmoc-OX-1
Fmoc-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-S33
8.4
100
573


76
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S33
9.8
100
672


77
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Trp(Boc)
Fmoc-S33
11.5
100
649


78
Fmoc-OX-1
Fmoc-Val
Fmoc-D-Trp(Boc)
Fmoc-S33
8.9
100
585


79
Fmoc-OX-1
Fmoc-Ala
Fmoc-D-Tyr(But)
Fmoc-S33
7.2
100
534


80
Fmoc-OX-1
Fmoc-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-S33
11.9
100
577


81
Fmoc-OX-1
Fmoc-D-Ala
Fmoc-D-Tyr(But)
Fmoc-S33
8.8
100
534


82
Fmoc-OX-1
Fmoc-Dap(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
5.7
100
549


83
Fmoc-OX-1
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-S33
11.7
100
577


84
Fmoc-OX-1
Fmoc-D-Dap(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
7.2
100
549


85
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-D-Tyr(But)
Fmoc-S33
10.2
96
591


86
Fmoc-OX-1
Fmoc-D-Glu(OBut)
Fmoc-D-Tyr(But)
Fmoc-S33
10.1
97
592


87
Fmoc-OX-1
Fmoc-D-His(Trt)
Fmoc-D-Tyr(But)
Fmoc-S33
8.2
100
600


88
Fmoc-OX-1
Fmoc-D-Ile
Fmoc-D-Tyr(But)
Fmoc-S33
10.0
98
576


89
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
8.2
100
591


90
Fmoc-OX-1
Fmoc-D-Nva
Fmoc-D-Tyr(But)
Fmoc-S33
9.0
100
562


91
Fmoc-OX-1
Fmoc-D-Phe
Fmoc-D-Tyr(But)
Fmoc-S33
10.7
97
610


92
Fmoc-OX-1
Fmoc-D-Pro
Fmoc-D-Tyr(But)
Fmoc-S33
3.8
100
560


93
Fmoc-OX-1
Fmoc-D-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-S33
6.7
100
550


94
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
9.4
100
649


95
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Tyr(But)
Fmoc-S33
10.5
95
626


96
Fmoc-OX-1
Fmoc-D-Val
Fmoc-D-Tyr(But)
Fmoc-S33
9.3
100
562


97
Fmoc-OX-1
Fmoc-Glu(OBut)
Fmoc-D-Tyr(But)
Fmoc-S33
9.3
100
592


98
Fmoc-OX-1
Fmoc-Sar
Fmoc-D-Tyr(But)
Fmoc-S33
7.8
100
534


99
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-D-Tyr(But)
Fmoc-S33
5.9
100
600


100
Fmoc-OX-1
Fmoc-Ile
Fmoc-D-Tyr(But)
Fmoc-S33
7.4
100
576


101
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
5.6
100
591


102
Fmoc-OX-1
Fmoc-Nva
Fmoc-D-Tyr(But)
Fmoc-S33
7.7
100
562


103
Fmoc-OX-1
Fmoc-Phe
Fmoc-D-Tyr(But)
Fmoc-S33
9.8
100
610


104
Fmoc-OX-1
Fmoc-Pro
Fmoc-D-Tyr(But)
Fmoc-S33
3.7
100
560


105
Fmoc-OX-1
Fmoc-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-S33
13.4
100
550


106
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Tyr(But)
Fmoc-S33
9.7
100
649


107
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Tyr(But)
Fmoc-S33
13.9
100
626


108
Fmoc-OX-1
Fmoc-Val
Fmoc-D-Tyr(But)
Fmoc-S33
9.8
100
562


109
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Val
Fmoc-S33
9.0
95
585


110
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Val
Fmoc-S33
2.7
100
562


111
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Val
Fmoc-S33
5.5
100
585


112
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Val
Fmoc-S33
9.4
96
562


113
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-S33
5.8
100
557


114
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-S33
9.0
100
534


115
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-S33
9.4
97
557


116
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-S33
5.9
100
534


117
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-His(Trt)
Fmoc-S33
7.8
100
623


118
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-His(Trt)
Fmoc-S33
4.8
100
600


119
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-His(Trt)
Fmoc-S33
6.7
100
623


120
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-His(Trt)
Fmoc-S33
7.4
100
600


121
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-S33
6.2
100
614


122
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-S33
6.7
100
591


123
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-S33
6.5
100
614


124
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-S33
8.8
100
591


125
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Nva
Fmoc-S33
7.1
100
585


126
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Nva
Fmoc-S33
8.1
100
562


127
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Nva
Fmoc-S33
5.7
100
585


128
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Nva
Fmoc-S33
6.4
100
562


129
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Phe
Fmoc-S33
9.9
100
633


130
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Phe
Fmoc-S33
9.6
100
610


131
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Phe
Fmoc-S33
5.8
100
633


132
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Phe
Fmoc-S33
6.6
100
610


133
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Pro
Fmoc-S33
8.7
100
583


134
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Pro
Fmoc-S33
9.5
100
560


135
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Pro
Fmoc-S33
9.7
100
583


136
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Pro
Fmoc-S33
10.8
100
560


137
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Ser(But)
Fmoc-S33
9.3
100
573


138
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Ser(But)
Fmoc-S33
7.8
100
550


139
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Ser(But)
Fmoc-S33
6.7
100
573


140
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Ser(But)
Fmoc-S33
6.2
100
550


141
Fmoc-OX-1
Fmoc-Ala
Fmoc-Trp(Boc)
Fmoc-S33
6.7
100
557


142
Fmoc-OX-1
Fmoc-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-S33
4.4
100
600


143
Fmoc-OX-1
Fmoc-D-Ala
Fmoc-Trp(Boc)
Fmoc-S33
7.7
100
557


144
Fmoc-OX-1
Fmoc-Dap(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
5.5
95
572


145
Fmoc-OX-1
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-S33
12.4
100
600


146
Fmoc-OX-1
Fmoc-D-Dap(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
7.4
100
572


147
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-Trp(Boc)
Fmoc-S33
8.5
100
614


148
Fmoc-OX-1
Fmoc-D-Glu(OBut)
Fmoc-Trp(Boc)
Fmoc-S33
7.0
100
615


149
Fmoc-OX-1
Fmoc-D-His(Trt)
Fmoc-Trp(Boc)
Fmoc-S33
7.8
100
623


150
Fmoc-OX-1
Fmoc-D-Ile
Fmoc-Trp(Boc)
Fmoc-S33
8.0
100
599


151
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
5.4
100
614


152
Fmoc-OX-1
Fmoc-D-Nva
Fmoc-Trp(Boc)
Fmoc-S33
7.0
100
585


153
Fmoc-OX-1
Fmoc-D-Phe
Fmoc-Trp(Boc)
Fmoc-S33
9.0
100
633


154
Fmoc-OX-1
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-S33
9.3
100
583


155
Fmoc-OX-1
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-S33
6.4
100
573


156
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
8.5
100
672


157
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Trp(Boc)
Fmoc-S33
8.4
100
649


158
Fmoc-OX-1
Fmoc-D-Val
Fmoc-Trp(Boc)
Fmoc-S33
8.0
100
585


159
Fmoc-OX-1
Fmoc-Glu(OBut)
Fmoc-Trp(Boc)
Fmoc-S33
6.3
100
615


160
Fmoc-OX-1
Fmoc-Sar
Fmoc-Trp(Boc)
Fmoc-S33
7.6
100
557


161
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-Trp(Boc)
Fmoc-S33
4.5
100
623


162
Fmoc-OX-1
Fmoc-Ile
Fmoc-Trp(Boc)
Fmoc-S33
6.4
100
599


163
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
4.6
100
614


164
Fmoc-OX-1
Fmoc-Nva
Fmoc-Trp(Boc)
Fmoc-S33
6.8
100
585


165
Fmoc-OX-1
Fmoc-Phe
Fmoc-Trp(Boc)
Fmoc-S33
7.3
100
633


166
Fmoc-OX-1
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-S33
5.1
100
583


167
Fmoc-OX-1
Fmoc-Ser(But)
Fmoc-Trp(Boc)
Fmoc-S33
3.8
100
573


168
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Trp(Boc)
Fmoc-S33
6.3
100
672


169
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Trp(Boc)
Fmoc-S33
5.6
100
649


170
Fmoc-OX-1
Fmoc-Val
Fmoc-Trp(Boc)
Fmoc-S33
7.6
100
585


171
Fmoc-OX-1
Fmoc-Ala
Fmoc-Tyr(But)
Fmoc-S33
4.8
100
534


172
Fmoc-OX-1
Fmoc-Ala
Fmoc-Tyr(But)
Fmoc-S31
3.5
100
472


173
Fmoc-OX-1
Fmoc-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-S33
5.8
100
577


174
Fmoc-OX-1
Fmoc-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-S31
na
na
na


175
Fmoc-OX-1
Fmoc-D-Ala
Fmoc-Tyr(But)
Fmoc-S33
7.3
100
534


176
Fmoc-OX-1
Fmoc-D-Ala
Fmoc-Tyr(But)
Fmoc-S31
3.6
100
472


177
Fmoc-OX-1
Fmoc-Dap(Boc)
Fmoc-Tyr(But)
Fmoc-S33
5.0
100
549


178
Fmoc-OX-1
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-S33
12.4
100
577


179
Fmoc-OX-1
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-S31
6.1
100
515


180
Fmoc-OX-1
Fmoc-D-Dap(Boc)
Fmoc-Tyr(But)
Fmoc-S33
6.2
100
549


181
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-Tyr(But)
Fmoc-S33
11.3
100
591


182
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-Tyr(But)
Fmoc-S31
7.4
100
529


183
Fmoc-OX-1
Fmoc-D-Glu(OBut)
Fmoc-Tyr(But)
Fmoc-S33
8.4
100
592


184
Fmoc-OX-1
Fmoc-D-Glu(OBut)
Fmoc-Tyr(But)
Fmoc-S31
4.4
100
530


185
Fmoc-OX-1
Fmoc-D-His(Trt)
Fmoc-Tyr(But)
Fmoc-S33
7.0
100
600


186
Fmoc-OX-1
Fmoc-D-His(Trt)
Fmoc-Tyr(But)
Fmoc-S31
5.9
100
538


187
Fmoc-OX-1
Fmoc-D-Ile
Fmoc-Tyr(But)
Fmoc-S33
8.3
100
576


188
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-S33
5.7
100
591


189
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-S31
3.4
100
529


190
Fmoc-OX-1
Fmoc-D-Nva
Fmoc-Tyr(But)
Fmoc-S33
7.9
100
562


191
Fmoc-OX-1
Fmoc-D-Nva
Fmoc-Tyr(But)
Fmoc-S31
4.1
100
500


192
Fmoc-OX-1
Fmoc-D-Phe
Fmoc-Tyr(But)
Fmoc-S33
9.0
100
610


193
Fmoc-OX-1
Fmoc-D-Phe
Fmoc-Tyr(But)
Fmoc-S31
4.6
100
548


194
Fmoc-OX-1
Fmoc-D-Pro
Fmoc-Tyr(But)
Fmoc-S33
8.4
100
560


195
Fmoc-OX-1
Fmoc-D-Pro
Fmoc-Tyr(But)
Fmoc-S31
5.2
100
498


196
Fmoc-OX-1
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-S33
7.4
100
550


197
Fmoc-OX-1
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-S31
4.0
100
488


198
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-S33
9.4
100
649


199
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-S31
5.4
100
587


200
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Tyr(But)
Fmoc-S33
9.1
100
626


201
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Tyr(But)
Fmoc-S31
5.3
100
564


202
Fmoc-OX-1
Fmoc-D-Val
Fmoc-Tyr(But)
Fmoc-S33
7.2
100
562


203
Fmoc-OX-1
Fmoc-D-Val
Fmoc-Tyr(But)
Fmoc-S31
4.1
100
500


204
Fmoc-OX-1
Fmoc-Glu(OBut)
Fmoc-Tyr(But)
Fmoc-S33
4.1
100
592


205
Fmoc-OX-1
Fmoc-Glu(OBut)
Fmoc-Tyr(But)
Fmoc-S31
5.7
100
530


206
Fmoc-OX-1
Fmoc-Sar
Fmoc-Tyr(But)
Fmoc-S33
7.1
100
534


207
Fmoc-OX-1
Fmoc-Sar
Fmoc-Tyr(But)
Fmoc-S31
2.2
100
472


208
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-Tyr(But)
Fmoc-S33
5.2
100
600


209
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-Tyr(But)
Fmoc-S31
9.2
100
538


210
Fmoc-OX-1
Fmoc-Ile
Fmoc-Tyr(But)
Fmoc-S33
8.8
100
576


211
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-S33
5.7
100
591


212
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-S31
5.4
100
529


213
Fmoc-OX-1
Fmoc-Nva
Fmoc-Tyr(But)
Fmoc-S33
8.9
100
562


214
Fmoc-OX-1
Fmoc-Nva
Fmoc-Tyr(But)
Fmoc-S31
5.3
100
500


215
Fmoc-OX-1
Fmoc-Phe
Fmoc-Tyr(But)
Fmoc-S33
6.5
100
610


216
Fmoc-OX-1
Fmoc-Phe
Fmoc-Tyr(But)
Fmoc-S31
7.3
100
548


217
Fmoc-OX-1
Fmoc-Pro
Fmoc-Tyr(But)
Fmoc-S33
4.2
100
560


218
Fmoc-OX-1
Fmoc-Pro
Fmoc-Tyr(But)
Fmoc-S31
2.4
100
498


219
Fmoc-OX-1
Fmoc-Ser(But)
Fmoc-Tyr(But)
Fmoc-S33
3.5
100
550


220
Fmoc-OX-1
Fmoc-Ser(But)
Fmoc-Tyr(But)
Fmoc-S31
5.1
100
488


221
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-S33
7.7
100
649


222
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-S31
6.6
100
587


223
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Tyr(But)
Fmoc-S33
7.4
100
626


224
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Tyr(But)
Fmoc-S31
7.1
100
564


225
Fmoc-OX-1
Fmoc-Val
Fmoc-Tyr(But)
Fmoc-S33
7.8
100
562


226
Fmoc-OX-1
Fmoc-Val
Fmoc-Tyr(But)
Fmoc-S31
5.6
100
500


227
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Val
Fmoc-S33
8.6
100
585


228
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Val
Fmoc-S33
8.7
100
562


229
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Val
Fmoc-S33
6.4
100
585


230
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Val
Fmoc-S33
6.5
100
562


231
Fmoc-OX-1
Fmoc-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-S33
2.5
100
619


232
Fmoc-OX-1
Fmoc-Arg(Pbf)
Fmoc-Trp(Boc)
Fmoc-S33
2.9
100
642


233
Fmoc-OX-1
Fmoc-Arg(Pbf)
Fmoc-D-Tyr(But)
Fmoc-S33
1.7
100
619


234
Fmoc-OX-1
Fmoc-Arg(Pbf)
Fmoc-D-Trp(Boc)
Fmoc-S33
2.2
100
642


235
Fmoc-OX-1
Fmoc-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-S31
0.6
85
557


236
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-S33
5.3
100
619


237
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-Trp(Boc)
Fmoc-S33
6.1
100
642


238
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-D-Tyr(But)
Fmoc-S33
9.9
100
619


239
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-D-Trp(Boc)
Fmoc-S33
9.4
100
642


240
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-S31
3.7
100
557


241
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-S33
6.6
100
642


242
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-S33
5.0
100
619


243
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-S33
6.0
100
642


244
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-S33
8.6
100
619


245
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-S33
6.7
100
642


246
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-S33
8.6
100
619


247
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-S33
8.5
100
642


248
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-S33
6.6
100
619


249
Fmoc-OX-5
Fmoc-D-Val
Fmoc-D-Phe
Fmoc-S48
na
na
na


250
Fmoc-OX-6
Fmoc-D-Val
Fmoc-D-Phe
Fmoc-S48
na
na
na


251
Fmoc-OX-5
Fmoc-Val
Fmoc-D-Phe
Fmoc-S48
na
na
na


252
Fmoc-OX-6
Fmoc-Val
Fmoc-D-Phe
Fmoc-S48
na
na
na


253
Fmoc-OX-5
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S48
na
na
na


254
Fmoc-OX-6
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S48
na
na
na


255
Fmoc-OX-5
Fmoc-Ser(But)
Fmoc-D-Phe
Fmoc-S48
na
na
na


256
Fmoc-OX-6
Fmoc-Ser(But)
Fmoc-D-Phe
Fmoc-S48
na
na
na


257
Fmoc-OX-5
Fmoc-Dap(Boc)
Fmoc-D-Phe
Fmoc-S48
na
na
na


258
Fmoc-OX-6
Fmoc-Dap(Boc)
Fmoc-D-Phe
Fmoc-S48
na
na
na


259
Fmoc-OX-5
Fmoc-Ala
Fmoc-D-Phe
Fmoc-S48
na
na
na


260
Fmoc-OX-6
Fmoc-Ala
Fmoc-D-Phe
Fmoc-S48
na
na
na


261
Fmoc-OX-5
Fmoc-D-Ala
Fmoc-D-Phe
Fmoc-S48
na
na
na


262
Fmoc-OX-6
Fmoc-D-Ala
Fmoc-D-Phe
Fmoc-S48
na
na
na


263
Fmoc-OX-5
Fmoc-D-Val
Fmoc-Phe
Fmoc-S48
na
na
na


264
Fmoc-OX-6
Fmoc-D-Val
Fmoc-Phe
Fmoc-S48
na
na
na


265
Fmoc-OX-5
Fmoc-Val
Fmoc-Phe
Fmoc-S48
na
na
na


266
Fmoc-OX-6
Fmoc-Val
Fmoc-Phe
Fmoc-S48
na
na
na


267
Fmoc-OX-5
Fmoc-D-Val
Fmoc-D-Phe
Fmoc-S33
na
na
na


268
Fmoc-OX-6
Fmoc-D-Val
Fmoc-D-Phe
Fmoc-S33
na
na
na


269
Fmoc-OX-5
Fmoc-Val
Fmoc-D-Phe
Fmoc-S33
na
na
na


270
Fmoc-OX-6
Fmoc-Val
Fmoc-D-Phe
Fmoc-S33
na
na
na


271
Fmoc-OX-5
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S33
na
na
na


272
Fmoc-OX-6
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S33
na
na
na


273
Fmoc-OX-5
Fmoc-Ser(But)
Fmoc-D-Phe
Fmoc-S33
na
na
na


274
Fmoc-OX-6
Fmoc-Ser(But)
Fmoc-D-Phe
Fmoc-S33
na
na
na


275
Fmoc-OX-5
Fmoc-Dap(Boc)
Fmoc-D-Phe
Fmoc-S33
na
na
na


276
Fmoc-OX-6
Fmoc-Dap(Boc)
Fmoc-D-Phe
Fmoc-S33
na
na
na


277
Fmoc-OX-5
Fmoc-Ala
Fmoc-D-Phe
Fmoc-S33
na
na
na


278
Fmoc-OX-6
Fmoc-Ala
Fmoc-D-Phe
Fmoc-S33
na
na
na


279
Fmoc-OX-5
Fmoc-D-Ala
Fmoc-D-Phe
Fmoc-S33
na
na
na


280
Fmoc-OX-6
Fmoc-D-Ala
Fmoc-D-Phe
Fmoc-S33
na
na
na


281
Fmoc-OX-5
Fmoc-D-Val
Fmoc-Phe
Fmoc-S33
na
na
na


282
Fmoc-OX-6
Fmoc-D-Val
Fmoc-Phe
Fmoc-S33
na
na
na


283
Fmoc-OX-5
Fmoc-Val
Fmoc-Phe
Fmoc-S33
na
na
na


284
Fmoc-OX-6
Fmoc-Val
Fmoc-Phe
Fmoc-S33
na
na
na


285
Fmoc-OX-5
Fmoc-D-Dap(Boc)
Fmoc-D-Phe
Fmoc-S48
na
na
na


286
Fmoc-OX-6
Fmoc-D-Dap(Boc)
Fmoc-D-Phe
Fmoc-S48
na
na
na


287
Fmoc-OX-5
Fmoc-D-Dap(Boc)
Fmoc-D-Phe
Fmoc-S33
na
na
na


288
Fmoc-OX-6
Fmoc-D-Dap(Boc)
Fmoc-D-Phe
Fmoc-S33
na
na
na


289
Fmoc-OX-6
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S33
na
na
na





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 1B







embedded image




















Cpd
R1
R2
R3





 1


embedded image




embedded image


H





 2


embedded image




embedded image


H





 3


embedded image




embedded image


H





 4


embedded image




embedded image


H





 5


embedded image




embedded image


H





 6


embedded image




embedded image


H





 7


embedded image




embedded image


H





 8


embedded image




embedded image


H





 9


embedded image




embedded image


H





 10


embedded image




embedded image


H





 11


embedded image




embedded image


H





 12


embedded image




embedded image


H





 13


embedded image




embedded image


H





 14


embedded image




embedded image


H





 15


embedded image




embedded image


H





 16


embedded image




embedded image


H





 17


embedded image




embedded image


H





 18


embedded image




embedded image


H





 19


embedded image




embedded image


H





 20


embedded image




embedded image


H





 21


embedded image




embedded image


H





 22


embedded image




embedded image


H





 23


embedded image




embedded image


H





 24


embedded image




embedded image


H





 25


embedded image




embedded image


H





 26


embedded image




embedded image


H





 27


embedded image




embedded image


H





 28


embedded image




embedded image


H





 29


embedded image




embedded image


H





 30


embedded image




embedded image


H





 31


embedded image




embedded image


H





 32


embedded image




embedded image


H





 33


embedded image




embedded image


H





 34


embedded image




embedded image


H





 35


embedded image




embedded image


H





 36


embedded image




embedded image


H





 37


embedded image




embedded image


H





 38


embedded image




embedded image


H





 39


embedded image




embedded image


H





 40


embedded image




embedded image


H





 41


embedded image




embedded image


H





 42


embedded image




embedded image


H





 43


embedded image




embedded image


H





 44


embedded image




embedded image


H





 45


embedded image




embedded image


H





 46


embedded image




embedded image


H





 47


embedded image




embedded image


H





 48


embedded image




embedded image


H





 49


embedded image


(S)-CH3
H





 50


embedded image




embedded image


H





 51


embedded image


(R)-CH3
H





 52


embedded image




embedded image


H





 53


embedded image




embedded image


H





 54


embedded image




embedded image


H





 55


embedded image




embedded image


H





 56


embedded image




embedded image


H





 57


embedded image




embedded image


H





 58


embedded image




embedded image


H





 59


embedded image




embedded image


H





 60


embedded image




embedded image


H





 61


embedded image




embedded image


H





 62


embedded image




embedded image


H





 63


embedded image




embedded image


H





 64


embedded image




embedded image


H





 65


embedded image




embedded image


H





 66


embedded image




embedded image


H





 67


embedded image




embedded image


H





 68


embedded image


H
Me





 69


embedded image




embedded image


H





 70


embedded image




embedded image


H





 71


embedded image




embedded image


H





 72


embedded image




embedded image


H





 73


embedded image




embedded image


H





 74


embedded image




embedded image


H





 75


embedded image




embedded image


H





 76


embedded image




embedded image


H





 77


embedded image




embedded image


H





 78


embedded image




embedded image


H





 79


embedded image


(S)-CH3
H





 80


embedded image




embedded image


H





 81


embedded image


(R)-CH3
H





 82


embedded image




embedded image


H





 83


embedded image




embedded image


H





 84


embedded image




embedded image


H





 85


embedded image




embedded image


H





 86


embedded image




embedded image


H





 87


embedded image




embedded image


H





 88


embedded image




embedded image


H





 89


embedded image




embedded image


H





 90


embedded image




embedded image


H





 91


embedded image




embedded image


H





 92


embedded image




embedded image


H





 93


embedded image




embedded image


H





 94


embedded image




embedded image


H





 95


embedded image




embedded image


H





 96


embedded image




embedded image


H





 97


embedded image




embedded image


H





 98


embedded image


H
Me





 99


embedded image




embedded image


H





100


embedded image




embedded image


H





101


embedded image




embedded image


H





102


embedded image




embedded image


H





103


embedded image




embedded image


H





104


embedded image




embedded image


H





105


embedded image




embedded image


H





106


embedded image




embedded image


H





107


embedded image




embedded image


H





108


embedded image




embedded image


H





109


embedded image




embedded image


H





110


embedded image




embedded image


H





111


embedded image




embedded image


H





112


embedded image




embedded image


H





113


embedded image




embedded image


H





114


embedded image




embedded image


H





115


embedded image




embedded image


H





116


embedded image




embedded image


H





117


embedded image




embedded image


H





118


embedded image




embedded image


H





119


embedded image




embedded image


H





120


embedded image




embedded image


H





121


embedded image




embedded image


H





122


embedded image




embedded image


H





123


embedded image




embedded image


H





124


embedded image




embedded image


H





125


embedded image




embedded image


H





126


embedded image




embedded image


H





127


embedded image




embedded image


H





128


embedded image




embedded image


H





129


embedded image




embedded image


H





130


embedded image




embedded image


H





131


embedded image




embedded image


H





132


embedded image




embedded image


H





133


embedded image




embedded image


H





134


embedded image




embedded image


H





135


embedded image




embedded image


H





136


embedded image




embedded image


H





137


embedded image




embedded image


H





138


embedded image




embedded image


H





139


embedded image




embedded image


H





140


embedded image




embedded image


H





141


embedded image


(S)-CH3
H





142


embedded image




embedded image


H





143


embedded image


(R)-CH3
H





144


embedded image




embedded image


H





145


embedded image




embedded image


H





146


embedded image




embedded image


H





147


embedded image




embedded image


H





148


embedded image




embedded image


H





149


embedded image




embedded image


H





150


embedded image




embedded image


H





151


embedded image




embedded image


H





152


embedded image




embedded image


H





153


embedded image




embedded image


H





154


embedded image




embedded image


H





155


embedded image




embedded image


H





156


embedded image




embedded image


H





157


embedded image




embedded image


H





158


embedded image




embedded image


H





159


embedded image




embedded image


H





160


embedded image


H
Me





161


embedded image




embedded image


H





162


embedded image




embedded image


H





163


embedded image




embedded image


H





164


embedded image




embedded image


H





165


embedded image




embedded image


H





166


embedded image




embedded image


H





167


embedded image




embedded image


H





168


embedded image




embedded image


H





169


embedded image




embedded image


H





170


embedded image




embedded image


H





171


embedded image


(S)-CH3
H





172


embedded image


(S)-CH3
H





173


embedded image




embedded image


H





174


embedded image




embedded image


H





175


embedded image


(R)-CH3
H





176


embedded image


(R)-CH3
H





177


embedded image




embedded image


H





178


embedded image




embedded image


H





179


embedded image




embedded image


H





180


embedded image




embedded image


H





181


embedded image




embedded image


H





182


embedded image




embedded image


H





183


embedded image




embedded image


H





184


embedded image




embedded image


H





185


embedded image




embedded image


H





186


embedded image




embedded image


H





187


embedded image




embedded image


H





188


embedded image




embedded image


H





189


embedded image




embedded image


H





190


embedded image




embedded image


H





191


embedded image




embedded image


H





192


embedded image




embedded image


H





193


embedded image




embedded image


H





194


embedded image




embedded image


H





195


embedded image




embedded image


H





196


embedded image




embedded image


H





197


embedded image




embedded image


H





198


embedded image




embedded image


H





199


embedded image




embedded image


H





200


embedded image




embedded image


H





201


embedded image




embedded image


H





202


embedded image




embedded image


H





203


embedded image




embedded image


H





204


embedded image




embedded image


H





205


embedded image




embedded image


H





206


embedded image


H
Me





207


embedded image


H
Me





208


embedded image




embedded image


H





209


embedded image




embedded image


H





210


embedded image




embedded image


H





211


embedded image




embedded image


H





212


embedded image




embedded image


H





213


embedded image




embedded image


H





214


embedded image




embedded image


H





215


embedded image




embedded image


H





216


embedded image




embedded image


H





217


embedded image




embedded image


H





218


embedded image




embedded image


H





219


embedded image




embedded image


H





220


embedded image




embedded image


H





221


embedded image




embedded image


H





222


embedded image




embedded image


H





223


embedded image




embedded image


H





224


embedded image




embedded image


H





225


embedded image




embedded image


H





226


embedded image




embedded image


H





227


embedded image




embedded image


H





228


embedded image




embedded image


H





229


embedded image




embedded image


H





230


embedded image




embedded image


H





231


embedded image




embedded image


H





232


embedded image




embedded image


H





233


embedded image




embedded image


H





234


embedded image




embedded image


H





235


embedded image




embedded image


H





236


embedded image




embedded image


H





237


embedded image




embedded image


H





238


embedded image




embedded image


H





239


embedded image




embedded image


H





240


embedded image




embedded image


H





241


embedded image




embedded image


H





242


embedded image




embedded image


H





243


embedded image




embedded image


H





244


embedded image




embedded image


H





245


embedded image




embedded image


H





246


embedded image




embedded image


H





247


embedded image




embedded image


H





248


embedded image




embedded image


H





249


embedded image




embedded image


H





250


embedded image




embedded image


H





251


embedded image




embedded image


H





252


embedded image




embedded image


H





253


embedded image




embedded image


H





254


embedded image




embedded image


H





255


embedded image




embedded image


H





256


embedded image




embedded image


H





257


embedded image




embedded image


H





258


embedded image




embedded image


H





259


embedded image


(S)-CH3
H





260


embedded image


(S)-CH3
H





261


embedded image


(R)-CH3
H





262


embedded image


(R)-CH3
H





263


embedded image




embedded image


H





264


embedded image




embedded image


H





265


embedded image




embedded image


H





266


embedded image




embedded image


H





267


embedded image




embedded image


H





268


embedded image




embedded image


H





269


embedded image




embedded image


H





270


embedded image




embedded image


H





271


embedded image




embedded image


H





272


embedded image




embedded image


H





273


embedded image




embedded image


H





274


embedded image




embedded image


H





275


embedded image




embedded image


H





276


embedded image




embedded image


H





277


embedded image


(S)-CH3
H





278


embedded image


(S)-CH3
H





279


embedded image


(R)-CH3
H





280


embedded image


(R)-CH3
H





281


embedded image




embedded image


H





282


embedded image




embedded image


H





283


embedded image




embedded image


H





284


embedded image




embedded image


H





285


embedded image




embedded image


H





286


embedded image




embedded image


H





287


embedded image




embedded image


H





288


embedded image




embedded image


H





289


embedded image




embedded image


H













Cpd
R4
R5
R6





 1
(S)-CH3
H


embedded image







 2
(S)-CH3
H


embedded image







 3
(S)-CH3
H


embedded image







 4
(S)-CH3
H


embedded image







 5


embedded image


H


embedded image







 6


embedded image


H


embedded image







 7


embedded image


H


embedded image







 8


embedded image


H


embedded image







 9


embedded image


H


embedded image







 10


embedded image


H


embedded image







 11


embedded image


H


embedded image







 12


embedded image


H


embedded image







 13
(R)-CH3
H


embedded image







 14
(R)-CH3
H


embedded image







 15
(R)-CH3
H


embedded image







 16
(R)-CH3
H


embedded image







 17


embedded image


H


embedded image







 18


embedded image


H


embedded image







 19


embedded image


H


embedded image







 20


embedded image


H


embedded image







 21


embedded image


H


embedded image







 22


embedded image


H


embedded image







 23


embedded image


H


embedded image







 24


embedded image


H


embedded image







 25


embedded image


H


embedded image







 26


embedded image


H


embedded image







 27


embedded image


H


embedded image







 28


embedded image


H


embedded image







 29


embedded image


H


embedded image







 30


embedded image


H


embedded image







 31


embedded image


H


embedded image







 32


embedded image


H


embedded image







 33


embedded image


H


embedded image







 34


embedded image


H


embedded image







 35


embedded image


H


embedded image







 36


embedded image


H


embedded image







 37


embedded image


H


embedded image







 38


embedded image


H


embedded image







 39


embedded image


H


embedded image







 40


embedded image


H


embedded image







 41


embedded image


H


embedded image







 42


embedded image


H


embedded image







 43


embedded image


H


embedded image







 44


embedded image


H


embedded image







 45


embedded image


H


embedded image







 46


embedded image


H


embedded image







 47


embedded image


H


embedded image







 48


embedded image


H


embedded image







 49


embedded image


H


embedded image







 50


embedded image


H


embedded image







 51


embedded image


H


embedded image







 52


embedded image


H


embedded image







 53


embedded image


H


embedded image







 54


embedded image


H


embedded image







 55


embedded image


H


embedded image







 56


embedded image


H


embedded image







 57


embedded image


H


embedded image







 58


embedded image


H


embedded image







 59


embedded image


H


embedded image







 60


embedded image


H


embedded image







 61


embedded image


H


embedded image







 62


embedded image


H


embedded image







 63


embedded image


H


embedded image







 64


embedded image


H


embedded image







 65


embedded image


H


embedded image







 66


embedded image


H


embedded image







 67


embedded image


H


embedded image







 68


embedded image


H


embedded image







 69


embedded image


H


embedded image







 70


embedded image


H


embedded image







 71


embedded image


H


embedded image







 72


embedded image


H


embedded image







 73


embedded image


H


embedded image







 74


embedded image


H


embedded image







 75


embedded image


H


embedded image







 76


embedded image


H


embedded image







 77


embedded image


H


embedded image







 78


embedded image


H


embedded image







 79


embedded image


H


embedded image







 80


embedded image


H


embedded image







 81


embedded image


H


embedded image







 82


embedded image


H


embedded image







 83


embedded image


H


embedded image







 84


embedded image


H


embedded image







 85


embedded image


H


embedded image







 86


embedded image


H


embedded image







 87


embedded image


H


embedded image







 88


embedded image


H


embedded image







 89


embedded image


H


embedded image







 90


embedded image


H


embedded image







 91


embedded image


H


embedded image







 92


embedded image


H


embedded image







 93


embedded image


H


embedded image







 94


embedded image


H


embedded image







 95


embedded image


H


embedded image







 96


embedded image


H


embedded image







 97


embedded image


H


embedded image







 98


embedded image


H


embedded image







 99


embedded image


H


embedded image







100


embedded image


H


embedded image







101


embedded image


H


embedded image







102


embedded image


H


embedded image







103


embedded image


H


embedded image







104


embedded image


H


embedded image







105


embedded image


H


embedded image







106


embedded image


H


embedded image







107


embedded image


H


embedded image







108


embedded image


H


embedded image







109


embedded image


H


embedded image







110


embedded image


H


embedded image







111


embedded image


H


embedded image







112


embedded image


H


embedded image







113
H
Me


embedded image







114
H
Me


embedded image







115
H
Me


embedded image







116
H
Me


embedded image







117


embedded image


H


embedded image







118


embedded image


H


embedded image







119


embedded image


H


embedded image







120


embedded image


H


embedded image







121


embedded image


H


embedded image







122


embedded image


H


embedded image







123


embedded image


H


embedded image







124


embedded image


H


embedded image







125


embedded image


H


embedded image







126


embedded image


H


embedded image







127


embedded image


H


embedded image







128


embedded image


H


embedded image







129


embedded image


H


embedded image







130


embedded image


H


embedded image







131


embedded image


H


embedded image







132


embedded image


H


embedded image







133


embedded image


H


embedded image







134


embedded image


H


embedded image







135


embedded image


H


embedded image







136


embedded image


H


embedded image







137


embedded image


H


embedded image







138


embedded image


H


embedded image







139


embedded image


H


embedded image







140


embedded image


H


embedded image







141


embedded image


H


embedded image







142


embedded image


H


embedded image







143


embedded image


H


embedded image







144


embedded image


H


embedded image







145


embedded image


H


embedded image







146


embedded image


H


embedded image







147


embedded image


H


embedded image







148


embedded image


H


embedded image







149


embedded image


H


embedded image







150


embedded image


H


embedded image







151


embedded image


H


embedded image







152


embedded image


H


embedded image







153


embedded image


H


embedded image







154


embedded image


H


embedded image







155


embedded image


H


embedded image







156


embedded image


H


embedded image







157


embedded image


H


embedded image







158


embedded image


H


embedded image







159


embedded image


H


embedded image







160


embedded image


H


embedded image







161


embedded image


H


embedded image







162


embedded image


H


embedded image







163


embedded image


H


embedded image







164


embedded image


H


embedded image







165


embedded image


H


embedded image







166


embedded image


H


embedded image







167


embedded image


H


embedded image







168


embedded image


H


embedded image







169


embedded image


H


embedded image







170


embedded image


H


embedded image







171


embedded image


H


embedded image







172


embedded image


H


embedded image







173


embedded image


H


embedded image







174


embedded image


H


embedded image







175


embedded image


H


embedded image







176


embedded image


H


embedded image







177


embedded image


H


embedded image







178


embedded image


H


embedded image







179


embedded image


H


embedded image







180


embedded image


H


embedded image







181


embedded image


H


embedded image







182


embedded image


H


embedded image







183


embedded image


H


embedded image







184


embedded image


H


embedded image







185


embedded image


H


embedded image







186


embedded image


H


embedded image







187


embedded image


H


embedded image







188


embedded image


H


embedded image







189


embedded image


H


embedded image







190


embedded image


H


embedded image







191


embedded image


H


embedded image







192


embedded image


H


embedded image







193


embedded image


H


embedded image







194


embedded image


H


embedded image







195


embedded image


H


embedded image







196


embedded image


H


embedded image







197


embedded image


H


embedded image







198


embedded image


H


embedded image







199


embedded image


H


embedded image







200


embedded image


H


embedded image







201


embedded image


H


embedded image







202


embedded image


H


embedded image







203


embedded image


H


embedded image







204


embedded image


H


embedded image







205


embedded image


H


embedded image







206


embedded image


H


embedded image







207


embedded image


H


embedded image







208


embedded image


H


embedded image







209


embedded image


H


embedded image







210


embedded image


H


embedded image







211


embedded image


H


embedded image







212


embedded image


H


embedded image







213


embedded image


H


embedded image







214


embedded image


H


embedded image







215


embedded image


H


embedded image







216


embedded image


H


embedded image







217


embedded image


H


embedded image







218


embedded image


H


embedded image







219


embedded image


H


embedded image







220


embedded image


H


embedded image







221


embedded image


H


embedded image







222


embedded image


H


embedded image







223


embedded image


H


embedded image







224


embedded image


H


embedded image







225


embedded image


H


embedded image







226


embedded image


H


embedded image







227


embedded image


H


embedded image







228


embedded image


H


embedded image







229


embedded image


H


embedded image







230


embedded image


H


embedded image







231


embedded image


H


embedded image







232


embedded image


H


embedded image







233


embedded image


H


embedded image







234


embedded image


H


embedded image







235


embedded image


H


embedded image







236


embedded image


H


embedded image







237


embedded image


H


embedded image







238


embedded image


H


embedded image







239


embedded image


H


embedded image







240


embedded image


H


embedded image







241


embedded image


H


embedded image







242


embedded image


H


embedded image







243


embedded image


H


embedded image







244


embedded image


H


embedded image







245


embedded image


H


embedded image







246


embedded image


H


embedded image







247


embedded image


H


embedded image







248


embedded image


H


embedded image







249


embedded image


H


embedded image







250


embedded image


H


embedded image







251


embedded image


H


embedded image







252


embedded image


H


embedded image







253


embedded image


H


embedded image







254


embedded image


H


embedded image







255


embedded image


H


embedded image







256


embedded image


H


embedded image







257


embedded image


H


embedded image







258


embedded image


H


embedded image







259


embedded image


H


embedded image







260


embedded image


H


embedded image







261


embedded image


H


embedded image







262


embedded image


H


embedded image







263


embedded image


H


embedded image







264


embedded image


H


embedded image







265


embedded image


H


embedded image







266


embedded image


H


embedded image







267


embedded image


H


embedded image







268


embedded image


H


embedded image







269


embedded image


H


embedded image







270


embedded image


H


embedded image







271


embedded image


H


embedded image







272


embedded image


H


embedded image







273


embedded image


H


embedded image







274


embedded image


H


embedded image







275


embedded image


H


embedded image







276


embedded image


H


embedded image







277


embedded image


H


embedded image







278


embedded image


H


embedded image







279


embedded image


H


embedded image







280


embedded image


H


embedded image







281


embedded image


H


embedded image







282


embedded image


H


embedded image







283


embedded image


H


embedded image







284


embedded image


H


embedded image







285


embedded image


H


embedded image







286


embedded image


H


embedded image







287


embedded image


H


embedded image







288


embedded image


H


embedded image







289


embedded image


H


embedded image











Example 3
Synthesis of a Representative Library of Macrocyclic Compounds of Formula (Ic)

The synthetic scheme presented in Scheme 3 was followed to prepare the library of macrocyclic compounds 301-597 on solid support. The first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D), then, after removal of the Fmoc protection (Method 1F), the oxazole building block (BB2) attached through amide bond formation (Method 1G) or reductive amination (Method 1J). The next amino acid building block (BB3) was coupled (Method 1G) after Fmoc-deprotection (Method 1F) to extend the intermediate chain, then the last building block component added using reductive amination (Method 1I or 1J) to complete the cyclization precursor. N-Terminal Fmoc deprotection (Method 1F), macrocyclization (Method 1R) and removal of side chain protecting groups (Method 1S) gave the crude product after evaporation under reduced pressure. The quantities of each macrocycle obtained, their HPLC purity and confirmation of their identity by mass spectrometry (MS) after purification by preparative HPLC (Method 2B) are included in Table 2A. Individual compound structures are provided in Table 2B.
















TABLE 2A





Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
MS (M + H)






















301
Fmoc-Ala
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
8.7
100
557


302
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
14.5
100
600


303
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
8.4
100
557


304
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
13.9
100
600


305
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
9.6
100
614


306
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
7.7
100
615


307
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
10.4
100
623


308
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
8.2
100
614


309
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
11.4
100
585


310
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
10.8
100
633


311
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
9.6
100
583


312
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
11.8
100
573


313
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
8.2
100
672


314
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
10.8
100
649


315
Fmoc-D-Val
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
9.3
100
585


316
Fmoc-Gln(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
11.2
100
614


317
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
7.3
100
615


318
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
6.3
100
623


319
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
7.2
100
614


320
Fmoc-Nva
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
9.1
100
585


321
Fmoc-Phe
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
11.9
100
633


322
Fmoc-Pro
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
11.5
100
583


323
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
10.9
100
573


324
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
5.9
100
672


325
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S31
1.1
100
587


326
Fmoc-Val
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
8.6
100
585


327
Fmoc-Ala
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
8.6
100
534


328
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
14.8
100
577


329
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
8.5
100
534


330
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
12.7
100
577


331
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.7
100
591


332
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
6.5
100
592


333
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
9.2
100
600


334
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
8.3
100
591


335
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.0
100
562


336
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
9.9
100
610


337
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.0
100
560


338
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
11.3
100
550


339
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
8.6
100
649


340
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
11.9
100
626


341
Fmoc-D-Val
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
7.7
100
562


342
Fmoc-Gln(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
9.7
100
591


343
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
7.3
100
592


344
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
6.8
100
600


345
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
8.2
100
591


346
Fmoc-Nva
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.1
100
562


347
Fmoc-Phe
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.2
100
610


348
Fmoc-Pro
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
13.6
100
560


349
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.9
100
550


350
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
7.9
100
649


351
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.7
100
626


352
Fmoc-Val
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
10.1
100
562


353
Fmoc-Ala
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
10.4
100
557


354
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
13.4
100
600


355
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
8.3
100
557


356
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
17.6
100
600


357
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
10.5
100
614


358
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
6.9
100
615


359
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
7.3
100
623


360
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
6.8
100
614


361
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
11.0
100
585


362
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
11.8
100
633


363
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
8.6
87
583


364
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
9.4
100
573


365
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
8.2
100
672


366
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
12.3
95
649


367
Fmoc-D-Val
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
6.7
100
585


368
Fmoc-Gln(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
22.7
100
614


369
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
7.5
100
615


370
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
na
na
na


371
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
8.2
100
614


372
Fmoc-Nva
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
11.5
100
585


373
Fmoc-Phe
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
10.7
100
633


374
Fmoc-Pro
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
14.2
100
583


375
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
10.9
100
573


376
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
8.6
100
672


377
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
13.0
100
649


378
Fmoc-Val
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
11.2
100
585


379
Fmoc-Ala
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
11.0
100
534


380
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
16.8
100
577


381
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
8.9
100
534


382
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
15.0
100
577


383
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
10.8
100
591


384
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
6.7
100
592


385
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
13.0
100
600


386
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
10.1
100
591


387
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
13.3
100
562


388
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.8
100
610


389
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
11.3
100
560


390
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
13.9
100
550


391
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
7.2
100
649


392
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.8
100
626


393
Fmoc-D-Val
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
7.7
100
562


394
Fmoc-Gln(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
19.0
100
591


395
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
10.4
100
592


396
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
10.2
100
600


397
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
11.8
100
591


398
Fmoc-Nva
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.6
100
562


399
Fmoc-Phe
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.8
100
610


400
Fmoc-Pro
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.5
100
560


401
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
16.4
100
550


402
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
11.6
100
649


403
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
12.3
100
626


404
Fmoc-Val
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
9.8
100
562


405
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
7.8
100
619


406
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
7.3
100
642


407
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
5.8
100
619


408
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
7.1
100
642


409
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-Tyr(But)
Fmoc-S37
7.7
100
619


410
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S37
5.4
100
642


411
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-D-Tyr(But)
Fmoc-S37
5.5
100
619


412
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S37
5.7
100
642


413
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-S35
0.7
100
592


414
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-S35
1.5
100
569


415
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-S35
2.2
92
601


416
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-His(Trt)
Fmoc-S35
3.4
67
578


417
Fmoc-Phe
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
5.8
100
611


418
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
2.8
100
611


419
Fmoc-Val
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
5.5
72
563


420
Fmoc-D-Val
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
1.5
100
563


421
Fmoc-Ala
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
4.6
78
535


422
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
2.6
100
535


423
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
7.3
na
na


424
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
3.4
100
551


425
Fmoc-Leu
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
5.2
77
577


426
Fmoc-D-Leu
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
1.9
100
577


427
Fmoc-Gln(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
4.0
54
592


428
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
2.3
100
592


429
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
3.0
100
592


430
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.3
100
569


431
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.1
100
592


432
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.1
100
569


433
Fmoc-Phe
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.5
100
553


434
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.4
100
553


435
Fmoc-Val
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S35
2.0
92
563


436
Fmoc-D-Val
Fmoc-OX-1
Fmoc-D-Trp(Boc)
Fmoc-S35
4.8
100
563


437
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
8.4
100
586


438
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
12.3
100
563


439
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
10.5
100
586


440
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
12.3
100
563


441
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
7.7
100
559


442
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
4.2
100
536


443
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
7.1
100
559


444
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
6.4
100
536


445
Fmoc-Phe
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
1.6
100
547


446
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
2.8
96
547


447
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Phe
Fmoc-S37
10.9
100
561


448
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-D-Phe
Fmoc-S37
2.5
89
561


449
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-Ala
Fmoc-S37
0.2
100
444


450
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-D-Ala
Fmoc-S37
0.4
100
444


451
Fmoc-Ala
Fmoc-OX-13
Fmoc-Tyr(But)
Fmoc-S37
0.9
100
520


452
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-D-Tyr(But)
Fmoc-S37
2.8
100
520


453
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
1.4
96
586


454
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
0.8
67
563


455
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
1.9
100
586


456
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
3.0
91
563


457
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
2.1
100
559


458
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
1.7
68
536


459
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
1.8
100
559


460
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
1.3
100
536


461
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
3.6
100
501


462
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
4.1
100
501


463
Fmoc-Phe
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.0
na
na


464
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.3
95
504


465
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
7.5
65
485


466
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
7.4
100
485


467
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.0
79
444


468
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
1.6
100
444


469
Fmoc-Ala
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
1.4
100
428


470
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.2
100
428


471
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
3.0
100
543


472
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
1.5
100
520


473
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.6
90
543


474
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
1.2
91
520


475
Fmoc-Dap(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
3.5
90
443


476
Fmoc-D-Dap(Boc)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
4.0
87
443


477
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
2.1
na
na


478
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-Sar
Fmoc-S37
1.3
100
513


479
Fmoc-Dap(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
2.5
100
486


480
Fmoc-D-Dap(Boc)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
3.9
100
486


481
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-Phe
Fmoc-S37
2.1
100
589


482
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-D-Phe
Fmoc-S37
2.2
90
589


483
Fmoc-Val
Fmoc-OX-13
Fmoc-Tyr(But)
Fmoc-S37
3.6
87
548


484
Fmoc-D-Val
Fmoc-OX-13
Fmoc-D-Tyr(But)
Fmoc-S37
4.5
100
548


485
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
2.0
na
na


486
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
1.9
79
537


487
Fmoc-Pro
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
0.6
100
497


488
Fmoc-D-Fmoc-Pro
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S37
0.8
100
497


489
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
1.4
90
510


490
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
1.3
na
na


491
Fmoc-Pro
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
0.6
100
470


492
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S37
0.7
100
470


493
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
3.1
100
537


494
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
3.2
100
537


495
Fmoc-Pro
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
0.9
100
497


496
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S37
0.9
100
497


497
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
2.1
100
510


498
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
1.9
100
510


499
Fmoc-Pro
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
0.9
100
470


500
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S37
0.7
100
470


501
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
3.0
100
573


502
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
1.6
100
550


503
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
2.9
100
573


504
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
2.5
82
550


505
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
7.3
100
515


506
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
10.3
100
515


507
Fmoc-Phe
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
3.2
90
534


508
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
0.9
100
534


509
Fmoc-Dap(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
2.5
100
473


510
Fmoc-D-Dap(Boc)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
3.3
100
473


511
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
2.2
100
543


512
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
2.7
100
543


513
Fmoc-Val
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
4.2
100
486


514
Fmoc-D-Val
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
8.6
97
486


515
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S37
2.0
100
524


516
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S37
2.6
100
524


517
Fmoc-Pro
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
0.3
na
539


518
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
0.2
100
539


519
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.2
100
628


520
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
2.2
100
605


521
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.4
100
628


522
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.9
89
605


523
Fmoc-Phe
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.6
87
589


524
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.0
100
589


525
Fmoc-Val
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
2.2
100
541


526
Fmoc-D-Val
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
2.6
100
541


527
Fmoc-Ala
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
0.6
100
513


528
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
0.8
100
513


529
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.1
100
529


530
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-Arg(Pbf)
Fmoc-S37
1.2
100
529


531
Fmoc-Pro
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
na
na
na


532
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
0.3
100
539


533
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.0
100
628


534
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.6
100
605


535
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
0.8
100
628


536
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.3
100
605


537
Fmoc-Phe
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.4
100
589


538
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.7
100
589


539
Fmoc-Val
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.6
100
541


540
Fmoc-D-Val
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.8
100
541


541
Fmoc-Ala
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
0.4
100
513


542
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
0.5
100
513


543
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
0.6
100
529


544
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-D-Arg(Pbf)
Fmoc-S37
1.3
100
529


545
Fmoc-Phe
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
7.0
95
525


546
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
6.2
na
na


547
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Phe
Fmoc-S35
2.8
100
539


548
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-Ala
Fmoc-S35
1.3
100
422


549
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-D-Ala
Fmoc-S35
1.4
100
422


550
Fmoc-Ala
Fmoc-OX-13
Fmoc-Tyr(But)
Fmoc-S35
1.8
100
498


551
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-D-Tyr(But)
Fmoc-S35
2.2
100
498


552
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
na
na
na


553
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
4.9
86
541


554
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
5.0
100
564


555
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
0.9
63
541


556
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
4.9
89
514


557
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
4.0
100
514


558
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
3.0
100
479


559
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
4.2
100
479


560
Fmoc-Dap(Boc)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
3.7
92
464


561
Fmoc-D-Dap(Boc)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
3.6
100
464


562
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-Phe
Fmoc-S35
1.0
100
567


563
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-D-Phe
Fmoc-S35
1.6
100
567


564
Fmoc-Val
Fmoc-OX-13
Fmoc-Tyr(But)
Fmoc-S35
8.3
92
526


565
Fmoc-D-Val
Fmoc-OX-13
Fmoc-D-Tyr(But)
Fmoc-S35
5.8
100
526


566
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
4.3
100
515


567
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
5.3
96
515


568
Fmoc-Ala
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
2.6
100
449


569
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-Asn(Trt)
Fmoc-S35
2.6
100
449


570
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
3.1
90
488


571
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
4.3
100
488


572
Fmoc-Ala
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
1.3
100
422


573
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
2.8
100
422


574
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
5.1
100
515


575
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
5.4
100
515


576
Fmoc-Ala
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
2.4
100
449


577
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-D-Asn(Trt)
Fmoc-S35
2.1
100
449


578
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S35
4.2
100
488


579
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S35
3.7
100
488


580
Fmoc-Ala
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S35
2.1
100
422


581
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-D-Ser(But)
Fmoc-S35
1.7
100
422


582
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
3.4
100
551


583
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
3.6
100
528


584
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
5.3
100
551


585
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
4.0
100
528


586
Fmoc-Lys(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
7.7
100
493


587
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
7.6
100
493


588
Fmoc-Phe
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
7.0
88
512


589
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
3.1
100
512


590
Fmoc-Dap(Boc)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
3.9
100
451


591
Fmoc-D-Dap(Boc)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
1.7
100
451


592
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
2.9
100
521


593
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
1.7
100
521


594
Fmoc-Val
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
7.0
100
464


595
Fmoc-D-Val
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
9.9
100
464


596
Fmoc-His(Trt)
Fmoc-OX-13
Fmoc-Thr(But)
Fmoc-S35
0.3
100
502


597
Fmoc-D-His(Trt)
Fmoc-OX-13
Fmoc-D-Thr(But)
Fmoc-S35
5.4
100
502





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 2B







embedded image




















Cpd
R1
Q
R2





301
(S)-CH3
C═O


embedded image







302


embedded image


C═O


embedded image







303
(R)-CH3
C═O


embedded image







304


embedded image


C═O


embedded image







305


embedded image


C═O


embedded image







306


embedded image


C═O


embedded image







307


embedded image


C═O


embedded image







308


embedded image


C═O


embedded image







309


embedded image


C═O


embedded image







310


embedded image


C═O


embedded image







311


embedded image


C═O


embedded image







312


embedded image


C═O


embedded image







313


embedded image


C═O


embedded image







314


embedded image


C═O


embedded image







315


embedded image


C═O


embedded image







316


embedded image


C═O


embedded image







317


embedded image


C═O


embedded image







318


embedded image


C═O


embedded image







319


embedded image


C═O


embedded image







320


embedded image


C═O


embedded image







321


embedded image


C═O


embedded image







322


embedded image


C═O


embedded image







323


embedded image


C═O


embedded image







324


embedded image


C═O


embedded image







325


embedded image


C═O


embedded image







326


embedded image


C═O


embedded image







327
(S)-CH3
C═O


embedded image







328


embedded image


C═O


embedded image







329
(R)-CH3
C═O


embedded image







330


embedded image


C═O


embedded image







331


embedded image


C═O


embedded image







332


embedded image


C═O


embedded image







333


embedded image


C═O


embedded image







334


embedded image


C═O


embedded image







335


embedded image


C═O


embedded image







336


embedded image


C═O


embedded image







337


embedded image


C═O


embedded image







338


embedded image


C═O


embedded image







339


embedded image


C═O


embedded image







340


embedded image


C═O


embedded image







341


embedded image


C═O


embedded image







342


embedded image


C═O


embedded image







343


embedded image


C═O


embedded image







344


embedded image


C═O


embedded image







345


embedded image


C═O


embedded image







346


embedded image


C═O


embedded image







347


embedded image


C═O


embedded image







348


embedded image


C═O


embedded image







349


embedded image


C═O


embedded image







350


embedded image


C═O


embedded image







351


embedded image


C═O


embedded image







352


embedded image


C═O


embedded image







353
(S)-CH3
C═O


embedded image







354


embedded image


C═O


embedded image







355
(R)-CH3
C═O


embedded image







356


embedded image


C═O


embedded image







357


embedded image


C═O


embedded image







358


embedded image


C═O


embedded image







359


embedded image


C═O


embedded image







360


embedded image


C═O


embedded image







361


embedded image


C═O


embedded image







362


embedded image


C═O


embedded image







363


embedded image


C═O


embedded image







364


embedded image


C═O


embedded image







365


embedded image


C═O


embedded image







366


embedded image


C═O


embedded image







367


embedded image


C═O


embedded image







368


embedded image


C═O


embedded image







369


embedded image


C═O


embedded image







370


embedded image


C═O


embedded image







371


embedded image


C═O


embedded image







372


embedded image


C═O


embedded image







373


embedded image


C═O


embedded image







374


embedded image


C═O


embedded image







375


embedded image


C═O


embedded image







376


embedded image


C═O


embedded image







377


embedded image


C═O


embedded image







378


embedded image


C═O


embedded image







379
(S)-CH3
C═O


embedded image







380


embedded image


C═O


embedded image







381
(R)-CH3
C═O


embedded image







382


embedded image


C═O


embedded image







383


embedded image


C═O


embedded image







384


embedded image


C═O


embedded image







385


embedded image


C═O


embedded image







386


embedded image


C═O


embedded image







387


embedded image


C═O


embedded image







388


embedded image


C═O


embedded image







389


embedded image


C═O


embedded image







390


embedded image


C═O


embedded image







391


embedded image


C═O


embedded image







392


embedded image


C═O


embedded image







393


embedded image


C═O


embedded image







394


embedded image


C═O


embedded image







395


embedded image


C═O


embedded image







396


embedded image


C═O


embedded image







397


embedded image


C═O


embedded image







398


embedded image


C═O


embedded image







399


embedded image


C═O


embedded image







400


embedded image


C═O


embedded image







401


embedded image


C═O


embedded image







402


embedded image


C═O


embedded image







403


embedded image


C═O


embedded image







404


embedded image


C═O


embedded image







405


embedded image


C═O


embedded image







406


embedded image


C═O


embedded image







407


embedded image


C═O


embedded image







408


embedded image


C═O


embedded image







409


embedded image


C═O


embedded image







410


embedded image


C═O


embedded image







411


embedded image


C═O


embedded image







412


embedded image


C═O


embedded image







413


embedded image


C═O


embedded image







414


embedded image


C═O


embedded image







415


embedded image


C═O


embedded image







416


embedded image


C═O


embedded image







417


embedded image


C═O


embedded image







418


embedded image


C═O


embedded image







419


embedded image


C═O


embedded image







420


embedded image


C═O


embedded image







421
(S)-CH3
C═O


embedded image







422
(R)-CH3
C═O


embedded image







423


embedded image


C═O


embedded image







424


embedded image


C═O


embedded image







425


embedded image


C═O


embedded image







426


embedded image


C═O


embedded image







427


embedded image


C═O


embedded image







428


embedded image


C═O


embedded image







429


embedded image


C═O


embedded image







430


embedded image


C═O


embedded image







431


embedded image


C═O


embedded image







432


embedded image


C═O


embedded image







433


embedded image


C═O


embedded image







434


embedded image


C═O


embedded image







435


embedded image


C═O


embedded image







436


embedded image


C═O


embedded image







437


embedded image


CH2


embedded image







438


embedded image


CH2


embedded image







439


embedded image


CH2


embedded image







440


embedded image


CH2


embedded image







441


embedded image


CH2


embedded image







442


embedded image


CH2


embedded image







443


embedded image


CH2


embedded image







444


embedded image


CH2


embedded image







445


embedded image


CH2


embedded image







446


embedded image


CH2


embedded image







447


embedded image


CH2


embedded image







448


embedded image


CH2


embedded image







449


embedded image


CH2


embedded image







450


embedded image


CH2


embedded image







451
(S)-CH3
CH2


embedded image







452
(R)-CH3
CH2


embedded image







453


embedded image


CH2


embedded image







454


embedded image


CH2


embedded image







455


embedded image


CH2


embedded image







456


embedded image


CH2


embedded image







457


embedded image


CH2


embedded image







458


embedded image


CH2


embedded image







459


embedded image


CH2


embedded image







460


embedded image


CH2


embedded image







461


embedded image


CH2


embedded image







462


embedded image


CH2


embedded image







463


embedded image


CH2


embedded image







464


embedded image


CH2


embedded image







465


embedded image


CH2


embedded image







466


embedded image


CH2


embedded image







467


embedded image


CH2


embedded image







468


embedded image


CH2


embedded image







469
(S)-CH3
CH2


embedded image







470
(R)-CH3
CH2


embedded image







471


embedded image


CH2


embedded image







472


embedded image


CH2


embedded image







473


embedded image


CH2


embedded image







474


embedded image


CH2


embedded image







475


embedded image


CH2


embedded image







476


embedded image


CH2


embedded image







477


embedded image


CH2


embedded image







478


embedded image


CH2


embedded image







479


embedded image


CH2


embedded image







480


embedded image


CH2


embedded image







481


embedded image


CH2


embedded image







482


embedded image


CH2


embedded image







483


embedded image


CH2


embedded image







484


embedded image


CH2


embedded image







485


embedded image


CH2


embedded image







486


embedded image


CH2


embedded image







487


embedded image


CH2


embedded image







488


embedded image


CH2


embedded image







489


embedded image


CH2


embedded image







490


embedded image


CH2


embedded image







491


embedded image


CH2


embedded image







492


embedded image


CH2


embedded image







493


embedded image


CH2


embedded image







494


embedded image


CH2


embedded image







495


embedded image


CH2


embedded image







496


embedded image


CH2


embedded image







497


embedded image


CH2


embedded image







498


embedded image


CH2


embedded image







499


embedded image


CH2


embedded image







500


embedded image


CH2


embedded image







501


embedded image


CH2


embedded image







502


embedded image


CH2


embedded image







503


embedded image


CH2


embedded image







504


embedded image


CH2


embedded image







505


embedded image


CH2


embedded image







506


embedded image


CH2


embedded image







507


embedded image


CH2


embedded image







508


embedded image


CH2


embedded image







509


embedded image


CH2


embedded image







510


embedded image


CH2


embedded image







511


embedded image


CH2


embedded image







512


embedded image


CH2


embedded image







513


embedded image


CH2


embedded image







514


embedded image


CH2


embedded image







515


embedded image


CH2


embedded image







516


embedded image


CH2


embedded image







517


embedded image


CH2


embedded image







518


embedded image


CH2


embedded image







519


embedded image


CH2


embedded image







520


embedded image


CH2


embedded image







521


embedded image


CH2


embedded image







522


embedded image


CH2


embedded image







523


embedded image


CH2


embedded image







524


embedded image


CH2


embedded image







525


embedded image


CH2


embedded image







526


embedded image


CH2


embedded image







527
(S)-CH3
CH2


embedded image







528
(R)-CH3
CH2


embedded image







529


embedded image


CH2


embedded image







530


embedded image


CH2


embedded image







531


embedded image


CH2


embedded image







532


embedded image


CH2


embedded image







533


embedded image


CH2


embedded image







534


embedded image


CH2


embedded image







535


embedded image


CH2


embedded image







536


embedded image


CH2


embedded image







537


embedded image


CH2


embedded image







538


embedded image


CH2


embedded image







539


embedded image


CH2


embedded image







540


embedded image


CH2


embedded image







541
(S)-CH3
CH2


embedded image







542
(R)-CH3
CH2


embedded image







543


embedded image


CH2


embedded image







544


embedded image


CH2


embedded image







545


embedded image


CH2


embedded image







546


embedded image


CH2


embedded image







547


embedded image


CH2


embedded image







548


embedded image


CH2


embedded image







549


embedded image


CH2


embedded image







550
(S)-CH3
CH2


embedded image







551
(R)-CH3
CH2


embedded image







552


embedded image


CH2


embedded image







553


embedded image


CH2


embedded image







554


embedded image


CH2


embedded image







555


embedded image


CH2


embedded image







556


embedded image


CH2


embedded image







557


embedded image


CH2


embedded image







558


embedded image


CH2


embedded image







559


embedded image


CH2


embedded image







560


embedded image


CH2


embedded image







561


embedded image


CH2


embedded image







562


embedded image


CH2


embedded image







563


embedded image


CH2


embedded image







564


embedded image


CH2


embedded image







565


embedded image


CH2


embedded image







566


embedded image


CH2


embedded image







567


embedded image


CH2


embedded image







568
(S)-CH3
CH2


embedded image







569
(R)-CH3
CH2


embedded image







570


embedded image


CH2


embedded image







571


embedded image


CH2


embedded image







572
(S)-CH3
CH2


embedded image







573
(R)-CH3
CH2


embedded image







574


embedded image


CH2


embedded image







575


embedded image


CH2


embedded image







576
(S)-CH3
CH2


embedded image







577
(R)-CH3
CH2


embedded image







578


embedded image


CH2


embedded image







579


embedded image


CH2


embedded image







580
(S)-CH3
CH2


embedded image







581
(R)-CH3
CH2


embedded image







582


embedded image


CH2


embedded image







583


embedded image


CH2


embedded image







584


embedded image


CH2


embedded image







585


embedded image


CH2


embedded image







586


embedded image


CH2


embedded image







587


embedded image


CH2


embedded image







588


embedded image


CH2


embedded image







589


embedded image


CH2


embedded image







590


embedded image


CH2


embedded image







591


embedded image


CH2


embedded image







592


embedded image


CH2


embedded image







593


embedded image


CH2


embedded image







594


embedded image


CH2


embedded image







595


embedded image


CH2


embedded image







596


embedded image


CH2


embedded image







597


embedded image


CH2


embedded image







Cpd
R3
R4
R7





301


embedded image


H


embedded image







302


embedded image


H


embedded image







303


embedded image


H


embedded image







304


embedded image


H


embedded image







305


embedded image


H


embedded image







306


embedded image


H


embedded image







307


embedded image


H


embedded image







308


embedded image


H


embedded image







309


embedded image


H


embedded image







310


embedded image


H


embedded image







311


embedded image


H


embedded image







312


embedded image


H


embedded image







313


embedded image


H


embedded image







314


embedded image


H


embedded image







315


embedded image


H


embedded image







316


embedded image


H


embedded image







317


embedded image


H


embedded image







318


embedded image


H


embedded image







319


embedded image


H


embedded image







320


embedded image


H


embedded image







321


embedded image


H


embedded image







322


embedded image


H


embedded image







323


embedded image


H


embedded image







324


embedded image


H


embedded image







325


embedded image


H


embedded image







326


embedded image


H


embedded image







327


embedded image


H


embedded image







328


embedded image


H


embedded image







329


embedded image


H


embedded image







330


embedded image


H


embedded image







331


embedded image


H


embedded image







332


embedded image


H


embedded image







333


embedded image


H


embedded image







334


embedded image


H


embedded image







335


embedded image


H


embedded image







336


embedded image


H


embedded image







337


embedded image


H


embedded image







338


embedded image


H


embedded image







339


embedded image


H


embedded image







340


embedded image


H


embedded image







341


embedded image


H


embedded image







342


embedded image


H


embedded image







343


embedded image


H


embedded image







344


embedded image


H


embedded image







345


embedded image


H


embedded image







346


embedded image


H


embedded image







347


embedded image


H


embedded image







348


embedded image


H


embedded image







349


embedded image


H


embedded image







350


embedded image


H


embedded image







351


embedded image


H


embedded image







352


embedded image


H


embedded image







353


embedded image


H


embedded image







354


embedded image


H


embedded image







355


embedded image


H


embedded image







356


embedded image


H


embedded image







357


embedded image


H


embedded image







358


embedded image


H


embedded image







359


embedded image


H


embedded image







360


embedded image


H


embedded image







361


embedded image


H


embedded image







362


embedded image


H


embedded image







363


embedded image


H


embedded image







364


embedded image


H


embedded image







365


embedded image


H


embedded image







366


embedded image


H


embedded image







367


embedded image


H


embedded image







368


embedded image


H


embedded image







369


embedded image


H


embedded image







370


embedded image


H


embedded image







371


embedded image


H


embedded image







372


embedded image


H


embedded image







373


embedded image


H


embedded image







374


embedded image


H


embedded image







375


embedded image


H


embedded image







376


embedded image


H


embedded image







377


embedded image


H


embedded image







378


embedded image


H


embedded image







379


embedded image


H


embedded image







380


embedded image


H


embedded image







381


embedded image


H


embedded image







382


embedded image


H


embedded image







383


embedded image


H


embedded image







384


embedded image


H


embedded image







385


embedded image


H


embedded image







386


embedded image


H


embedded image







387


embedded image


H


embedded image







388


embedded image


H


embedded image







389


embedded image


H


embedded image







390


embedded image


H


embedded image







391


embedded image


H


embedded image







392


embedded image


H


embedded image







393


embedded image


H


embedded image







394


embedded image


H


embedded image







395


embedded image


H


embedded image







396


embedded image


H


embedded image







397


embedded image


H


embedded image







398


embedded image


H


embedded image







399


embedded image


H


embedded image







400


embedded image


H


embedded image







401


embedded image


H


embedded image







402


embedded image


H


embedded image







403


embedded image


H


embedded image







404


embedded image


H


embedded image







405


embedded image


H


embedded image







406


embedded image


H


embedded image







407


embedded image


H


embedded image







408


embedded image


H


embedded image







409


embedded image


H


embedded image







410


embedded image


H


embedded image







411


embedded image


H


embedded image







412


embedded image


H


embedded image







413


embedded image


H


embedded image







414


embedded image


H


embedded image







415


embedded image


H


embedded image







416


embedded image


H


embedded image







417


embedded image


H


embedded image







418


embedded image


H


embedded image







419


embedded image


H


embedded image







420


embedded image


H


embedded image







421


embedded image


H


embedded image







422


embedded image


H


embedded image







423


embedded image


H


embedded image







424


embedded image


H


embedded image







425


embedded image


H


embedded image







426


embedded image


H


embedded image







427


embedded image


H


embedded image







428


embedded image


H


embedded image







429


embedded image


H


embedded image







430


embedded image


H


embedded image







431


embedded image


H


embedded image







432


embedded image


H


embedded image







433


embedded image


H


embedded image







434


embedded image


H


embedded image







435


embedded image


H


embedded image







436


embedded image


H


embedded image







437


embedded image


H


embedded image







438


embedded image


H


embedded image







439


embedded image


H


embedded image







440


embedded image


H


embedded image







441


embedded image


H


embedded image







442


embedded image


H


embedded image







443


embedded image


H


embedded image







444


embedded image


H


embedded image







445


embedded image


H


embedded image







446


embedded image


H


embedded image







447


embedded image


H


embedded image







448


embedded image


H


embedded image







449
(S)-CH3
H


embedded image







450
(R)-CH3
H


embedded image







451


embedded image


H


embedded image







452


embedded image


H


embedded image







453


embedded image


H


embedded image







454


embedded image


H


embedded image







455


embedded image


H


embedded image







456


embedded image


H


embedded image







457


embedded image


H


embedded image







458


embedded image


H


embedded image







459


embedded image


H


embedded image







460


embedded image


H


embedded image







461


embedded image


H


embedded image







462


embedded image


H


embedded image







463
H
Me


embedded image







464
H
Me


embedded image







465
H
Me


embedded image







466
H
Me


embedded image







467
H
Me


embedded image







468
H
Me


embedded image







469
H
Me


embedded image







470
H
Me


embedded image







471
H
Me


embedded image







472
H
Me


embedded image







473
H
Me


embedded image







474
H
Me


embedded image







475
H
Me


embedded image







476
H
Me


embedded image







477
H
Me


embedded image







478
H
Me


embedded image







479


embedded image


H


embedded image







480


embedded image


H


embedded image







481


embedded image


H


embedded image







482


embedded image


H


embedded image







483


embedded image


H


embedded image







484


embedded image


H


embedded image







485


embedded image


H


embedded image







486


embedded image


H


embedded image







487


embedded image


H


embedded image







488


embedded image


H


embedded image







489


embedded image


H


embedded image







490


embedded image


H


embedded image







491


embedded image


H


embedded image







492


embedded image


H


embedded image







493


embedded image


H


embedded image







494


embedded image


H


embedded image







495


embedded image


H


embedded image







496


embedded image


H


embedded image







497


embedded image


H


embedded image







498


embedded image


H


embedded image







499


embedded image


H


embedded image







500


embedded image


H


embedded image







501


embedded image


H


embedded image







502


embedded image


H


embedded image







503


embedded image


H


embedded image







504


embedded image


H


embedded image







505


embedded image


H


embedded image







506


embedded image


H


embedded image







507


embedded image


H


embedded image







508


embedded image


H


embedded image







509


embedded image


H


embedded image







510


embedded image


H


embedded image







511


embedded image


H


embedded image







512


embedded image


H


embedded image







513


embedded image


H


embedded image







514


embedded image


H


embedded image







515


embedded image


H


embedded image







516


embedded image


H


embedded image







517


embedded image


H


embedded image







518


embedded image


H


embedded image







519


embedded image


H


embedded image







520


embedded image


H


embedded image







521


embedded image


H


embedded image







522


embedded image


H


embedded image







523


embedded image


H


embedded image







524


embedded image


H


embedded image







525


embedded image


H


embedded image







526


embedded image


H


embedded image







527


embedded image


H


embedded image







528


embedded image


H


embedded image







529


embedded image


H


embedded image







530


embedded image


H


embedded image







531


embedded image


H


embedded image







532


embedded image


H


embedded image







533


embedded image


H


embedded image







534


embedded image


H


embedded image







535


embedded image


H


embedded image







536


embedded image


H


embedded image







537


embedded image


H


embedded image







538


embedded image


H


embedded image







539


embedded image


H


embedded image







540


embedded image


H


embedded image







541


embedded image


H


embedded image







542


embedded image


H


embedded image







543


embedded image


H


embedded image







544


embedded image


H


embedded image







545


embedded image


H


embedded image







546


embedded image


H


embedded image







547


embedded image


H


embedded image







548
(S)-CH3
H


embedded image







549
(R)-CH3
H


embedded image







550


embedded image


H


embedded image







551


embedded image


H


embedded image







552


embedded image


H


embedded image







553


embedded image


H


embedded image







554


embedded image


H


embedded image







555


embedded image


H


embedded image







556


embedded image


H


embedded image







557


embedded image


H


embedded image







558


embedded image


H


embedded image







559


embedded image


H


embedded image







560


embedded image


H


embedded image







561


embedded image


H


embedded image







562


embedded image


H


embedded image







563


embedded image


H


embedded image







564


embedded image


H


embedded image







565


embedded image


H


embedded image







566


embedded image


H


embedded image







567


embedded image


H


embedded image







568


embedded image


H


embedded image







569


embedded image


H


embedded image







570


embedded image


H


embedded image







571


embedded image


H


embedded image







572


embedded image


H


embedded image







573


embedded image


H


embedded image







574


embedded image


H


embedded image







575


embedded image


H


embedded image







576


embedded image


H


embedded image







577


embedded image


H


embedded image







578


embedded image


H


embedded image







579


embedded image


H


embedded image







580


embedded image


H


embedded image







581


embedded image


H


embedded image







582


embedded image


H


embedded image







583


embedded image


H


embedded image







584


embedded image


H


embedded image







585


embedded image


H


embedded image







586


embedded image


H


embedded image







587


embedded image


H


embedded image







588


embedded image


H


embedded image







589


embedded image


H


embedded image







590


embedded image


H


embedded image







591


embedded image


H


embedded image







592


embedded image


H


embedded image







593


embedded image


H


embedded image







594


embedded image


H


embedded image







595


embedded image


H


embedded image







596


embedded image


H


embedded image







597


embedded image


H


embedded image











For all compounds R5═H and R6═H, except for those compounds in which Fmoc-Pro or Fmoc-D-Pro is BB1 wherein R1 and (N)R6 form a cyclic five-membered ring, including the nitrogen atom, as shown for R1 in Table 2B and those compounds in which BB4 is Fmoc-S35 wherein (N)R5 and R7 are part of a six-membered ring, including the nitrogen atom, as shown for R7 in Table 2B.


Example 4
Synthesis of a Representative Library of Macrocyclic Compounds of Formula (Ia)

The synthetic scheme presented in Scheme 4 was followed to prepare the library of macrocyclic compounds 601-948 on solid support. The first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D), then, after removal of the Fmoc protection (Method 1F), the second amino acid building block (BB2) attached through amide bond formation (Method 1G). The Fmoc group was cleaved (Method 1F), then the oxazole building block (BB3) attached by reductive amination (Method 1J) or amide coupling (Method 1G) to extend the intermediate chain. After deprotection (Method 1F), the final building block was then added using reductive amination (Method 1I or 1J) to complete the pre-cyclization intermediate. Deprotection of the N-terminal Fmoc group (Method 1F), cleavage from the resin (Method 1Q), macrocyclization (Method 1R) and removal of the side chain protecting groups (Method 1S) followed by evaporation under reduced pressure gave the crude macrocycle. The results after purification by preparative HPLC (Method 2B) are included in Table 3A, including, for each compound, the amounts obtained, the HPLC purity and the confirmation of identity by MS. The macrocyclic structures are provided in Table 3B.
















TABLE 3A





Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
MS (M + H)






















601
Fmoc-D-Trp(Boc)
Fmoc-Ala
Fmoc-OX-1
Fmoc-S37
4.4
100
557


602
Fmoc-D-Tyr(But)
Fmoc-Ala
Fmoc-OX-1
Fmoc-S37
4.2
100
534


603
Fmoc-Trp(Boc)
Fmoc-Ala
Fmoc-OX-1
Fmoc-S37
7.0
97
557


604
Fmoc-Tyr(But)
Fmoc-Ala
Fmoc-OX-1
Fmoc-S37
6.6
100
534


605
Fmoc-D-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
11.1
100
600


606
Fmoc-D-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
16.8
100
577


607
Fmoc-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
19.0
100
600


608
Fmoc-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
14.0
100
577


609
Fmoc-D-Trp(Boc)
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-S37
7.7
100
557


610
Fmoc-D-Tyr(But)
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-S37
3.3
100
534


611
Fmoc-Trp(Boc)
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-S37
7.9
95
557


612
Fmoc-Tyr(But)
Fmoc-D-Ala
Fmoc-OX-1
Fmoc-S37
3.0
100
534


613
Fmoc-D-Trp(Boc)
Fmoc-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
5.0
100
572


614
Fmoc-D-Tyr(But)
Fmoc-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
4.1
100
549


615
Fmoc-Trp(Boc)
Fmoc-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
6.1
100
572


616
Fmoc-Tyr(But)
Fmoc-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
4.9
100
549


617
Fmoc-D-Trp(Boc)
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
16.3
100
600


618
Fmoc-D-Tyr(But)
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
11.7
91
577


619
Fmoc-Trp(Boc)
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
13.6
100
600


620
Fmoc-Tyr(But)
Fmoc-D-Asn(Trt)
Fmoc-OX-1
Fmoc-S37
11.0
100
577


621
Fmoc-D-Trp(Boc)
Fmoc-D-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
7.3
100
572


622
Fmoc-D-Tyr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
5.5
100
549


623
Fmoc-Trp(Boc)
Fmoc-D-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
7.0
100
572


624
Fmoc-Tyr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-1
Fmoc-S37
7.0
100
549


625
Fmoc-D-Trp(Boc)
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-S37
6.7
100
614


626
Fmoc-D-Tyr(But)
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-S37
1.7
100
591


627
Fmoc-Trp(Boc)
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-S37
10.7
100
614


628
Fmoc-Tyr(But)
Fmoc-D-Gln(Trt)
Fmoc-OX-1
Fmoc-S37
13.6
100
591


629
Fmoc-D-Trp(Boc)
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
5.8
100
615


630
Fmoc-D-Tyr(But)
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
7.3
100
592


631
Fmoc-Trp(Boc)
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
8.5
100
615


632
Fmoc-Tyr(But)
Fmoc-D-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
11.0
100
592


633
Fmoc-D-Trp(Boc)
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-S37
5.4
100
623


634
Fmoc-D-Tyr(But)
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-S37
5.8
100
600


635
Fmoc-Trp(Boc)
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-S37
5.6
100
623


636
Fmoc-Tyr(But)
Fmoc-D-His(Trt)
Fmoc-OX-1
Fmoc-S37
5.9
100
600


637
Fmoc-D-Trp(Boc)
Fmoc-D-Ile
Fmoc-OX-1
Fmoc-S37
6.0
99
599


638
Fmoc-D-Tyr(But)
Fmoc-D-Ile
Fmoc-OX-1
Fmoc-S37
6.5
100
576


639
Fmoc-Trp(Boc)
Fmoc-D-Ile
Fmoc-OX-1
Fmoc-S37
11.2
94
599


640
Fmoc-Tyr(But)
Fmoc-D-Ile
Fmoc-OX-1
Fmoc-S37
7.8
100
576


641
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
5.0
100
614


642
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
6.0
100
591


643
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
6.4
100
614


644
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
16.0
100
591


645
Fmoc-D-Trp(Boc)
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-S37
5.6
100
585


646
Fmoc-D-Tyr(But)
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-S37
6.1
100
562


647
Fmoc-Trp(Boc)
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-S37
6.1
100
585


648
Fmoc-Tyr(But)
Fmoc-D-Nva
Fmoc-OX-1
Fmoc-S31
1.4
100
500


649
Fmoc-D-Trp(Boc)
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-S37
12.1
100
633


650
Fmoc-D-Tyr(But)
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-S37
9.0
100
610


651
Fmoc-Trp(Boc)
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-S37
8.8
100
633


652
Fmoc-Tyr(But)
Fmoc-D-Phe
Fmoc-OX-1
Fmoc-S37
10.1
100
610


653
Fmoc-D-Trp(Boc)
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-S37
5.5
100
583


654
Fmoc-D-Tyr(But)
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-S37
4.3
100
560


655
Fmoc-Trp(Boc)
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-S37
7.2
96
583


656
Fmoc-Tyr(But)
Fmoc-D-Pro
Fmoc-OX-1
Fmoc-S37
6.3
100
560


657
Fmoc-D-Trp(Boc)
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-S37
8.0
100
573


658
Fmoc-D-Tyr(But)
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-S37
6.0
100
550


659
Fmoc-Trp(Boc)
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-S37
6.1
100
573


660
Fmoc-Tyr(But)
Fmoc-D-Ser(But)
Fmoc-OX-1
Fmoc-S37
6.9
100
550


661
Fmoc-Ala
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.1
100
557


662
Fmoc-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
17.3
100
600


663
Fmoc-Asp(OBut)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.1
100
601


664
Fmoc-D-Ala
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.7
100
557


665
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
17.4
100
600


666
Fmoc-D-Asp(OBut)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.9
100
601


667
Fmoc-D-His(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
0.3
100
623


668
Fmoc-D-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.7
100
614


669
Fmoc-D-Nva
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.6
100
585


670
Fmoc-D-Phe
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
10.0
100
633


671
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
5.5
100
583


672
Fmoc-D-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.9
100
573


673
Fmoc-D-Trp(Boc)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.6
100
672


674
Fmoc-D-Tyr(But)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.0
100
649


675
Fmoc-D-Val
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.5
100
585


676
Fmoc-His(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.4
100
623


677
Fmoc-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
11.8
100
614


678
Fmoc-Nva
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
11.0
100
585


679
Fmoc-Phe
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
13.2
98
633


680
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.7
100
583


681
Fmoc-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
13.4
100
573


682
Fmoc-Trp(Boc)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
12.6
100
672


683
Fmoc-Tyr(But)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
11.3
100
649


684
Fmoc-Val
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
10.5
100
585


685
Fmoc-Ala
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.8
100
534


686
Fmoc-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
18.8
100
577


687
Fmoc-Asp(OBut)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.8
100
578


688
Fmoc-D-Ala
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.3
100
534


689
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
16.3
100
577


690
Fmoc-D-Asp(OBut)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
11.4
100
578


691
Fmoc-D-His(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.9
100
600


692
Fmoc-D-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
10.3
100
591


693
Fmoc-D-Nva
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.2
100
562


694
Fmoc-D-Phe
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.5
100
610


695
Fmoc-D-Pro
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
5.3
100
560


696
Fmoc-D-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
11.5
100
550


697
Fmoc-D-Trp(Boc)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.5
100
649


698
Fmoc-D-Tyr(But)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.4
100
626


699
Fmoc-D-Val
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.2
100
562


700
Fmoc-His(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.5
100
600


701
Fmoc-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
2.4
100
591


702
Fmoc-Nva
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
10.4
100
562


703
Fmoc-Phe
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.3
100
610


704
Fmoc-Pro
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
5.2
100
560


705
Fmoc-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
11.6
100
550


706
Fmoc-Trp(Boc)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.9
100
649


707
Fmoc-Tyr(But)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
12.3
100
626


708
Fmoc-Val
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
10.0
100
562


709
Fmoc-D-Trp(Boc)
Fmoc-D-Val
Fmoc-OX-1
Fmoc-S37
10.6
100
585


710
Fmoc-D-Tyr(But)
Fmoc-D-Val
Fmoc-OX-1
Fmoc-S37
7.1
100
562


711
Fmoc-Trp(Boc)
Fmoc-D-Val
Fmoc-OX-1
Fmoc-S37
8.8
92
585


712
Fmoc-Tyr(But)
Fmoc-D-Val
Fmoc-OX-1
Fmoc-S37
8.0
100
562


713
Fmoc-D-Trp(Boc)
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
6.7
100
615


714
Fmoc-D-Tyr(But)
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
7.7
100
592


715
Fmoc-Trp(Boc)
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
5.1
100
615


716
Fmoc-Tyr(But)
Fmoc-Glu(OBut)
Fmoc-OX-1
Fmoc-S37
6.0
100
592


717
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-OX-1
Fmoc-S37
5.6
100
557


718
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-OX-1
Fmoc-S37
5.5
100
534


719
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-OX-1
Fmoc-S37
5.0
100
557


720
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-OX-1
Fmoc-S37
5.9
100
534


721
Fmoc-D-Trp(Boc)
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-S37
9.5
100
623


722
Fmoc-D-Tyr(But)
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-S37
7.5
100
600


723
Fmoc-Trp(Boc)
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-S37
5.4
100
623


724
Fmoc-Tyr(But)
Fmoc-His(Trt)
Fmoc-OX-1
Fmoc-S37
6.6
100
600


725
Fmoc-D-Trp(Boc)
Fmoc-Ile
Fmoc-OX-1
Fmoc-S37
9.6
96
599


726
Fmoc-D-Tyr(But)
Fmoc-Ile
Fmoc-OX-1
Fmoc-S37
9.1
100
576


727
Fmoc-Trp(Boc)
Fmoc-Ile
Fmoc-OX-1
Fmoc-S37
5.4
100
599


728
Fmoc-Tyr(But)
Fmoc-Ile
Fmoc-OX-1
Fmoc-S37
5.5
100
576


729
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
7.5
100
614


730
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
9.6
100
591


731
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
6.1
100
614


732
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-1
Fmoc-S37
4.9
100
591


733
Fmoc-D-Trp(Boc)
Fmoc-Nva
Fmoc-OX-1
Fmoc-S37
7.1
95
585


734
Fmoc-D-Tyr(But)
Fmoc-Nva
Fmoc-OX-1
Fmoc-S37
5.8
100
562


735
Fmoc-Trp(Boc)
Fmoc-Nva
Fmoc-OX-1
Fmoc-S37
5.3
100
585


736
Fmoc-Tyr(But)
Fmoc-Nva
Fmoc-OX-1
Fmoc-S37
4.9
100
562


737
Fmoc-D-Trp(Boc)
Fmoc-Phe
Fmoc-OX-1
Fmoc-S37
7.3
87
633


738
Fmoc-D-Tyr(But)
Fmoc-Phe
Fmoc-OX-1
Fmoc-S37
10.7
100
610


739
Fmoc-Trp(Boc)
Fmoc-Phe
Fmoc-OX-1
Fmoc-S37
7.6
100
633


740
Fmoc-Tyr(But)
Fmoc-Phe
Fmoc-OX-1
Fmoc-S37
7.9
100
610


741
Fmoc-D-Trp(Boc)
Fmoc-Pro
Fmoc-OX-1
Fmoc-S37
5.3
100
583


742
Fmoc-D-Tyr(But)
Fmoc-Pro
Fmoc-OX-1
Fmoc-S37
4.1
100
560


743
Fmoc-Trp(Boc)
Fmoc-Pro
Fmoc-OX-1
Fmoc-S37
5.5
100
583


744
Fmoc-Tyr(But)
Fmoc-Pro
Fmoc-OX-1
Fmoc-S37
4.7
100
560


745
Fmoc-D-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-S37
6.0
100
573


746
Fmoc-D-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-S37
5.9
100
550


747
Fmoc-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-S37
6.2
100
573


748
Fmoc-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-1
Fmoc-S37
13.1
100
550


749
Fmoc-Ala
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.5
100
557


750
Fmoc-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
12.3
100
600


751
Fmoc-Asp(OBut)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.3
100
601


752
Fmoc-D-Ala
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.8
100
557


753
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
12.7
100
600


754
Fmoc-D-Asp(OBut)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.3
100
601


755
Fmoc-D-His(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.3
100
623


756
Fmoc-D-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
11.4
100
614


757
Fmoc-D-Nva
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.4
100
585


758
Fmoc-D-Phe
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
9.7
100
633


759
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
4.7
100
583


760
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
10.3
100
573


761
Fmoc-D-Trp(Boc)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
11.7
100
672


762
Fmoc-D-Tyr(But)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
10.0
100
649


763
Fmoc-D-Val
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.7
100
585


764
Fmoc-His(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.2
100
623


765
Fmoc-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.1
100
614


766
Fmoc-Nva
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.0
100
585


767
Fmoc-Phe
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.5
100
633


768
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.9
100
583


769
Fmoc-Ser(But)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
7.6
100
573


770
Fmoc-Trp(Boc)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.7
96
672


771
Fmoc-Tyr(But)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
14.5
100
649


772
Fmoc-Val
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.3
100
585


773
Fmoc-Ala
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.3
100
534


774
Fmoc-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
14.6
100
577


775
Fmoc-Asp(OBut)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
5.3
100
578


776
Fmoc-D-Ala
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.1
100
534


777
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
16.2
100
577


778
Fmoc-D-Asp(OBut)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.7
100
578


779
Fmoc-D-His(Trt)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.2
100
600


780
Fmoc-D-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
12.0
100
591


781
Fmoc-D-Nva
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
10.1
100
562


782
Fmoc-D-Phe
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.7
100
610


783
Fmoc-D-Pro
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.0
100
560


784
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.4
100
550


785
Fmoc-D-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.6
95
649


786
Fmoc-D-Tyr(But)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.2
100
626


787
Fmoc-D-Val
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.5
100
562


788
Fmoc-His(Trt)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.6
100
600


789
Fmoc-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
9.6
100
591


790
Fmoc-Nva
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.1
100
562


791
Fmoc-Phe
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.7
100
610


792
Fmoc-Pro
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
10.8
100
560


793
Fmoc-Ser(But)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
15.5
100
550


794
Fmoc-Trp(Boc)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.4
100
649


795
Fmoc-Tyr(But)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
5.7
100
626


796
Fmoc-Val
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.2
100
562


797
Fmoc-D-Trp(Boc)
Fmoc-Val
Fmoc-OX-1
Fmoc-S37
7.4
100
585


798
Fmoc-D-Tyr(But)
Fmoc-Val
Fmoc-OX-1
Fmoc-S37
7.9
100
562


799
Fmoc-Trp(Boc)
Fmoc-Val
Fmoc-OX-1
Fmoc-S37
6.0
100
585


800
Fmoc-Tyr(But)
Fmoc-Val
Fmoc-OX-1
Fmoc-S37
6.1
100
562


801
Fmoc-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.7
100
619


802
Fmoc-Arg(Pbf)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.1
100
642


803
Fmoc-Arg(Pbf)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
8.4
100
619


804
Fmoc-Arg(Pbf)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
8.1
100
642


805
Fmoc-D-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-OX-1
Fmoc-S37
7.7
100
619


806
Fmoc-D-Arg(Pbf)
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
5.1
100
642


807
Fmoc-D-Arg(Pbf)
Fmoc-D-Tyr(But)
Fmoc-OX-1
Fmoc-S37
6.5
100
619


808
Fmoc-D-Arg(Pbf)
Fmoc-D-Trp(Boc)
Fmoc-OX-1
Fmoc-S37
6.3
100
642


809
Fmoc-D-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
11.5
100
642


810
Fmoc-D-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
13.2
100
619


811
Fmoc-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
5.4
100
642


812
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
8.3
100
619


813
Fmoc-D-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
8.7
100
642


814
Fmoc-D-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
8.6
100
619


815
Fmoc-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
12.2
100
642


816
Fmoc-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-1
Fmoc-S37
14.8
100
619


817
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-S37
10.5
100
586


818
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-S37
12.5
92
563


819
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-S37
11.0
100
586


820
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-S37
11.6
100
563


821
Fmoc-D-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-OX-13
Fmoc-S37
13.2
84
559


822
Fmoc-D-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-S37
15.9
100
536


823
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-S37
16.2
100
559


824
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-S37
19.1
100
536


825
Fmoc-Phe
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
3.9
100
547


826
Fmoc-D-Phe
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
4.9
100
547


827
Fmoc-Lys(Boc)
Fmoc-Phe
Fmoc-OX-13
Fmoc-S37
2.1
100
561


828
Fmoc-D-Lys(Boc)
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-S37
4.7
80
561


829
Fmoc-Ser(But)
Fmoc-Ala
Fmoc-OX-13
Fmoc-S37
5.3
100
444


830
Fmoc-D-Ser(But)
Fmoc-D-Ala
Fmoc-OX-13
Fmoc-S37
6.2
100
444


831
Fmoc-Ala
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-S37
5.2
100
520


832
Fmoc-D-Ala
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-S37
4.9
90
520


833
Fmoc-D-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
6.1
100
586


834
Fmoc-D-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
8.4
100
563


835
Fmoc-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
4.3
100
586


836
Fmoc-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
2.9
100
563


837
Fmoc-D-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
4.8
100
559


838
Fmoc-D-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
5.7
100
536


839
Fmoc-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
3.2
100
559


840
Fmoc-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
4.8
100
536


841
Fmoc-Lys(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
5.6
72
501


842
Fmoc-D-Lys(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
9.2
100
501


843
Fmoc-Phe
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.0
na
504


844
Fmoc-D-Phe
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.5
na
504


845
Fmoc-Lys(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
5.0
100
485


846
Fmoc-D-Lys(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
5.4
100
485


847
Fmoc-Ser(But)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
5.0
100
444


848
Fmoc-D-Ser(But)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
5.0
100
444


849
Fmoc-Ala
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.3
100
428


850
Fmoc-D-Ala
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.6
100
428


851
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.6
86
543


852
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.7
81
520


853
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
0.5
100
543


854
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
0.8
na
520


855
Fmoc-Dap(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
0.9
100
443


856
Fmoc-D-Dap(Boc)
Fmoc-Sar
Fmoc-OX-13
Fmoc-S37
1.7
100
443


857
Fmoc-Arg(Pbf)
Fmoc-N-Me-D-Phe
Fmoc-OX-13
Fmoc-S37
0.7
100
603


858
Fmoc-D-Arg(Pbf)
Fmoc-N-Me-D-Phe
Fmoc-OX-13
Fmoc-S37
0.6
na
603


859
Fmoc-Dap(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
1.5
100
486


860
Fmoc-D-Dap(Boc)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
1.9
100
486


861
Fmoc-Arg(Pbf)
Fmoc-Phe
Fmoc-OX-13
Fmoc-S37
1.0
100
589


862
Fmoc-D-Arg(Pbf)
Fmoc-D-Phe
Fmoc-OX-13
Fmoc-S37
1.6
88
589


863
Fmoc-Val
Fmoc-Tyr(But)
Fmoc-OX-13
Fmoc-S37
9.5
100
548


864
Fmoc-D-Val
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-S37
4.1
89
548


865
Fmoc-His(Trt)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
4.9
100
537


866
Fmoc-D-His(Trt)
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
8.6
100
537


867
Fmoc-Pro
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
6.0
100
497


868
Fmoc-D-Pro
Fmoc-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
4.7
100
497


869
Fmoc-His(Trt)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
5.6
100
510


870
Fmoc-D-His(Trt)
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
8.0
100
510


871
Fmoc-Pro
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
6.9
100
470


872
Fmoc-D-Pro
Fmoc-Ser(But)
Fmoc-OX-13
Fmoc-S37
3.0
100
470


873
Fmoc-His(Trt)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
5.6
100
537


874
Fmoc-D-His(Trt)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
5.9
100
537


875
Fmoc-Pro
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
3.2
100
497


876
Fmoc-D-Pro
Fmoc-D-Asn(Trt)
Fmoc-OX-13
Fmoc-S37
5.9
100
497


877
Fmoc-His(Trt)
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-S37
5.6
100
510


878
Fmoc-D-His(Trt)
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-S37
3.6
100
510


879
Fmoc-Pro
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-S37
6.2
100
470


880
Fmoc-D-Pro
Fmoc-D-Ser(But)
Fmoc-OX-13
Fmoc-S37
7.5
100
470


881
Fmoc-D-Trp(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
11.5
100
573


882
Fmoc-D-Tyr(But)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
5.4
82
550


883
Fmoc-Trp(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
6.4
100
573


884
Fmoc-Tyr(But)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
13.6
100
550


885
Fmoc-Lys(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
9.5
100
515


886
Fmoc-D-Lys(Boc)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
9.2
100
515


887
Fmoc-Phe
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
5.3
100
534


888
Fmoc-D-Phe
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
5.3
91
534


889
Fmoc-Dap(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
3.6
100
473


890
Fmoc-D-Dap(Boc)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
5.4
100
473


891
Fmoc-Arg(Pbf)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
1.3
100
543


892
Fmoc-D-Arg(Pbf)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
1.3
100
543


893
Fmoc-Val
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
3.1
100
486


894
Fmoc-D-Val
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
6.8
93
486


895
Fmoc-His(Trt)
Fmoc-Thr(But)
Fmoc-OX-13
Fmoc-S37
7.7
100
524


896
Fmoc-D-His(Trt)
Fmoc-D-Thr(But)
Fmoc-OX-13
Fmoc-S37
5.6
100
524


897
Fmoc-D-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.4
100
628


898
Fmoc-D-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
5.5
100
605


899
Fmoc-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.4
100
628


900
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
5.0
100
605


901
Fmoc-Phe
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.1
100
589


902
Fmoc-D-Phe
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.1
100
589


903
Fmoc-Val
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.4
100
541


904
Fmoc-D-Val
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
5.2
100
541


905
Fmoc-Ala
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.0
100
513


906
Fmoc-D-Ala
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.6
100
513


907
Fmoc-Ser(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
5.7
100
529


908
Fmoc-D-Ser(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
7.7
100
529


909
Fmoc-D-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.6
100
628


910
Fmoc-D-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.3
88
605


911
Fmoc-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.5
100
628


912
Fmoc-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
6.9
100
605


913
Fmoc-Phe
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
4.7
100
589


914
Fmoc-D-Phe
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.8
100
589


915
Fmoc-Val
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
6.0
100
541


916
Fmoc-D-Val
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
3.1
77
541


917
Fmoc-Ala
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
na
na
na


918
Fmoc-D-Ala
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
2.9
97
513


919
Fmoc-Ser(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
9.1
100
529


920
Fmoc-D-Ser(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
Fmoc-S37
5.5
100
529


921
Fmoc-D-Trp(Boc)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
3.1
97
569


922
Fmoc-D-Tyr(But)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
2.8
78
546


923
Fmoc-Ser(But)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
3.0
91
470


924
Fmoc-D-Ser(But)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
6.7
100
470


925
Fmoc-Glu(OBut)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
1.4
na
na


926
Fmoc-D-Glu(OBut)
Fmoc-Pro
Fmoc-OX-13
Fmoc-S37
4.2
100
512


927
Fmoc-Trp(Boc)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
2.9
89
569


928
Fmoc-Tyr(But)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
2.4
89
546


929
Fmoc-Ser(But)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
4.5
100
470


930
Fmoc-D-Ser(But)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
3.0
85
470


931
Fmoc-Gln(Trt)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
3.9
100
511


932
Fmoc-D-Gln(Trt)
Fmoc-D-Pro
Fmoc-OX-13
Fmoc-S37
1.8
na
na


933
Fmoc-Nva
Fmoc-D-Val
Fmoc-OX-3
Fmoc-S48
6.6
100
610


934
Fmoc-Nva
Fmoc-D-Val
Fmoc-OX-2
Fmoc-S48
3.7
100
610


935
Fmoc-D-Nva
Fmoc-D-Val
Fmoc-OX-3
Fmoc-S48
3.0
100
610


936
Fmoc-D-Nva
Fmoc-D-Val
Fmoc-OX-2
Fmoc-S48
4.8
100
610


937
Fmoc-Nva
Fmoc-Val
Fmoc-OX-3
Fmoc-S48
5.3
100
610


938
Fmoc-Nva
Fmoc-Val
Fmoc-OX-2
Fmoc-S48
5.8
100
610


939
Fmoc-Nva
Fmoc-D-Val
Fmoc-OX-3
Fmoc-S37
7.3
100
532


940
Fmoc-Nva
Fmoc-D-Val
Fmoc-OX-2
Fmoc-S37
11.6
100
532


941
Fmoc-D-Nva
Fmoc-D-Val
Fmoc-OX-3
Fmoc-S37
7.0
100
532


942
Fmoc-D-Nva
Fmoc-D-Val
Fmoc-OX-2
Fmoc-S37
7.8
100
532


943
Fmoc-Nva
Fmoc-Val
Fmoc-OX-3
Fmoc-S37
7.0
100
532


944
Fmoc-Nva
Fmoc-Val
Fmoc-OX-2
Fmoc-S37
7.5
100
532


945
Fmoc-D-Nva
Fmoc-Val
Fmoc-OX-3
Fmoc-S48
10.5
100
610


946
Fmoc-D-Nva
Fmoc-Val
Fmoc-OX-2
Fmoc-S48
11.8
100
610


947
Fmoc-D-Nva
Fmoc-Val
Fmoc-OX-3
Fmoc-S37
15.4
100
532


948
Fmoc-D-Nva
Fmoc-Val
Fmoc-OX-2
Fmoc-S37
15.4
100
532





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 3B









embedded image


















Cpd
R1
R2
R3
Q
R4
R6





601


embedded image


(S)-CH3
H
C═O


embedded image




embedded image







602


embedded image


(S)-CH3
H
C═O


embedded image




embedded image







603


embedded image


(S)-CH3
H
C═O


embedded image




embedded image







604


embedded image


(S)-CH3
H
C═O


embedded image




embedded image







605


embedded image




embedded image


H
C═O


embedded image




embedded image







606


embedded image




embedded image


H
C═O


embedded image




embedded image







607


embedded image




embedded image


H
C═O


embedded image




embedded image







608


embedded image




embedded image


H
C═O


embedded image




embedded image







609


embedded image


(R)-CH3
H
C═O


embedded image




embedded image







610


embedded image


(R)-CH3
H
C═O


embedded image




embedded image







611


embedded image


(R)-CH3
H
C═O


embedded image




embedded image







612


embedded image


(R)-CH3
H
C═O


embedded image




embedded image







613


embedded image




embedded image


H
C═O


embedded image




embedded image







614


embedded image




embedded image


H
C═O


embedded image




embedded image







615


embedded image




embedded image


H
C═O


embedded image




embedded image







616


embedded image




embedded image


H
C═O


embedded image




embedded image







617


embedded image




embedded image


H
C═O


embedded image




embedded image







618


embedded image




embedded image


H
C═O


embedded image




embedded image







619


embedded image




embedded image


H
C═O


embedded image




embedded image







620


embedded image




embedded image


H
C═O


embedded image




embedded image







621


embedded image




embedded image


H
C═O


embedded image




embedded image







622


embedded image




embedded image


H
C═O


embedded image




embedded image







623


embedded image




embedded image


H
C═O


embedded image




embedded image







624


embedded image




embedded image


H
C═O


embedded image




embedded image







625


embedded image




embedded image


H
C═O


embedded image




embedded image







626


embedded image




embedded image


H
C═O


embedded image




embedded image







627


embedded image




embedded image


H
C═O


embedded image




embedded image







628


embedded image




embedded image


H
C═O


embedded image




embedded image







629


embedded image




embedded image


H
C═O


embedded image




embedded image







630


embedded image




embedded image


H
C═O


embedded image




embedded image







631


embedded image




embedded image


H
C═O


embedded image




embedded image







632


embedded image




embedded image


H
C═O


embedded image




embedded image







633


embedded image




embedded image


H
C═O


embedded image




embedded image







634


embedded image




embedded image


H
C═O


embedded image




embedded image







635


embedded image




embedded image


H
C═O


embedded image




embedded image







636


embedded image




embedded image


H
C═O


embedded image




embedded image







637


embedded image




embedded image


H
C═O


embedded image




embedded image







638


embedded image




embedded image


H
C═O


embedded image




embedded image







639


embedded image




embedded image


H
C═O


embedded image




embedded image







640


embedded image




embedded image


H
C═O


embedded image




embedded image







641


embedded image




embedded image


H
C═O


embedded image




embedded image







642


embedded image




embedded image


H
C═O


embedded image




embedded image







643


embedded image




embedded image


H
C═O


embedded image




embedded image







644


embedded image




embedded image


H
C═O


embedded image




embedded image







645


embedded image




embedded image


H
C═O


embedded image




embedded image







646


embedded image




embedded image


H
C═O


embedded image




embedded image







647


embedded image




embedded image


H
C═O


embedded image




embedded image







648


embedded image




embedded image


H
C═O


embedded image




embedded image







649


embedded image




embedded image


H
C═O


embedded image




embedded image







650


embedded image




embedded image


H
C═O


embedded image




embedded image







651


embedded image




embedded image


H
C═O


embedded image




embedded image







652


embedded image




embedded image


H
C═O


embedded image




embedded image







653


embedded image




embedded image


H
C═O


embedded image




embedded image







654


embedded image




embedded image


H
C═O


embedded image




embedded image







655


embedded image




embedded image


H
C═O


embedded image




embedded image







656


embedded image




embedded image


H
C═O


embedded image




embedded image







657


embedded image




embedded image


H
C═O


embedded image




embedded image







658


embedded image




embedded image


H
C═O


embedded image




embedded image







659


embedded image




embedded image


H
C═O


embedded image




embedded image







660


embedded image




embedded image


H
C═O


embedded image




embedded image







661
(S)-CH3


embedded image


H
C═O


embedded image




embedded image







662


embedded image




embedded image


H
C═O


embedded image




embedded image







663


embedded image




embedded image


H
C═O


embedded image




embedded image







664
(R)-CH3


embedded image


H
C═O


embedded image




embedded image







665


embedded image




embedded image


H
C═O


embedded image




embedded image







666


embedded image




embedded image


H
C═O


embedded image




embedded image







667


embedded image




embedded image


H
C═O


embedded image




embedded image







668


embedded image




embedded image


H
C═O


embedded image




embedded image







669


embedded image




embedded image


H
C═O


embedded image




embedded image







670


embedded image




embedded image


H
C═O


embedded image




embedded image







671


embedded image




embedded image


H
C═O


embedded image




embedded image







672


embedded image




embedded image


H
C═O


embedded image




embedded image







673


embedded image




embedded image


H
C═O


embedded image




embedded image







674


embedded image




embedded image


H
C═O


embedded image




embedded image







675


embedded image




embedded image


H
C═O


embedded image




embedded image







676


embedded image




embedded image


H
C═O


embedded image




embedded image







677


embedded image




embedded image


H
C═O


embedded image




embedded image







678


embedded image




embedded image


H
C═O


embedded image




embedded image







679


embedded image




embedded image


H
C═O


embedded image




embedded image







680


embedded image




embedded image


H
C═O


embedded image




embedded image







681


embedded image




embedded image


H
C═O


embedded image




embedded image







682


embedded image




embedded image


H
C═O


embedded image




embedded image







683


embedded image




embedded image


H
C═O


embedded image




embedded image







684


embedded image




embedded image


H
C═O


embedded image




embedded image







685
(S)-CH3


embedded image


H
C═O


embedded image




embedded image







686


embedded image




embedded image


H
C═O


embedded image




embedded image







687


embedded image




embedded image


H
C═O


embedded image




embedded image







688
(R)-CH3


embedded image


H
C═O


embedded image




embedded image







689


embedded image




embedded image


H
C═O


embedded image




embedded image







690


embedded image




embedded image


H
C═O


embedded image




embedded image







691


embedded image




embedded image


H
C═O


embedded image




embedded image







692


embedded image




embedded image


H
C═O


embedded image




embedded image







693


embedded image




embedded image


H
C═O


embedded image




embedded image







694


embedded image




embedded image


H
C═O


embedded image




embedded image







695


embedded image




embedded image


H
C═O


embedded image




embedded image







696


embedded image




embedded image


H
C═O


embedded image




embedded image







697


embedded image




embedded image


H
C═O


embedded image




embedded image







698


embedded image




embedded image


H
C═O


embedded image




embedded image







699


embedded image




embedded image


H
C═O


embedded image




embedded image







700


embedded image




embedded image


H
C═O


embedded image




embedded image







701


embedded image




embedded image


H
C═O


embedded image




embedded image







702


embedded image




embedded image


H
C═O


embedded image




embedded image







703


embedded image




embedded image


H
C═O


embedded image




embedded image







704


embedded image




embedded image


H
C═O


embedded image




embedded image







705


embedded image




embedded image


H
C═O


embedded image




embedded image







706


embedded image




embedded image


H
C═O


embedded image




embedded image







707


embedded image




embedded image


H
C═O


embedded image




embedded image







708


embedded image




embedded image


H
C═O


embedded image




embedded image







709


embedded image




embedded image


H
C═O


embedded image




embedded image







710


embedded image




embedded image


H
C═O


embedded image




embedded image







711


embedded image




embedded image


H
C═O


embedded image




embedded image







712


embedded image




embedded image


H
C═O


embedded image




embedded image







713


embedded image




embedded image


H
C═O


embedded image




embedded image







714


embedded image




embedded image


H
C═O


embedded image




embedded image







715


embedded image




embedded image


H
C═O


embedded image




embedded image







716


embedded image




embedded image


H
C═O


embedded image




embedded image







717


embedded image


H
Me
C═O


embedded image




embedded image







718


embedded image


H
Me
C═O


embedded image




embedded image







719


embedded image


H
Me
C═O


embedded image




embedded image







720


embedded image


H
Me
C═O


embedded image




embedded image







721


embedded image




embedded image


H
C═O


embedded image




embedded image







722


embedded image




embedded image


H
C═O


embedded image




embedded image







723


embedded image




embedded image


H
C═O


embedded image




embedded image







724


embedded image




embedded image


H
C═O


embedded image




embedded image







725


embedded image




embedded image


H
C═O


embedded image




embedded image







726


embedded image




embedded image


H
C═O


embedded image




embedded image







727


embedded image




embedded image


H
C═O


embedded image




embedded image







728


embedded image




embedded image


H
C═O


embedded image




embedded image







729


embedded image




embedded image


H
C═O


embedded image




embedded image







730


embedded image




embedded image


H
C═O


embedded image




embedded image







731


embedded image




embedded image


H
C═O


embedded image




embedded image







732


embedded image




embedded image


H
C═O


embedded image




embedded image







733


embedded image




embedded image


H
C═O


embedded image




embedded image







734


embedded image




embedded image


H
C═O


embedded image




embedded image







735


embedded image




embedded image


H
C═O


embedded image




embedded image







736


embedded image




embedded image


H
C═O


embedded image




embedded image







737


embedded image




embedded image


H
C═O


embedded image




embedded image







738


embedded image




embedded image


H
C═O


embedded image




embedded image







739


embedded image




embedded image


H
C═O


embedded image




embedded image







740


embedded image




embedded image


H
C═O


embedded image




embedded image







741


embedded image




embedded image


H
C═O


embedded image




embedded image







742


embedded image




embedded image


H
C═O


embedded image




embedded image







743


embedded image




embedded image


H
C═O


embedded image




embedded image







744


embedded image




embedded image


H
C═O


embedded image




embedded image







745


embedded image




embedded image


H
C═O


embedded image




embedded image







746


embedded image




embedded image


H
C═O


embedded image




embedded image







747


embedded image




embedded image


H
C═O


embedded image




embedded image







748


embedded image




embedded image


H
C═O


embedded image




embedded image







749
(S)-CH3


embedded image


H
C═O


embedded image




embedded image







750


embedded image




embedded image


H
C═O


embedded image




embedded image







751


embedded image




embedded image


H
C═O


embedded image




embedded image







752
(R)-CH3


embedded image


H
C═O


embedded image




embedded image







753


embedded image




embedded image


H
C═O


embedded image




embedded image







754


embedded image




embedded image


H
C═O


embedded image




embedded image







755


embedded image




embedded image


H
C═O


embedded image




embedded image







756


embedded image




embedded image


H
C═O


embedded image




embedded image







757


embedded image




embedded image


H
C═O


embedded image




embedded image







758


embedded image




embedded image


H
C═O


embedded image




embedded image







759


embedded image




embedded image


H
C═O


embedded image




embedded image







760


embedded image




embedded image


H
C═O


embedded image




embedded image







761


embedded image




embedded image


H
C═O


embedded image




embedded image







762


embedded image




embedded image


H
C═O


embedded image




embedded image







763


embedded image




embedded image


H
C═O


embedded image




embedded image







764


embedded image




embedded image


H
C═O


embedded image




embedded image







765


embedded image




embedded image


H
C═O


embedded image




embedded image







766


embedded image




embedded image


H
C═O


embedded image




embedded image







767


embedded image




embedded image


H
C═O


embedded image




embedded image







768


embedded image




embedded image


H
C═O


embedded image




embedded image







769


embedded image




embedded image


H
C═O


embedded image




embedded image







770


embedded image




embedded image


H
C═O


embedded image




embedded image







771


embedded image




embedded image


H
C═O


embedded image




embedded image







772


embedded image




embedded image


H
C═O


embedded image




embedded image







773
(S)-CH3


embedded image


H
C═O


embedded image




embedded image







774


embedded image




embedded image


H
C═O


embedded image




embedded image







775


embedded image




embedded image


H
C═O


embedded image




embedded image







776
(R)-CH3


embedded image


H
C═O


embedded image




embedded image







777


embedded image




embedded image


H
C═O


embedded image




embedded image







778


embedded image




embedded image


H
C═O


embedded image




embedded image







779


embedded image




embedded image


H
C═O


embedded image




embedded image







780


embedded image




embedded image


H
C═O


embedded image




embedded image







781


embedded image




embedded image


H
C═O


embedded image




embedded image







782


embedded image




embedded image


H
C═O


embedded image




embedded image







783


embedded image




embedded image


H
C═O


embedded image




embedded image







784


embedded image




embedded image


H
C═O


embedded image




embedded image







785


embedded image




embedded image


H
C═O


embedded image




embedded image







786


embedded image




embedded image


H
C═O


embedded image




embedded image







787


embedded image




embedded image


H
C═O


embedded image




embedded image







788


embedded image




embedded image


H
C═O


embedded image




embedded image







789


embedded image




embedded image


H
C═O


embedded image




embedded image







790


embedded image




embedded image


H
C═O


embedded image




embedded image







791


embedded image




embedded image


H
C═O


embedded image




embedded image







792


embedded image




embedded image


H
C═O


embedded image




embedded image







793


embedded image




embedded image


H
C═O


embedded image




embedded image







794


embedded image




embedded image


H
C═O


embedded image




embedded image







795


embedded image




embedded image


H
C═O


embedded image




embedded image







796


embedded image




embedded image


H
C═O


embedded image




embedded image







797


embedded image




embedded image


H
C═O


embedded image




embedded image







798


embedded image




embedded image


H
C═O


embedded image




embedded image







799


embedded image




embedded image


H
C═O


embedded image




embedded image







800


embedded image




embedded image


H
C═O


embedded image




embedded image







801


embedded image




embedded image


H
C═O


embedded image




embedded image







802


embedded image




embedded image


H
C═O


embedded image




embedded image







803


embedded image




embedded image


H
C═O


embedded image




embedded image







804


embedded image




embedded image


H
C═O


embedded image




embedded image







805


embedded image




embedded image


H
C═O


embedded image




embedded image







806


embedded image




embedded image


H
C═O


embedded image




embedded image







807


embedded image




embedded image


H
C═O


embedded image




embedded image







808


embedded image




embedded image


H
C═O


embedded image




embedded image







809


embedded image




embedded image


H
C═O


embedded image




embedded image







810


embedded image




embedded image


H
C═O


embedded image




embedded image







811


embedded image




embedded image


H
C═O


embedded image




embedded image







812


embedded image




embedded image


H
C═O


embedded image




embedded image







813


embedded image




embedded image


H
C═O


embedded image




embedded image







814


embedded image




embedded image


H
C═O


embedded image




embedded image







815


embedded image




embedded image


H
C═O


embedded image




embedded image







816


embedded image




embedded image


H
C═O


embedded image




embedded image







817


embedded image




embedded image


H
CH2


embedded image




embedded image







818


embedded image




embedded image


H
CH2


embedded image




embedded image







819


embedded image




embedded image


H
CH2


embedded image




embedded image







820


embedded image




embedded image


H
CH2


embedded image




embedded image







821


embedded image




embedded image


H
CH2


embedded image




embedded image







822


embedded image




embedded image


H
CH2


embedded image




embedded image







823


embedded image




embedded image


H
CH2


embedded image




embedded image







824


embedded image




embedded image


H
CH2


embedded image




embedded image







825


embedded image




embedded image


H
CH2


embedded image




embedded image







826


embedded image




embedded image


H
CH2


embedded image




embedded image







827


embedded image




embedded image


H
CH2


embedded image




embedded image







828


embedded image




embedded image


H
CH2


embedded image




embedded image







829


embedded image


(S)-CH3
H
CH2


embedded image




embedded image







830


embedded image


(R)-CH3
H
CH2


embedded image




embedded image







831
(S)-CH3


embedded image


H
CH2


embedded image




embedded image







832
(R)-CH3


embedded image


H
CH2


embedded image




embedded image







833


embedded image




embedded image


H
CH2


embedded image




embedded image







834


embedded image




embedded image


H
CH2


embedded image




embedded image







835


embedded image




embedded image


H
CH2


embedded image




embedded image







836


embedded image




embedded image


H
CH2


embedded image




embedded image







837


embedded image




embedded image


H
CH2


embedded image




embedded image







838


embedded image




embedded image


H
CH2


embedded image




embedded image







839


embedded image




embedded image


H
CH2


embedded image




embedded image







840


embedded image




embedded image


H
CH2


embedded image




embedded image







841


embedded image




embedded image


H
CH2


embedded image




embedded image







842


embedded image




embedded image


H
CH2


embedded image




embedded image







843


embedded image


H
Me
CH2


embedded image




embedded image







844


embedded image


H
Me
CH2


embedded image




embedded image







845


embedded image


H
Me
CH2


embedded image




embedded image







846


embedded image


H
Me
CH2


embedded image




embedded image







847


embedded image


H
Me
CH2


embedded image




embedded image







848


embedded image


H
Me
CH2


embedded image




embedded image







849
(S)-CH3
H
Me
CH2


embedded image




embedded image







850
(R)-CH3
H
Me
CH2


embedded image




embedded image







851


embedded image


H
Me
CH2


embedded image




embedded image







852


embedded image


H
Me
CH2


embedded image




embedded image







853


embedded image


H
Me
CH2


embedded image




embedded image







854


embedded image


H
Me
CH2


embedded image




embedded image







855


embedded image


H
Me
CH2


embedded image




embedded image







856


embedded image


H
Me
CH2


embedded image




embedded image







857


embedded image




embedded image


Me
CH2


embedded image




embedded image







858


embedded image




embedded image


Me
CH2


embedded image




embedded image







859


embedded image




embedded image


H
CH2


embedded image




embedded image







860


embedded image




embedded image


H
CH2


embedded image




embedded image







861


embedded image




embedded image


H
CH2


embedded image




embedded image







862


embedded image




embedded image


H
CH2


embedded image




embedded image







863


embedded image




embedded image


H
CH2


embedded image




embedded image







864


embedded image




embedded image


H
CH2


embedded image




embedded image







865


embedded image




embedded image


H
CH2


embedded image




embedded image







866


embedded image




embedded image


H
CH2


embedded image




embedded image







867


embedded image




embedded image


H
CH2


embedded image




embedded image







868


embedded image




embedded image


H
CH2


embedded image




embedded image







869


embedded image




embedded image


H
CH2


embedded image




embedded image







870


embedded image




embedded image


H
CH2


embedded image




embedded image







871


embedded image




embedded image


H
CH2


embedded image




embedded image







872


embedded image




embedded image


H
CH2


embedded image




embedded image







873


embedded image




embedded image


H
CH2


embedded image




embedded image







874


embedded image




embedded image


H
CH2


embedded image




embedded image







875


embedded image




embedded image


H
CH2


embedded image




embedded image







876


embedded image




embedded image


H
CH2


embedded image




embedded image







877


embedded image




embedded image


H
CH2


embedded image




embedded image







878


embedded image




embedded image


H
CH2


embedded image




embedded image







879


embedded image




embedded image


H
CH2


embedded image




embedded image







880


embedded image




embedded image


H
CH2


embedded image




embedded image







881


embedded image




embedded image


H
CH2


embedded image




embedded image







882


embedded image




embedded image


H
CH2


embedded image




embedded image







883


embedded image




embedded image


H
CH2


embedded image




embedded image







884


embedded image




embedded image


H
CH2


embedded image




embedded image







885


embedded image




embedded image


H
CH2


embedded image




embedded image







886


embedded image




embedded image


H
CH2


embedded image




embedded image







887


embedded image




embedded image


H
CH2


embedded image




embedded image







888


embedded image




embedded image


H
CH2


embedded image




embedded image







889


embedded image




embedded image


H
CH2


embedded image




embedded image







890


embedded image




embedded image


H
CH2


embedded image




embedded image







891


embedded image




embedded image


H
CH2


embedded image




embedded image







892


embedded image




embedded image


H
CH2


embedded image




embedded image







893


embedded image




embedded image


H
CH2


embedded image




embedded image







894


embedded image




embedded image


H
CH2


embedded image




embedded image







895


embedded image




embedded image


H
CH2


embedded image




embedded image







896


embedded image




embedded image


H
CH2


embedded image




embedded image







897


embedded image




embedded image


H
CH2


embedded image




embedded image







898


embedded image




embedded image


H
CH2


embedded image




embedded image







899


embedded image




embedded image


H
CH2


embedded image




embedded image







900


embedded image




embedded image


H
CH2


embedded image




embedded image







901


embedded image




embedded image


H
CH2


embedded image




embedded image







902


embedded image




embedded image


H
CH2


embedded image




embedded image







903


embedded image




embedded image


H
CH2


embedded image




embedded image







904


embedded image




embedded image


H
CH2


embedded image




embedded image







905
(S)-CH3


embedded image


H
CH2


embedded image




embedded image







906
(R)-CH3


embedded image


H
CH2


embedded image




embedded image







907


embedded image




embedded image


H
CH2


embedded image




embedded image







908


embedded image




embedded image


H
CH2


embedded image




embedded image







909


embedded image




embedded image


H
CH2


embedded image




embedded image







910


embedded image




embedded image


H
CH2


embedded image




embedded image







911


embedded image




embedded image


H
CH2


embedded image




embedded image







912


embedded image




embedded image


H
CH2


embedded image




embedded image







913


embedded image




embedded image


H
CH2


embedded image




embedded image







914


embedded image




embedded image


H
CH2


embedded image




embedded image







915


embedded image




embedded image


H
CH2


embedded image




embedded image







916


embedded image




embedded image


H
CH2


embedded image




embedded image







917
(S)-CH3


embedded image


H
CH2


embedded image




embedded image







918
(R)-CH3


embedded image


H
CH2


embedded image




embedded image







919


embedded image




embedded image


H
CH2


embedded image




embedded image







920


embedded image




embedded image


H
CH2


embedded image




embedded image







921


embedded image




embedded image


H
CH2


embedded image




embedded image







922


embedded image




embedded image


H
CH2


embedded image




embedded image







923


embedded image




embedded image


H
CH2


embedded image




embedded image







924


embedded image




embedded image


H
CH2


embedded image




embedded image







925


embedded image




embedded image


H
CH2


embedded image




embedded image







926


embedded image




embedded image


H
CH2


embedded image




embedded image







927


embedded image




embedded image


H
CH2


embedded image




embedded image







928


embedded image




embedded image


H
CH2


embedded image




embedded image







929


embedded image




embedded image


H
CH2


embedded image




embedded image







930


embedded image




embedded image


H
CH2


embedded image




embedded image







931


embedded image




embedded image


H
CH2


embedded image




embedded image







932


embedded image




embedded image


H
CH2


embedded image




embedded image







933


embedded image




embedded image


H
C═O


embedded image




embedded image







934


embedded image




embedded image


H
C═O


embedded image




embedded image







935


embedded image




embedded image


H
C═O


embedded image




embedded image







936


embedded image




embedded image


H
C═O


embedded image




embedded image







937


embedded image




embedded image


H
C═O


embedded image




embedded image







938


embedded image




embedded image


H
C═O


embedded image




embedded image







939


embedded image




embedded image


H
C═O


embedded image




embedded image







940


embedded image




embedded image


H
C═O


embedded image




embedded image







941


embedded image




embedded image


H
C═O


embedded image




embedded image







942


embedded image




embedded image


H
C═O


embedded image




embedded image







943


embedded image




embedded image


H
C═O


embedded image




embedded image







944


embedded image




embedded image


H
C═O


embedded image




embedded image







945


embedded image




embedded image


H
C═O


embedded image




embedded image







946


embedded image




embedded image


H
C═O


embedded image




embedded image







947


embedded image




embedded image


H
C═O


embedded image




embedded image







948


embedded image




embedded image


H
C═O


embedded image




embedded image











For all compounds R5═H, except for those compounds in which Fmoc-Pro or Fmoc-D-Pro is the BB1 component wherein R1 and (N)R5 form a five-membered ring, including the nitrogen atom, as shown for R1 in Table 3B. Similarly, compounds in which BB2 is Fmoc-Pro or Fmoc-D-Pro have (N)R3 and R2 are part of a five-membered ring, including the nitrogen atom, as shown for a combined R2-R3 in Table 3B.


Example 5
Synthesis of a Representative Library of Macrocyclic Compounds of Formula (Ie)

The series of synthetic schemes in Schemes 5, 6 and 7 were employed for the solid phase construction of macrocyclic compounds 1001-1065, 1066-1142 and 1143-1189, respectively. For all of the compounds, the first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D). For compounds 1001-1065 and 1143-1189, the second amino acid building block (BB2) was attached through peptide coupling (Method 1G) following Fmoc deprotection (Method 1F). BB2 was added using reductive amination (Method 1I or 1J) for the remaining compounds (1066-1142). For this latter set of macrocycles (1066-1142), as well as compounds 1001-1065, the third building block (BB3) was installed after Fmoc deprotection (Method 1F) via amide bond formation (Method 1G), while for 1143-1189, reductive amination (Method 1I or 1J) was employed for BB3. After Fmoc removal ((Method 1F), addition of the oxazole building block (BB4) for all compounds was performed using reductive amination (Method 1J) or amide bond formation (Method 1G). With each scheme, deprotection of the Fmoc moiety (Method 1F), resin cleavage (Method 1Q), macrocycle formation (Method 1R) and removal of the side chain protection (Method 1S) were followed by evaporation in vacuo to yield the crude macrocycle. Upon purification by preparative HPLC (Method 2B), the desired macrocyclic library compounds were obtained. For each macrocycle, the quantities, purity (HPLC) and identity conformation (MS) are presented in Table 4A, with the structures shown in Tables 4B, 4C and 4D.
















TABLE 4A





Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
MS (M + H)






















1001
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
19.8
100
595


1002
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
16.9
100
572


1003
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
20.7
88
595


1004
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
25.6
100
572


1005
Fmoc-D-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
17.4
100
568


1006
Fmoc-D-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
9.7
100
545


1007
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
25.9
100
568


1008
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
23.6
100
545


1009
Fmoc-Lys(Boc)
Fmoc-Ser(But)
Fmoc-Asp(OBut)
Fmoc-OX-13
15.1
100
497


1010
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
13.5
100
595


1011
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
9.6
82
572


1012
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
12.5
100
595


1013
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
11.2
100
572


1014
Fmoc-D-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
13.2
100
568


1015
Fmoc-D-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
10.7
100
545


1016
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
21.4
97
568


1017
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
19.3
100
545


1018
Fmoc-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
10.9
100
595


1019
Fmoc-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
20.8
100
572


1020
Fmoc-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
4.0
92
595


1021
Fmoc-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
3.3
78
572


1022
Fmoc-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
26.4
100
568


1023
Fmoc-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
23.0
100
545


1024
Fmoc-Ser(But)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
9.0
85
568


1025
Fmoc-Ser(But)
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
8.7
77
545


1026
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
11.5
100
578


1027
Fmoc-D-Pro
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
5.7
93
555


1028
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
3.0
100
578


1029
Fmoc-D-Pro
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
24.2
100
555


1030
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
4.5
85
578


1031
Fmoc-D-Pro
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
7.3
100
555


1032
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.0
100
578


1033
Fmoc-D-Pro
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
26.4
100
555


1034
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
2.9
100
552


1035
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
9.7
100
529


1036
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
12.0
100
552


1037
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
18.4
100
529


1038
Fmoc-Phe
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
13.5
100
513


1039
Fmoc-D-Phe
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
6.8
100
513


1040
Fmoc-Val
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
21.8
100
465


1041
Fmoc-D-Val
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
12.9
100
465


1042
Fmoc-Ala
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
11.6
100
437


1043
Fmoc-D-Ala
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
6.6
100
437


1044
Fmoc-Ser(But)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
17.1
100
453


1045
Fmoc-D-Ser(But)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
13.8
100
453


1046
Fmoc-Leu
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
15.0
100
479


1047
Fmoc-D-Leu
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
7.9
100
479


1048
Fmoc-Glu(OBut)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
11.8
100
495


1049
Fmoc-D-Glu(OBut)
Fmoc-Sar
Fmoc-Lys(Boc)
Fmoc-OX-13
5.7
100
495


1050
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
8.8
100
552


1051
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
11.6
100
529


1052
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.6
100
552


1053
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
8.1
98
529


1054
Fmoc-Phe
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
8.7
100
513


1055
Fmoc-D-Phe
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
8.6
100
513


1056
Fmoc-Val
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
16.8
100
465


1057
Fmoc-D-Val
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
14.7
100
465


1058
Fmoc-Ala
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
4.3
100
437


1059
Fmoc-D-Ala
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
10.2
100
437


1060
Fmoc-Ser(But)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
16.8
100
453


1061
Fmoc-D-Ser(But)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
15.0
100
453


1062
Fmoc-Leu
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
9.6
100
479


1063
Fmoc-D-Leu
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
12.5
100
479


1064
Fmoc-Glu(OBut)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
5.8
100
495


1065
Fmoc-D-Glu(OBut)
Fmoc-Sar
Fmoc-D-Lys(Boc)
Fmoc-OX-13
7.8
100
495


1066
Fmoc-D-Asn(Trt)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
6.0
100
524


1067
Fmoc-Asn(Trt)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
4.0
100
524


1068
Fmoc-D-His(Trt)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
1.5
100
547


1069
Fmoc-His(Trt)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
1.4
100
547


1070
Fmoc-D-Ser(But)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
3.8
100
497


1071
Fmoc-Ser(But)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
3.1
100
497


1072
Fmoc-D-Lys(Boc)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
4.1
100
538


1073
Fmoc-Lys(Boc)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-13
5.1
100
538


1074
Fmoc-D-Trp(Boc)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
2.0
100
538


1075
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
3.0
100
515


1076
Fmoc-Trp(Boc)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
1.9
99
538


1077
Fmoc-Tyr(But)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
3.5
100
515


1078
Fmoc-Phe
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
3.6
100
499


1079
Fmoc-D-Phe
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-13
4.6
93
499


1080
Fmoc-Val
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
1.3
88
486


1081
Fmoc-D-Val
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
0.3
100
486


1082
Fmoc-Ala
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
0.6
100
458


1083
Fmoc-D-Ala
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
1.2
100
458


1084
Fmoc-Ser(But)
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
2.6
100
474


1085
Fmoc-D-Ser(But)
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
2.7
100
474


1086
Fmoc-Leu
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
1.4
100
500


1087
Fmoc-D-Leu
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
1.3
100
500


1088
Fmoc-Glu(OBut)
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
na
na
na


1089
Fmoc-D-Glu(OBut)
Fmoc-S30
Fmoc-Tyr(But)
Fmoc-OX-13
0.8
80
516


1090
Fmoc-D-Trp(Boc)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.1
100
538


1091
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.7
100
515


1092
Fmoc-Trp(Boc)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.5
76
538


1093
Fmoc-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.0
78
515


1094
Fmoc-Phe
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.3
na
na


1095
Fmoc-D-Phe
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.9
100
499


1096
Fmoc-Val
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
0.5
100
486


1097
Fmoc-D-Val
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
1.7
100
486


1098
Fmoc-Ala
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
1.4
na
na


1099
Fmoc-D-Ala
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
0.9
100
458


1100
Fmoc-Ser(But)
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
1.8
100
474


1101
Fmoc-D-Ser(But)
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
2.6
100
474


1102
Fmoc-Leu
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
0.6
100
500


1103
Fmoc-D-Leu
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
1.6
89
500


1104
Fmoc-Glu(OBut)
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
3.3
100
516


1105
Fmoc-D-Glu(OBut)
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
0.4
77
516


1106
Fmoc-Trp(Boc)
Fmoc-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
0.5
45
538


1107
Fmoc-Tyr(But)
Fmoc-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
0.9
70
515


1108
Fmoc-Ser(But)
Fmoc-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.2
100
439


1109
Fmoc-D-Ser(But)
Fmoc-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.6
100
439


1110
Fmoc-D-Trp(Boc)
Fmoc-S35
Fmoc-Lys(Boc)
Fmoc-OX-13
2.3
100
578


1111
Fmoc-D-Tyr(But)
Fmoc-S35
Fmoc-Lys(Boc)
Fmoc-OX-13
1.6
100
555


1112
Fmoc-Trp(Boc)
Fmoc-S35
Fmoc-His(Trt)
Fmoc-OX-13
0.9
na
na


1113
Fmoc-Tyr(But)
Fmoc-S35
Fmoc-His(Trt)
Fmoc-OX-13
0.8
na
na


1114
Fmoc-Phe
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
0.9
88
597


1115
Fmoc-D-Phe
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
0.7
70
597


1116
Fmoc-Val
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.0
64
549


1117
Fmoc-D-Val
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.5
76
549


1118
Fmoc-Ala
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.1
72
521


1119
Fmoc-D-Ala
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.3
69
521


1120
Fmoc-Ser(But)
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
0.8
70
537


1121
Fmoc-D-Ser(But)
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.0
56
537


1122
Fmoc-Leu
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.1
89
563


1123
Fmoc-D-Leu
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
1.3
87
563


1124
Fmoc-Glu(OBut)
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
0.7
45
579


1125
Fmoc-D-Glu(OBut)
Fmoc-S35
Fmoc-Trp(Boc)
Fmoc-OX-13
0.4
na
na


1126
Fmoc-D-Trp(Boc)
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.7
100
578


1127
Fmoc-D-Tyr(But)
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.5
100
555


1128
Fmoc-Trp(Boc)
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.0
100
578


1129
Fmoc-Tyr(But)
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.2
60
555


1130
Fmoc-Phe
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
3.4
47
539


1131
Fmoc-D-Phe
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.6
100
539


1132
Fmoc-Val
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.5
79
549


1133
Fmoc-D-Val
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.5
100
549


1134
Fmoc-Ala
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.1
64
521


1135
Fmoc-D-Ala
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
na
na
na


1136
Fmoc-Ser(But)
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.6
81
537


1137
Fmoc-D-Ser(But)
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
2.0
82
537


1138
Fmoc-Leu
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.3
100
563


1139
Fmoc-D-Leu
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.9
100
563


1140
Fmoc-Glu(OBut)
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.2
na
na


1141
Fmoc-D-Glu(OBut)
Fmoc-S35
Fmoc-D-Trp(Boc)
Fmoc-OX-13
1.0
73
579


1142
Fmoc-Ser(But)
Fmoc-S30
Fmoc-Trp(Boc)
Fmoc-OX-1
0.6
77
511


1143
Fmoc-D-Trp(Boc)
Fmoc-N-Me-Ser(But)
Fmoc-S37
Fmoc-OX-13
na
na
na


1144
Fmoc-D-Tyr(But)
Fmoc-N-Me-Ser(But)
Fmoc-S37
Fmoc-OX-13
na
na
na


1145
Fmoc-Trp(Boc)
Fmoc-N-Me-Ser(But)
Fmoc-S37
Fmoc-OX-13
na
na
na


1146
Fmoc-Tyr(But)
Fmoc-N-Me-Ser(But)
Fmoc-S37
Fmoc-OX-13
na
na
na


1147
Fmoc-D-Trp(Boc)
Fmoc-Ser(But)
Fmoc-S37
Fmoc-OX-13
3.4
100
559


1148
Fmoc-D-Tyr(But)
Fmoc-Ser(But)
Fmoc-S37
Fmoc-OX-13
4.3
100
536


1149
Fmoc-Trp(Boc)
Fmoc-Ser(But)
Fmoc-S37
Fmoc-OX-13
1.8
100
559


1150
Fmoc-Tyr(But)
Fmoc-Ser(But)
Fmoc-S37
Fmoc-OX-13
5.2
100
536


1151
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.6
100
600


1152
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.8
66
577


1153
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.2
100
600


1154
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.2
100
577


1155
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.5
100
600


1156
Fmoc-D-Tyr(But)
Fmoc-Pro
Fmoc-S37
Fmoc-OX-13
0.7
100
577


1157
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
0.3
100
600


1158
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-S37
Fmoc-OX-13
4.2
100
577


1159
Fmoc-Lys(Boc)
Fmoc-Phe
Fmoc-S37
Fmoc-OX-13
na
na
na


1160
Fmoc-Lys(Boc)
Fmoc-D-Phe
Fmoc-S37
Fmoc-OX-13
0.3
100
561


1161
Fmoc-D-Lys(Boc)
Fmoc-Phe
Fmoc-S37
Fmoc-OX-13
1.5
100
561


1162
Fmoc-D-Lys(Boc)
Fmoc-D-Phe
Fmoc-S37
Fmoc-OX-13
2.6
90
561


1163
Fmoc-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-S37
Fmoc-OX-13
0.6
100
600


1164
Fmoc-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-S37
Fmoc-OX-13
0.5
100
577


1165
Fmoc-D-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-S37
Fmoc-OX-13
0.5
100
600


1166
Fmoc-D-Lys(Boc)
Fmoc-N-Me-D-Phe
Fmoc-S37
Fmoc-OX-13
na
na
na


1167
Fmoc-Asp(OBut)
Fmoc-N-Me-D-Phe
Fmoc-S37
Fmoc-OX-13
na
na
na


1168
Fmoc-Asp(OBut)
Fmoc-D-Tyr(But)
Fmoc-S37
Fmoc-OX-13
na
na
na


1169
Fmoc-D-Asp(OBut)
Fmoc-Trp(Boc)
Fmoc-S37
Fmoc-OX-13
0.2
100
587


1170
Fmoc-D-Asp(OBut)
Fmoc-Tyr(But)
Fmoc-S37
Fmoc-OX-13
0.1
100
564


1171
Fmoc-Ser(But)
Fmoc-Phe
Fmoc-S37
Fmoc-OX-13
na
na
na


1172
Fmoc-Ser(But)
Fmoc-D-Phe
Fmoc-S37
Fmoc-OX-13
na
na
na


1173
Fmoc-D-Ser(But)
Fmoc-Phe
Fmoc-S37
Fmoc-OX-13
1.1
100
520


1174
Fmoc-D-Ser(But)
Fmoc-D-Phe
Fmoc-S37
Fmoc-OX-13
0.7
100
520


1175
Fmoc-Ser(But)
Fmoc-D-Trp(Boc)
Fmoc-S37
Fmoc-OX-13
3.5
na
na


1176
Fmoc-Ser(But)
Fmoc-D-Tyr(But)
Fmoc-S37
Fmoc-OX-13
0.8
100
536


1177
Fmoc-D-Ser(But)
Fmoc-Trp(Boc)
Fmoc-S37
Fmoc-OX-13
na
na
na


1178
Fmoc-D-Ser(But)
Fmoc-Tyr(But)
Fmoc-S37
Fmoc-OX-13
1.5
100
536


1179
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
na
na


1180
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
na
na


1181
Fmoc-Asp(OBut)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
na
na


1182
Fmoc-D-Asp(OBut)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
na
na


1183
Fmoc-Lys(Boc)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
0.9
100
485


1184
Fmoc-D-Lys(Boc)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
2.7
100
485


1185
Fmoc-Asp(OBut)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
100
na


1186
Fmoc-D-Asp(OBut)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
0.8
100
472


1187
Fmoc-Ser(But)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
na
na
na


1188
Fmoc-D-Ser(But)
Fmoc-Sar
Fmoc-S37
Fmoc-OX-13
2.6
100
444


1189
Fmoc-Ser(But)
Fmoc-Lys(Boc)
Fmoc-S30
Fmoc-OX-1
9.7
100
453





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 4B









embedded image


















Cpd
R1
R2
R3
R4
Q
R5





1001


embedded image




embedded image


H


embedded image


CH2


embedded image







1002


embedded image




embedded image


H


embedded image


CH2


embedded image







1003


embedded image




embedded image


H


embedded image


CH2


embedded image







1004


embedded image




embedded image


H


embedded image


CH2


embedded image







1005


embedded image




embedded image


H


embedded image


CH2


embedded image







1006


embedded image




embedded image


H


embedded image


CH2


embedded image







1007


embedded image




embedded image


H


embedded image


CH2


embedded image







1008


embedded image




embedded image


H


embedded image


CH2


embedded image







1009


embedded image




embedded image


H


embedded image


CH2


embedded image







1010


embedded image




embedded image


H


embedded image


CH2


embedded image







1011


embedded image




embedded image


H


embedded image


CH2


embedded image







1012


embedded image




embedded image


H


embedded image


CH2


embedded image







1013


embedded image




embedded image


H


embedded image


CH2


embedded image







1014


embedded image




embedded image


H


embedded image


CH2


embedded image







1015


embedded image




embedded image


H


embedded image


CH2


embedded image







1016


embedded image




embedded image


H


embedded image


CH2


embedded image







1017


embedded image




embedded image


H


embedded image


CH2


embedded image







1018


embedded image




embedded image


H


embedded image


CH2


embedded image







1019


embedded image




embedded image


H


embedded image


CH2


embedded image







1020


embedded image




embedded image


H


embedded image


CH2


embedded image







1021


embedded image




embedded image


H


embedded image


CH2


embedded image







1022


embedded image




embedded image


H


embedded image


CH2


embedded image







1023


embedded image




embedded image


H


embedded image


CH2


embedded image







1024


embedded image




embedded image


H


embedded image


CH2


embedded image







1025


embedded image




embedded image


H


embedded image


CH2


embedded image







1026


embedded image




embedded image


H


embedded image


CH2


embedded image







1027


embedded image




embedded image


H


embedded image


CH2


embedded image







1028


embedded image




embedded image


H


embedded image


CH2


embedded image







1029


embedded image




embedded image


H


embedded image


CH2


embedded image







1030


embedded image




embedded image


H


embedded image


CH2


embedded image







1031


embedded image




embedded image


H


embedded image


CH2


embedded image







1032


embedded image




embedded image


H


embedded image


CH2


embedded image







1033


embedded image




embedded image


H


embedded image


CH2


embedded image







1034


embedded image


H
Me


embedded image


CH2


embedded image







1035


embedded image


H
Me


embedded image


CH2


embedded image







1036


embedded image


H
Me


embedded image


CH2


embedded image







1037


embedded image


H
Me


embedded image


CH2


embedded image







1038


embedded image


H
Me


embedded image


CH2


embedded image







1039


embedded image


H
Me


embedded image


CH2


embedded image







1040


embedded image


H
Me


embedded image


CH2


embedded image







1041


embedded image


H
Me


embedded image


CH2


embedded image







1042
(S)-CH3
H
Me


embedded image


CH2


embedded image







1043
(R)-CH3
H
Me


embedded image


CH2


embedded image







1044


embedded image


H
Me


embedded image


CH2


embedded image







1045


embedded image


H
Me


embedded image


CH2


embedded image







1046


embedded image


H
Me


embedded image


CH2


embedded image







1047


embedded image


H
Me


embedded image


CH2


embedded image







1048


embedded image


H
Me


embedded image


CH2


embedded image







1049


embedded image


H
Me


embedded image


CH2


embedded image







1050


embedded image


H
Me


embedded image


CH2


embedded image







1051


embedded image


H
Me


embedded image


CH2


embedded image







1052


embedded image


H
Me


embedded image


CH2


embedded image







1053


embedded image


H
Me


embedded image


CH2


embedded image







1054


embedded image


H
Me


embedded image


CH2


embedded image







1055


embedded image


H
Me


embedded image


CH2


embedded image







1056


embedded image


H
Me


embedded image


CH2


embedded image







1057


embedded image


H
Me


embedded image


CH2


embedded image







1058
(S)-CH3
H
Me


embedded image


CH2


embedded image







1059
(R)-CH3
H
Me


embedded image


CH2


embedded image







1060


embedded image


H
Me


embedded image


CH2


embedded image







1061


embedded image


H
Me


embedded image


CH2


embedded image







1062


embedded image


H
Me


embedded image


CH2


embedded image







1063


embedded image


H
Me


embedded image


CH2


embedded image







1064


embedded image


H
Me


embedded image


CH2


embedded image







1065


embedded image


H
Me


embedded image


CH2


embedded image











For all compounds R6═H, except for those compounds in which Fmoc-Pro or Fmoc-D-Pro is the BB1 component wherein R1 and (N)R6 form a five-membered ring, including the nitrogen atom, as shown for R1 in compounds 1026-1033 in Table 4B.









TABLE 4C









embedded image


















Cpd
R1
R2
R3
R4
Q
R5





1066


embedded image




embedded image


Me


embedded image


CH2


embedded image







1067


embedded image




embedded image


Me


embedded image


CH2


embedded image







1068


embedded image




embedded image


Me


embedded image


CH2


embedded image







1069


embedded image




embedded image


Me


embedded image


CH2


embedded image







1070


embedded image




embedded image


Me


embedded image


CH2


embedded image







1071


embedded image




embedded image


Me


embedded image


CH2


embedded image







1072


embedded image




embedded image


Me


embedded image


CH2


embedded image







1073


embedded image




embedded image


Me


embedded image


CH2


embedded image







1074


embedded image




embedded image


Me


embedded image


CH2


embedded image







1075


embedded image




embedded image


Me


embedded image


CH2


embedded image







1076


embedded image




embedded image


Me


embedded image


CH2


embedded image







1077


embedded image




embedded image


Me


embedded image


CH2


embedded image







1078


embedded image




embedded image


Me


embedded image


CH2


embedded image







1079


embedded image




embedded image


Me


embedded image


CH2


embedded image







1080


embedded image




embedded image


Me


embedded image


CH2


embedded image







1081


embedded image




embedded image


Me


embedded image


CH2


embedded image







1082
(S)-CH3


embedded image


Me


embedded image


CH2


embedded image







1083
(R)-CH3


embedded image


Me


embedded image


CH2


embedded image







1084


embedded image




embedded image


Me


embedded image


CH2


embedded image







1085


embedded image




embedded image


Me


embedded image


CH2


embedded image







1086


embedded image




embedded image


Me


embedded image


CH2


embedded image







1087


embedded image




embedded image


Me


embedded image


CH2


embedded image







1088


embedded image




embedded image


Me


embedded image


CH2


embedded image







1089


embedded image




embedded image


Me


embedded image


CH2


embedded image







1090


embedded image




embedded image


Me


embedded image


CH2


embedded image







1091


embedded image




embedded image


Me


embedded image


CH2


embedded image







1092


embedded image




embedded image


Me


embedded image


CH2


embedded image







1093


embedded image




embedded image


Me


embedded image


CH2


embedded image







1094


embedded image




embedded image


Me


embedded image


CH2


embedded image







1095


embedded image




embedded image


Me


embedded image


CH2


embedded image







1096


embedded image




embedded image


Me


embedded image


CH2


embedded image







1097


embedded image




embedded image


Me


embedded image


CH2


embedded image







1098
(S)-CH3


embedded image


Me


embedded image


CH2


embedded image







1099
(R)-CH3


embedded image


Me


embedded image


CH2


embedded image







1100


embedded image




embedded image


Me


embedded image


CH2


embedded image







1101


embedded image




embedded image


Me


embedded image


CH2


embedded image







1102


embedded image




embedded image


Me


embedded image


CH2


embedded image







1103


embedded image




embedded image


Me


embedded image


CH2


embedded image







1104


embedded image




embedded image


Me


embedded image


CH2


embedded image







1105


embedded image




embedded image


Me


embedded image


CH2


embedded image







1106


embedded image




embedded image


H


embedded image


CH2


embedded image







1107


embedded image




embedded image


H


embedded image


CH2


embedded image







1108


embedded image




embedded image


H


embedded image


CH2


embedded image







1109


embedded image




embedded image


H


embedded image


CH2


embedded image

















1110


embedded image




embedded image




embedded image


CH2


embedded image







1111


embedded image




embedded image




embedded image


CH2


embedded image







1112


embedded image




embedded image




embedded image


CH2


embedded image







1113


embedded image




embedded image




embedded image


CH2


embedded image







1114


embedded image




embedded image




embedded image


CH2


embedded image







1115


embedded image




embedded image




embedded image


CH2


embedded image







1116


embedded image




embedded image




embedded image


CH2


embedded image







1117


embedded image




embedded image




embedded image


CH2


embedded image







1118
(S)-CH3


embedded image




embedded image


CH2


embedded image







1119
(R)-CH3


embedded image




embedded image


CH2


embedded image







1120


embedded image




embedded image




embedded image


CH2


embedded image







1121


embedded image




embedded image




embedded image


CH2


embedded image







1122


embedded image




embedded image




embedded image


CH2


embedded image







1123


embedded image




embedded image




embedded image


CH2


embedded image







1124


embedded image




embedded image




embedded image


CH2


embedded image







1125


embedded image




embedded image




embedded image


CH2


embedded image







1126


embedded image




embedded image




embedded image


CH2


embedded image







1127


embedded image




embedded image




embedded image


CH2


embedded image







1128


embedded image




embedded image




embedded image


CH2


embedded image







1129


embedded image




embedded image




embedded image


CH2


embedded image







1130


embedded image




embedded image




embedded image


CH2


embedded image







1131


embedded image




embedded image




embedded image


CH2


embedded image







1132


embedded image




embedded image




embedded image


CH2


embedded image







1133


embedded image




embedded image




embedded image


CH2


embedded image







1134
(S)-CH3


embedded image




embedded image


CH2


embedded image







1135
(R)-CH3


embedded image




embedded image


CH2


embedded image







1136


embedded image




embedded image




embedded image


CH2


embedded image







1137


embedded image




embedded image




embedded image


CH2


embedded image







1138


embedded image




embedded image




embedded image


CH2


embedded image







1139


embedded image




embedded image




embedded image


CH2


embedded image







1140


embedded image




embedded image




embedded image


CH2


embedded image







1141


embedded image




embedded image




embedded image


CH2


embedded image


















1142


embedded image




embedded image


Me


embedded image


C═O


embedded image











For compounds 1110-1141, in which BB2 is Fmoc-S35, (N)R3 and R2 form part of a six-membered ring, including the nitrogen atom, as shown for the combined R2—R3 in Table 4C.









TABLE 4D









embedded image


















Cpd
R1
R2
R3
R4
Q
R6





1143


embedded image




embedded image


Me


embedded image


CH2


embedded image







1144


embedded image




embedded image


Me


embedded image


CH2


embedded image







1145


embedded image




embedded image


Me


embedded image


CH2


embedded image







1146


embedded image




embedded image


Me


embedded image


CH2


embedded image







1147


embedded image




embedded image


H


embedded image


CH2


embedded image







1148


embedded image




embedded image


H


embedded image


CH2


embedded image







1149


embedded image




embedded image


H


embedded image


CH2


embedded image







1150


embedded image




embedded image


H


embedded image


CH2


embedded image







1151


embedded image




embedded image


H


embedded image


CH2


embedded image







1152


embedded image




embedded image


H


embedded image


CH2


embedded image







1153


embedded image




embedded image


H


embedded image


CH2


embedded image







1154


embedded image




embedded image


H


embedded image


CH2


embedded image







1155


embedded image




embedded image


H


embedded image


CH2


embedded image

















1156


embedded image




embedded image




embedded image


CH2


embedded image


















1157


embedded image




embedded image


H


embedded image


CH2


embedded image







1158


embedded image




embedded image


H


embedded image


CH2


embedded image







1159


embedded image




embedded image


H


embedded image


CH2


embedded image







1160


embedded image




embedded image


H


embedded image


CH2


embedded image







1161


embedded image




embedded image


H


embedded image


CH2


embedded image







1162


embedded image




embedded image


H


embedded image


CH2


embedded image







1163


embedded image




embedded image


H


embedded image


CH2


embedded image







1164


embedded image




embedded image


H


embedded image


CH2


embedded image







1165


embedded image




embedded image


H


embedded image


CH2


embedded image







1166


embedded image




embedded image


Me


embedded image


CH2


embedded image







1167


embedded image




embedded image


Me


embedded image


CH2


embedded image







1168


embedded image




embedded image


H


embedded image


CH2


embedded image







1169


embedded image




embedded image


H


embedded image


CH2


embedded image







1170


embedded image




embedded image


H


embedded image


CH2


embedded image







1171


embedded image




embedded image


H


embedded image


CH2


embedded image







1172


embedded image




embedded image


H


embedded image


CH2


embedded image







1173


embedded image




embedded image


H


embedded image


CH2


embedded image







1174


embedded image




embedded image


H


embedded image


CH2


embedded image







1175


embedded image




embedded image


H


embedded image


CH2


embedded image







1176


embedded image




embedded image


H


embedded image


CH2


embedded image







1177


embedded image




embedded image


H


embedded image


CH2


embedded image







1178


embedded image




embedded image


H


embedded image


CH2


embedded image







1179


embedded image


H
Me


embedded image


CH2


embedded image







1180


embedded image


H
Me


embedded image


CH2


embedded image







1181


embedded image


H
Me


embedded image


CH2


embedded image







1182


embedded image


H
Me


embedded image


CH2


embedded image







1183


embedded image


H
Me


embedded image


CH2


embedded image







1184


embedded image


H
Me


embedded image


CH2


embedded image







1185


embedded image


H
Me


embedded image


CH2


embedded image







1186


embedded image


H
Me


embedded image


CH2


embedded image







1187


embedded image


H
Me


embedded image


CH2


embedded image







1188


embedded image


H
Me


embedded image


CH2


embedded image







1189


embedded image




embedded image


H


embedded image


C═O


embedded image











For all compounds, R5═H, except for compound 1189 wherein R5═CH3. For compound 1156 in which Fmoc-Pro is the BB2 component, R2 and (N)R3 form a cyclic five-membered ring, including the nitrogen atom, as shown for the combined R2-R3 in Table 4D.


Example 6
Synthesis of a Representative Library of Macrocyclic Compounds of Formula (Id)

The synthetic scheme depicted in Scheme 8 was used to synthesize the library of macrocyclic compounds 1201-1334 on solid support. The first amino acid building block amino acid (BB1) was attached to the resin (Method 1D), then, after Fmoc deprotection (Method 1F), the second building block (BB2) was added through amide bond formation (Method 1G) or reductive amination (Method 1I or 1J). The N-protection was cleaved (Method 1F) and the oxazole building block (BB3) attached by reductive amination (Method 1J) or amide coupling (Method 1G) to give the macrocycle precursor scaffold. The crude product was obtained after sequential removal of the Fmoc (Method 1F), acidic cleavage from the resin (Method 1Q), cyclization (Method 1R) and cleavage of the side chain protecting groups (Method 1S) followed by concentration in vacuo. The purified macrocycles obtained after preparative HPLC (Method 2B are presented in Table 5A with the amounts, purity and confirmation of identity. Structures of the individual compounds in the library are provided in Table 5B.















TABLE 5A





Cpd
BB1
BB2
BB3
Wt (mg)1
Purity2
MS (M + H)





















1201
Fmoc-D-His(Trt)
Fmoc-D-Trp(Boc)
Fmoc-OX-13
11.7
100
490


1202
Fmoc-D-His(Trt)
Fmoc-D-Tyr(But)
Fmoc-OX-13
11.3
100
467


1203
Fmoc-D-His(Trt)
Fmoc-Trp(Boc)
Fmoc-OX-13
10.5
100
490


1204
Fmoc-D-His(Trt)
Fmoc-Tyr(But)
Fmoc-OX-13
12.7
100
467


1205
Fmoc-D-Lys(Boc)
Fmoc-D-Trp(Boc)
Fmoc-OX-13
14.3
100
481


1206
Fmoc-D-Lys(Boc)
Fmoc-D-Tyr(But)
Fmoc-OX-13
17.4
100
458


1207
Fmoc-D-Lys(Boc)
Fmoc-Trp(Boc)
Fmoc-OX-13
8.8
100
481


1208
Fmoc-D-Lys(Boc)
Fmoc-Tyr(But)
Fmoc-OX-13
10.7
100
458


1209
Fmoc-Phe
Fmoc-Asn(Trt)
Fmoc-OX-13
2.8
 97
428


1210
Fmoc-D-Phe
Fmoc-D-Asn(Trt)
Fmoc-OX-13
6.8
 95
428


1211
Fmoc-Lys(Boc)
Fmoc-Phe
Fmoc-OX-13
2.8
100
442


1212
Fmoc-D-Lys(Boc)
Fmoc-D-Phe
Fmoc-OX-13
10.9
 90
442


1213
Fmoc-Ser(But)
Fmoc-Ala
Fmoc-OX-13
10.3
100
325


1214
Fmoc-D-Ser(But)
Fmoc-D-Ala
Fmoc-OX-13
8.6
100
325


1215
Fmoc-Ala
Fmoc-Tyr(But)
Fmoc-OX-13
3.4
100
401


1216
Fmoc-D-Ala
Fmoc-D-Tyr(But)
Fmoc-OX-13
12.2
100
401


1217
Fmoc-D-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
7.9
100
467


1218
Fmoc-D-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-13
10.6
100
444


1219
Fmoc-Trp(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
2.8
100
467


1220
Fmoc-Tyr(But)
Fmoc-Asn(Trt)
Fmoc-OX-13
5.1
100
444


1221
Fmoc-D-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
4.9
 95
440


1222
Fmoc-D-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-13
7.3
100
417


1223
Fmoc-Trp(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
3.2
 96
440


1224
Fmoc-Tyr(But)
Fmoc-Ser(But)
Fmoc-OX-13
5.8
 97
417


1225
Fmoc-Lys(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
2.9
100
382


1226
Fmoc-D-Lys(Boc)
Fmoc-Ser(But)
Fmoc-OX-13
7.4
100
382


1227
Fmoc-Phe
Fmoc-Sar
Fmoc-OX-13
1.0
100
385


1228
Fmoc-D-Phe
Fmoc-Sar
Fmoc-OX-13
1.4
100
385


1229
Fmoc-Lys(Boc)
Fmoc-Sar
Fmoc-OX-13
3.0
100
366


1230
Fmoc-D-Lys(Boc)
Fmoc-Sar
Fmoc-OX-13
2.5
100
366


1231
Fmoc-Ser(But)
Fmoc-Sar
Fmoc-OX-13
2.3
100
325


1232
Fmoc-D-Ser(But)
Fmoc-Sar
Fmoc-OX-13
2.9
100
325


1233
Fmoc-Ala
Fmoc-Sar
Fmoc-OX-13
0.5
100
309


1234
Fmoc-D-Ala
Fmoc-Sar
Fmoc-OX-13
0.7
100
309


1235
Fmoc-D-Trp(Boc)
Fmoc-Sar
Fmoc-OX-13
0.9
100
424


1236
Fmoc-D-Tyr(But)
Fmoc-Sar
Fmoc-OX-13
1.6
 85
401


1237
Fmoc-Trp(Boc)
Fmoc-Sar
Fmoc-OX-13
1.0
100
424


1238
Fmoc-Tyr(But)
Fmoc-Sar
Fmoc-OX-13
1.1
100
401


1239
Fmoc-Dap(Boc)
Fmoc-Sar
Fmoc-OX-13
0.5
100
324


1240
Fmoc-D-Dap(Boc)
Fmoc-Sar
Fmoc-OX-13
0.6
100
324


1241
Fmoc-Arg(Pbf)
Fmoc-Sar
Fmoc-OX-13
na
na
na


1242
Fmoc-D-Arg(Pbf)
Fmoc-Sar
Fmoc-OX-13
0.9
100
394


1243
Fmoc-Dap(Boc)
Fmoc-Asn(Trt)
Fmoc-OX-13
1.7
100
367


1244
Fmoc-D-Dap(Boc)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
3.2
100
367


1245
Fmoc-Arg(Pbf)
Fmoc-Phe
Fmoc-OX-13
2.7
100
470


1246
Fmoc-D-Arg(Pbf)
Fmoc-D-Phe
Fmoc-OX-13
8.7
 97
470


1247
Fmoc-Val
Fmoc-Tyr(But)
Fmoc-OX-13
0.8
100
429


1248
Fmoc-D-Val
Fmoc-D-Tyr(But)
Fmoc-OX-13
14.7
 96
429


1249
Fmoc-His(Trt)
Fmoc-Asn(Trt)
Fmoc-OX-13
3.0
100
418


1250
Fmoc-D-His(Trt)
Fmoc-Asn(Trt)
Fmoc-OX-13
7.0
 96
418


1251
Fmoc-His(Trt)
Fmoc-Ser(But)
Fmoc-OX-13
4.5
100
391


1252
Fmoc-D-His(Trt)
Fmoc-Ser(But)
Fmoc-OX-13
11.4
100
391


1253
Fmoc-His(Trt)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
9.1
100
418


1254
Fmoc-D-His(Trt)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
4.5
100
418


1255
Fmoc-His(Trt)
Fmoc-D-Ser(But)
Fmoc-OX-13
2.6
100
391


1256
Fmoc-D-His(Trt)
Fmoc-D-Ser(But)
Fmoc-OX-13
8.3
100
391


1257
Fmoc-D-Trp(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
3.1
100
454


1258
Fmoc-D-Tyr(But)
Fmoc-D-Thr(But)
Fmoc-OX-13
13.8
100
431


1259
Fmoc-Trp(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
1.7
 88
454


1260
Fmoc-Tyr(But)
Fmoc-D-Thr(But)
Fmoc-OX-13
4.7
100
431


1261
Fmoc-Lys(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
1.7
100
396


1262
Fmoc-D-Lys(Boc)
Fmoc-D-Thr(But)
Fmoc-OX-13
22.6
100
396


1263
Fmoc-Phe
Fmoc-Thr(But)
Fmoc-OX-13
0.4
100
415


1264
Fmoc-D-Phe
Fmoc-D-Thr(But)
Fmoc-OX-13
13.3
 98
415


1265
Fmoc-Dap(Boc)
Fmoc-Thr(But)
Fmoc-OX-13
2.2
100
354


1266
Fmoc-D-Dap(Boc)
Fmoc-D-Thr(But)
Fmoc-OX-13
11.0
100
354


1267
Fmoc-Arg(Pbf)
Fmoc-Thr(But)
Fmoc-OX-13
1.2
100
424


1268
Fmoc-D-Arg(Pbf)
Fmoc-D-Thr(But)
Fmoc-OX-13
3.9
100
424


1269
Fmoc-Val
Fmoc-Thr(But)
Fmoc-OX-13
1.1
100
367


1270
Fmoc-D-Val
Fmoc-D-Thr(But)
Fmoc-OX-13
11.5
 97
367


1271
Fmoc-His(Trt)
Fmoc-Thr(But)
Fmoc-OX-13
10.4
100
405


1272
Fmoc-D-His(Trt)
Fmoc-D-Thr(But)
Fmoc-OX-13
16.4
100
405


1273
Fmoc-D-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-13
1.1
100
509


1274
Fmoc-D-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
4.3
100
486


1275
Fmoc-Trp(Boc)
Fmoc-Arg(Pbf)
Fmoc-OX-13
1.5
100
509


1276
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
4.3
100
486


1277
Fmoc-Phe
Fmoc-Arg(Pbf)
Fmoc-OX-13
3.2
100
470


1278
Fmoc-D-Phe
Fmoc-Arg(Pbf)
Fmoc-OX-13
1.8
100
470


1279
Fmoc-Val
Fmoc-Arg(Pbf)
Fmoc-OX-13
na
na
na


1280
Fmoc-D-Val
Fmoc-Arg(Pbf)
Fmoc-OX-13
8.9
100
422


1281
Fmoc-Ala
Fmoc-Arg(Pbf)
Fmoc-OX-13
3.7
100
394


1282
Fmoc-D-Ala
Fmoc-Arg(Pbf)
Fmoc-OX-13
1.2
100
394


1283
Fmoc-Ser(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
13.6
100
410


1284
Fmoc-D-Ser(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
6.4
100
410


1285
Fmoc-D-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
3.5
100
509


1286
Fmoc-D-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
15.5
100
486


1287
Fmoc-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
2.4
100
509


1288
Fmoc-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
5.6
100
486


1289
Fmoc-Phe
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
4.5
100
470


1290
Fmoc-D-Phe
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
8.9
100
470


1291
Fmoc-Val
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
4.8
100
422


1292
Fmoc-D-Val
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
14.3
100
422


1293
Fmoc-Ala
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
3.0
100
394


1294
Fmoc-D-Ala
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
8.0
100
394


1295
Fmoc-Ser(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
3.6
100
410


1296
Fmoc-D-Ser(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
6.2
100
410


1297
Fmoc-D-Trp(Boc)
Fmoc-Dap(Boc)
Fmoc-OX-13
2.1
100
439


1298
Fmoc-D-Tyr(But)
Fmoc-Dap(Boc)
Fmoc-OX-13
3.7
100
416


1299
Fmoc-Trp(Boc)
Fmoc-Dap(Boc)
Fmoc-OX-13
2.5
 81
439


1300
Fmoc-Tyr(But)
Fmoc-Dap(Boc)
Fmoc-OX-13
0.7
 81
416


1301
Fmoc-Phe
Fmoc-Dap(Boc)
Fmoc-OX-13
2.4
 73
400


1302
Fmoc-D-Phe
Fmoc-Dap(Boc)
Fmoc-OX-13
1.9
100
400


1303
Fmoc-Val
Fmoc-Dap(Boc)
Fmoc-OX-13
0.9
na
na


1304
Fmoc-D-Val
Fmoc-Dap(Boc)
Fmoc-OX-13
2.1
 95
352


1305
Fmoc-Ala
Fmoc-Dap(Boc)
Fmoc-OX-13
3.5
 74+
324


1306
Fmoc-D-Ala
Fmoc-Dap(Boc)
Fmoc-OX-13
4.1
100
324


1307
Fmoc-Ser(But)
Fmoc-Dap(Boc)
Fmoc-OX-13
2.2
100
340


1308
Fmoc-D-Ser(But)
Fmoc-Dap(Boc)
Fmoc-OX-13
5.3
100
340


1309
Fmoc-D-Trp(Boc)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
4.4
 86
439


1310
Fmoc-D-Tyr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
7.2
100
416


1311
Fmoc-Trp(Boc)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
2.2
 80
439


1312
Fmoc-Tyr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
3.2
 70+
416


1313
Fmoc-Phe
Fmoc-D-Dap(Boc)
Fmoc-OX-13
4.1
 57
400


1314
Fmoc-D-Phe
Fmoc-D-Dap(Boc)
Fmoc-OX-13
5.1
100
400


1315
Fmoc-Val
Fmoc-D-Dap(Boc)
Fmoc-OX-13
3.3
 61
352


1316
Fmoc-D-Val
Fmoc-D-Dap(Boc)
Fmoc-OX-13
5.3
100
352


1317
Fmoc-Ala
Fmoc-D-Dap(Boc)
Fmoc-OX-13
3.5
 67
324


1318
Fmoc-D-Ala
Fmoc-D-Dap(Boc)
Fmoc-OX-13
6.5
100
324


1319
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
4.2
 74+
340


1320
Fmoc-D-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
5.9
100
340


1321
Fmoc-Leu
Fmoc-D-Dap(Boc)
Fmoc-OX-13
1.1
100
366


1322
Fmoc-D-Leu
Fmoc-D-Dap(Boc)
Fmoc-OX-13
0.9
100
366


1323
Fmoc-Ser(But)
Fmoc-S31
Fmoc-OX-13
0.8
100
311


1324
Fmoc-D-Ser(But)
Fmoc-S31
Fmoc-OX-13
0.8
100
311


1325
Fmoc-D-Trp(Boc)
Fmoc-S31
Fmoc-OX-13
0.9
100
410


1326
Fmoc-D-Tyr(But)
Fmoc-S31
Fmoc-OX-13
2.5
100
387


1327
Fmoc-Trp(Boc)
Fmoc-S31
Fmoc-OX-13
1.0
100
410


1328
Fmoc-Tyr(But)
Fmoc-S31
Fmoc-OX-13
0.9
100
387


1329
Fmoc-Phe
Fmoc-S31
Fmoc-OX-13
1.9
100
371


1330
Fmoc-D-Phe
Fmoc-S31
Fmoc-OX-13
1.8
100
371


1331
Fmoc-Dap(Boc)
Fmoc-S31
Fmoc-OX-13
0.8
100
310


1332
Fmoc-D-Dap(Boc)
Fmoc-S31
Fmoc-OX-13
0.3
100
310


1333
Fmoc-Lys(Boc)
Fmoc-S31
Fmoc-OX-13
1.2
100
352


1334
Fmoc-D-Lys(Boc)
Fmoc-S31
Fmoc-OX-13
2.6
100
352





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 5B









embedded image


















Cpd
R1
Q1
R2
R3
Q2
R4





1201


embedded image


C═O


embedded image


H
CH2


embedded image







1202


embedded image


C═O


embedded image


H
CH2


embedded image







1203


embedded image


C═O


embedded image


H
CH2


embedded image







1204


embedded image


C═O


embedded image


H
CH2


embedded image







1205


embedded image


C═O


embedded image


H
CH2


embedded image







1206


embedded image


C═O


embedded image


H
CH2


embedded image







1207


embedded image


C═O


embedded image


H
CH2


embedded image







1208


embedded image


C═O


embedded image


H
CH2


embedded image







1209


embedded image


C═O


embedded image


H
CH2


embedded image







1210


embedded image


C═O


embedded image


H
CH2


embedded image







1211


embedded image


C═O


embedded image


H
CH2


embedded image







1212


embedded image


C═O


embedded image


H
CH2


embedded image







1213


embedded image


C═O


embedded image


H
CH2


embedded image







1214


embedded image


C═O


embedded image


H
CH2


embedded image







1215
(S)-CH3
C═O


embedded image


H
CH2


embedded image







1216
(R)-CH3
C═O


embedded image


H
CH2


embedded image







1217


embedded image


C═O


embedded image


H
CH2


embedded image







1218


embedded image


C═O


embedded image


H
CH2


embedded image







1219


embedded image


C═O


embedded image


H
CH2


embedded image







1220


embedded image


C═O


embedded image


H
CH2


embedded image







1221


embedded image


C═O


embedded image


H
CH2


embedded image







1222


embedded image


C═O


embedded image


H
CH2


embedded image







1223


embedded image


C═O


embedded image


H
CH2


embedded image







1224


embedded image


C═O


embedded image


H
CH2


embedded image







1225


embedded image


C═O


embedded image


H
CH2


embedded image







1226


embedded image


C═O


embedded image


H
CH2


embedded image







1227


embedded image


C═O


embedded image


Me
CH2


embedded image







1228


embedded image


C═O


embedded image


Me
CH2


embedded image







1229


embedded image


C═O


embedded image


Me
CH2


embedded image







1230


embedded image


C═O


embedded image


Me
CH2


embedded image







1231


embedded image


C═O


embedded image


Me
CH2


embedded image







1232


embedded image


C═O


embedded image


Me
CH2


embedded image







1233
(S)-CH3
C═O


embedded image


Me
CH2


embedded image







1234
(R)-CH3
C═O


embedded image


Me
CH2


embedded image







1235


embedded image


C═O


embedded image


Me
CH2


embedded image







1236


embedded image


C═O


embedded image


Me
CH2


embedded image







1237


embedded image


C═O


embedded image


Me
CH2


embedded image







1238


embedded image


C═O


embedded image


Me
CH2


embedded image







1239


embedded image


C═O


embedded image


Me
CH2


embedded image







1240


embedded image


C═O


embedded image


Me
CH2


embedded image







1241


embedded image


C═O


embedded image


Me
CH2


embedded image







1242


embedded image


C═O


embedded image


Me
CH2


embedded image







1243


embedded image


C═O


embedded image


H
CH2


embedded image







1244


embedded image


C═O


embedded image


H
CH2


embedded image







1245


embedded image


C═O


embedded image


H
CH2


embedded image







1246


embedded image


C═O


embedded image


H
CH2


embedded image







1247


embedded image


C═O


embedded image


H
CH2


embedded image







1248


embedded image


C═O


embedded image


H
CH2


embedded image







1249


embedded image


C═O


embedded image


H
CH2


embedded image







1250


embedded image


C═O


embedded image


H
CH2


embedded image







1251


embedded image


C═O


embedded image


H
CH2


embedded image







1252


embedded image


C═O


embedded image


H
CH2


embedded image







1253


embedded image


C═O


embedded image


H
CH2


embedded image







1254


embedded image


C═O


embedded image


H
CH2


embedded image







1255


embedded image


C═O


embedded image


H
CH2


embedded image







1256


embedded image


C═O


embedded image


H
CH2


embedded image







1257


embedded image


C═O


embedded image


H
CH2


embedded image







1258


embedded image


C═O


embedded image


H
CH2


embedded image







1259


embedded image


C═O


embedded image


H
CH2


embedded image







1260


embedded image


C═O


embedded image


H
CH2


embedded image







1261


embedded image


C═O


embedded image


H
CH2


embedded image







1262


embedded image


C═O


embedded image


H
CH2


embedded image







1263


embedded image


C═O


embedded image


H
CH2


embedded image







1264


embedded image


C═O


embedded image


H
CH2


embedded image







1265


embedded image


C═O


embedded image


H
CH2


embedded image







1266


embedded image


C═O


embedded image


H
CH2


embedded image







1267


embedded image


C═O


embedded image


H
CH2


embedded image







1268


embedded image


C═O


embedded image


H
CH2


embedded image







1269


embedded image


C═O


embedded image


H
CH2


embedded image







1270


embedded image


C═O


embedded image


H
CH2


embedded image







1271


embedded image


C═O


embedded image


H
CH2


embedded image







1272


embedded image


C═O


embedded image


H
CH2


embedded image







1273


embedded image


C═O


embedded image


H
CH2


embedded image







1274


embedded image


C═O


embedded image


H
CH2


embedded image







1275


embedded image


C═O


embedded image


H
CH2


embedded image







1276


embedded image


C═O


embedded image


H
CH2


embedded image







1277


embedded image


C═O


embedded image


H
CH2


embedded image







1278


embedded image


C═O


embedded image


H
CH2


embedded image







1279


embedded image


C═O


embedded image


H
CH2


embedded image







1280


embedded image


C═O


embedded image


H
CH2


embedded image







1281
(S)-CH3
C═O


embedded image


H
CH2


embedded image







1282
(R)-CH3
C═O


embedded image


H
CH2


embedded image







1283


embedded image


C═O


embedded image


H
CH2


embedded image







1284


embedded image


C═O


embedded image


H
CH2


embedded image







1285


embedded image


C═O


embedded image


H
CH2


embedded image







1286


embedded image


C═O


embedded image


H
CH2


embedded image







1287


embedded image


C═O


embedded image


H
CH2


embedded image







1288


embedded image


C═O


embedded image


H
CH2


embedded image







1289


embedded image


C═O


embedded image


H
CH2


embedded image







1290


embedded image


C═O


embedded image


H
CH2


embedded image







1291


embedded image


C═O


embedded image


H
CH2


embedded image







1292


embedded image


C═O


embedded image


H
CH2


embedded image







1293
(S)-CH3
C═O


embedded image


H
CH2


embedded image







1294
(R)-CH3
C═O


embedded image


H
CH2


embedded image







1295


embedded image


C═O


embedded image


H
CH2


embedded image







1296


embedded image


C═O


embedded image


H
CH2


embedded image







1297


embedded image


C═O


embedded image


H
CH2


embedded image







1298


embedded image


C═O


embedded image


H
CH2


embedded image







1299


embedded image


C═O


embedded image


H
CH2


embedded image







1300


embedded image


C═O


embedded image


H
CH2


embedded image







1301


embedded image


C═O


embedded image


H
CH2


embedded image







1302


embedded image


C═O


embedded image


H
CH2


embedded image







1303


embedded image


C═O


embedded image


H
CH2


embedded image







1304


embedded image


C═O


embedded image


H
CH2


embedded image







1305
(S)-CH3
C═O


embedded image


H
CH2


embedded image







1306
(R)-CH3
C═O


embedded image


H
CH2


embedded image







1307


embedded image


C═O


embedded image


H
CH2


embedded image







1308


embedded image


C═O


embedded image


H
CH2


embedded image







1309


embedded image


C═O


embedded image


H
CH2


embedded image







1310


embedded image


C═O


embedded image


H
CH2


embedded image







1311


embedded image


C═O


embedded image


H
CH2


embedded image







1312


embedded image


C═O


embedded image


H
CH2


embedded image







1313


embedded image


C═O


embedded image


H
CH2


embedded image







1314


embedded image


C═O


embedded image


H
CH2


embedded image







1315


embedded image


C═O


embedded image


H
CH2


embedded image







1316


embedded image


C═O


embedded image


H
CH2


embedded image







1317
(S)-CH3
C═O


embedded image


H
CH2


embedded image







1318
(R)-CH3
C═O


embedded image


H
CH2


embedded image







1319


embedded image


C═O


embedded image


H
CH2


embedded image







1320


embedded image


C═O


embedded image


H
CH2


embedded image







1321


embedded image


C═O


embedded image


H
CH2


embedded image







1322


embedded image


C═O


embedded image


H
CH2


embedded image







1323


embedded image


CH2


embedded image


H
CH2


embedded image







1324


embedded image


CH2


embedded image


H
CH2


embedded image







1325


embedded image


CH2


embedded image


H
CH2


embedded image







1326


embedded image


CH2


embedded image


H
CH2


embedded image







1327


embedded image


CH2


embedded image


H
CH2


embedded image







1328


embedded image


CH2


embedded image


H
CH2


embedded image







1329


embedded image


CH2


embedded image


H
CH2


embedded image







1330


embedded image


CH2


embedded image


H
CH2


embedded image







1331


embedded image


CH2


embedded image


H
CH2


embedded image







1332


embedded image


CH2


embedded image


H
CH2


embedded image







1333


embedded image


CH2


embedded image


H
CH2


embedded image







1334


embedded image


CH2


embedded image


H
CH2


embedded image











Example 7
High Throughput Screening Assay for Identification of Hepatitis C Virus NS3 Protease Inhibitors

Infection with hepatitis C virus (HCV) is a major global health concern causing chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The non-structural viral proteins are cleaved from a precursor protein by the HCV NS3 serine protease that requires the adjacent NS4A cofactor. The NS3 protease plays a vital role in protein processing as it directs proteolytic cleavages at the NS3/4A, NS4A/4B, NS4B/5A, and NS5A/5B junctions and is thus essential for replication and infectivity of the virus.


To identify new HCV NS3 protease inhibitors, a scintillation proximity assay (SPA) optimized for HTS is conducted as described in the literature (J. Biomol. Screen. 2000, 5, 153-158). The buffer used for the assay is 62.5 mM HEPES (pH 7.5), 30 mM dithiothreitol, 18.75% (v/v) glycerol, 0.062% (v/v) Triton X-100. HCV NS3 protease is activated by incubation with the NS4A cofactor (1000:1 cofactor:protease ratio) in assay buffer for 5 min at ambient temperature with mild agitation. Assays are conducted in 96 or 384-well microtiter plates with 50 μL assay buffer, 15 nM dual biotin and tritium-labelled protease substrate (biotin-DRMEECASHLPYK[propionyl-3H]—NH2), 6 mM biotinyl-protease substrate, nM HCV NS3 protease, 25 μM NS4A cofactor peptide (HKKKGSWIVGRIILSG-NH2), and library test compound in 2.5 μL DMSO. Reaction is initiated by the addition of 10 μL of the enzyme and cofactor. The plates are incubated for 30 min at ambient temperature with gentle agitation, then stopped by the addition of 100 μL of an appropriate stop solution (for example, streptavidin-coated YSi-SPA beads in PBS). Measurement of the radioactivity bound to the SPA beads is performed with an appropriate microplate scintillation counter (typically using a 1 min count time). Data thus obtained are analyzed using an appropriate software package, for example GraphPad Prism (La Jolla, Calif.).


Example 8
High Throughput Screening Assay for Identification of 5-Hydroxytryptamine Receptor Subtype 2A (5-HT2A) Inverse Agonists

The majority of clinically important antipsychotic agents have been found, in addition to their antagonistic action at dopamine D2 receptors, to be potent inverse agonists at the 5-HT2A receptor. For the identification of new such CNS therapeutic agents, the receptor selection and amplification assay as described in the literature (J. Pharm. Exp. Ther. 2001, 299, 268-276) is conducted.


Cell Culture


In preparation for the assay, appropriate cells (NIH-3T3 or other) are grown to 70-80% confluence in roller bottles or standard 96-well tissue culture plates in Dulbecco's modified essential media (DMEM) supplemented with 10% calf serum and 1% PSG (penicillin/streptomycin/glutamine. Transfection of cells with plasmid DNAs (cloned receptor) using standard methods for 12-16 h (o/n) followed. Co-expression of Gq was used to augment 5-HT2A receptor constitutive activity. If in plates, assays are performed with 1 to 50 ng/well cloned receptor and 20 ng/well β-galactosidase plasmid DNA. To assist with the 5-HT2A constitutive activity, 4-20 ng/well of Gq protein were also added. After transfection in roller bottles, the cells were trypsinized, harvested and frozen, or could be immediately used in the assay.


Assay


For the assay, cells were placed (or rapidly thawed, if previously forzen) in DMEM with 0.5% calf serum and 2% cyto-sf3 (Kemp Biotechnologies, Frederick, Md., USA), then added to the assay plates (typically 96- or 384-well) containing test compounds from the library, negative controls or positive controls (ritanserin). Alternatively, after the o/n transfection in plates, medium was replaced with serum-free DMEM containing 2% cyto-sf3 and 1% PSG and one (or more) concentrations of test library compounds or controls. In all cases, cells were grown in a humidified atmosphere with 5% ambient CO2 for 4-6 d. After removal of the medium, β-galactosidase activity in the plates is measured using standard methods, for example adding o-nitrophenyl β-D-galactopyranoside in phosphate buffered saline. The resulting colorimetric reaction was then measured using a spectrophotometric plate reader at the wavelength appropriate for the β-galactosidase method employed (420 nm for the example). Analysis of data is done using an appropriate software package, for example GraphPad Prism.


Example 9
Cell-Based High Throughput Screening Assay for Identification of Inhibitors of p53-MDM2 Interaction

The p53 transcription factor is a potent tumor suppressor that regulates expression of a variety of genes responsible for DNA repair, differentiation, cell cycle inhibition and apoptosis. The function of p53 is suppressed by the MDM2 oncoprotein through direct inhibition of its transcriptional activity and also enhancement of its degradation via the ubiquitin-proteosome pathway. Many human tumors overexpress MDM2 and effectively impair p53-mediated apoptosis. Hence, stabilization of p53 through inhibiting the p53-MDM2 interaction offers an approach for cancer chemotherapy. For the identification of such inhibitors, the validated cell-based assay as described in the literature is employed (J. Biomol. Screen. 2011, 16, 450-456). This is based upon mammalian two-hybrid technology utilizing a dual luciferase reporter system to eliminate false hits from cytotoxicity to the compounds.


Cell Culture


Appropriate cells (for example HEK293, U2OS, MDA-MB-435) were obtained from ATCC (Manassas, Va., USA) and maintained in DMEM with 10% fetal bovine serum (FBS), 100 mg/L penicillin, and 100 mg/L streptomycin at 37° C. in a humidified atmosphere of 5% CO2. About 1×106 cells were combined with plasmids (2-4 μg) in transfection buffer (200 μL), and electroporation executed for transient transfection.


Assay


A mammalian two-hybrid system (Stratagene, La Jolla, Calif.) was utilized for the cell-based assay developed for assessing the p53-MDM2 interaction. To effect this strategy, full-length p53 or MDM2 were inserted at the C-terminus of the DNA binding domain (BD) of GAL4 or the transcriptional activation domain (AD) of NFκB. Interaction of p53 and MDM2 brings the two domains (BD and AD) into proximity and thereby activates the downstream firefly luciferase reporter gene. Specifically, into the pCMV-AD and pCMV-BD vectors were cloned full-length cDNAs encoding human p53 and MDM2 in-frame with AD or BD at the N terminus. For single-luciferase analysis, cells were co-transfected with pCMV-AD-MDM2 (or -p53), pCMV-BD-p53 (or -MDM2), and the pFR-Luc firefly luciferase reporter plasmid at an equivalent ratio of 1:1:1. While for dual-luciferase analysis, an internal control, the pRL-TK plasmid encoding a renilla luciferase, was included. After transfection, seeding of cells is performed at a density of approximately 3×104 cells per well onto microplate (96 wells). The library test compounds at various concentrations are added 16 h post-transfection. Luciferase activities were measured after an additional 24 h using the Dual-Glo Luciferase system (Promega, Madison, Wis., USA) and an appropriate multiplate reader. Compounds are typically initially screened at a single concentration of 10 μM, 20 μM or 50 μM, then a dose-response curve obtained for those compounds found to be hits as defined below. In each 96-well plate, eight wells were used as positive controls (10 μM known inhibitor, for example nutilin-3, in 1% DMSO) and another eight wells as negative controls (1% DMSO). The luciferase activity was normalized to 100% and 0 in the wells treated with DMSO and known inhibitor, respectively. The compounds causing the luciferase activity to reduce to less than 30% could be considered as “hits” in the primary screening, although other values can also be selected. GraphPad Prism software, or other appropriate package, is used to analyze data and perform nonlinear regression analyses to generate dose-response curves and calculate IC50 values.


Example 10
Synthesis of a Representative Library of Macrocyclic Compounds of Formulae (Ia), (Ib), (Ic), (Id) and (Ie)

The synthetic scheme depicted in Scheme 8 was used to synthesize the library of macrocyclic compounds 1335-1383 on solid support except that BB1 was Fmoc-NR5—CHR1—CO2H. The first amino acid building block amino acid (BB1) was attached to the resin (Method 1D), then, after Fmoc deprotection (Method 1F), the second building block (BB2) was added through amide bond formation (Method 1G) or reductive amination (Method 1I or 1J). The N-protection was cleaved (Method 1F) and the oxazole building block (BB3) attached by reductive amination (Method 1J) or amide coupling (Method 1G) to give the macrocycle precursor scaffold. The crude product was obtained after sequential removal of the Fmoc (Method 1F), acidic cleavage from the resin (Method 1Q), cyclization (Method 1R) and cleavage of the side chain protecting groups (Method 1S) followed by concentration in vacuo. For compounds 1343, 1365 and 1377, prior to macrocyclization, the N-methyl group on BB3 (add R6 in place of H) is installed by the series of reactions described in Method 1P using methanol as the alcohol component. The purified macrocycles obtained after preparative HPLC (Method 2B) are presented in Table 6A with the amounts, purity and confirmation of identity. Structures of the individual compounds in the library are provided in Table 6B.















TABLE 6A





Cpd
BB1
BB2
BB3
Wt (mg)1
Purity2
MS (M + H)







1335
Fmoc-Glu(OBut)
Fmoc-D-Tyr(But)
Fmoc-OX-13
3.3
100
459


1336
Fmoc-Leu
Fmoc-D-Tyr(But)
Fmoc-OX-13
1.0
100
443


1337
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-16
10.3 
100
340


1338
Fmoc-Ser(But)
Fmoc-Dap(Boc)
Fmoc-OX-16
10.2 
100
340


1339
Fmoc-D-Ser(But)
Fmoc-Dap(Boc)
Fmoc-OX-16
5.0
100
340


1340
Fmoc-D-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-16
7.3
100
340


1341
Fmoc-N-Me-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
5.4
 90
354


1342
Fmoc-Ser(But)
Fmoc-N-Me-D-Dap(Boc)
Fmoc-OX-13
2.0
100
354


1343
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
6.0
100
354


1344
Fmoc-Thr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
5.2
100
354


1345
Fmoc-Asp(OBut)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
0.8
100
368


1346
Fmoc-Asn(Trt)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
2.5
100
367


1347
Fmoc-Tyr(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-13
3.9
 72
416


1348
Fmoc-Dap(Boc)
Fmoc-D-Ser(But)
Fmoc-OX-13
3.5
100
340


1349
Fmoc-Ser(But)
Fmoc-D-Dab(Boc)
Fmoc-OX-13
7.0
100
354


1350
Fmoc-Ser(But)
Fmoc-D-Orn(Boc)
Fmoc-OX-13
7.7
100
368


1351
Fmoc-Ser(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
6.7
100
382


1352
Fmoc-Ser(But)
Fmoc-D-Ser(But)
Fmoc-OX-13
5.5
100
341


1353
Fmoc-Ser(But)
Fmoc-D-Ala
Fmoc-OX-13
5.3
100
325


1354
Fmoc-Ser(But)
Fmoc-D-Asn(Trt)
Fmoc-OX-13
8.6
100
368


1355
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-33
6.2
 93
340


1356
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-32
3.0
100
340


1357
Fmoc-Ser(But)
Fmoc-D-Dap(Boc)
Fmoc-OX-31
na
na
na


1358
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
18.3 
100
458


1359
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
1.7
100
458


1360
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
1.8
100
458


1361
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
7.6
100
458


1362
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-16
2.8
100
458


1363
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-16
8.8
100
458


1364
Fmoc-D-Tyr(But)
Fmoc-NMe-D-Lys(Boc)
Fmoc-OX-13
3.5
100
472


1365
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
6.5
100
472


1366
Fmoc-D-Tyr(But)
Fmoc-D-Orn(Boc)
Fmoc-OX-13
5.6
100
444


1367
Fmoc-D-Tyr(But)
Fmoc-D-Dab(Boc)
Fmoc-OX-13
4.9
100
430


1368
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-33
9.9
100
458


1369
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-31
5.1
100
416


1370
Fmoc-D-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-32
7.1
100
458


1371
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-16
4.8
100
486


1372
Fmoc-D-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-16
2.7
100
486


1373
Fmoc-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-16
2.6
100
486


1374
Fmoc-D-Tyr(But)
Fmoc-D-Arg(Pbf)
Fmoc-OX-16
1.3
100
486


1375
Fmoc-N-Me-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
na
na
na


1376
Fmoc-Tyr(But)
Fmoc-N-Me-Arg(Pbf)
Fmoc-OX-13
na
na
na


1377
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-13
2.3
100
500


1378
Fmoc-Arg(Pbf)
Fmoc-Tyr(But)
Fmoc-OX-13
1.6
100
486


1379
Fmoc-Tyr(But)
Fmoc-Orn(Boc)
Fmoc-OX-13
3.7
100
444


1380
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-1
9.4
100
500


1381
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-31
na
na
na


1382
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-32
1.9
100
486


1383
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-OX-33
4.0
100
486





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.














TABLE 6B









embedded image


















Cpd
R1
Q1
R2
R3
Q2
R4





1335


embedded image


C═O


embedded image


H
CH2


embedded image







1336


embedded image


C═O


embedded image


H
CH2


embedded image







1337


embedded image


C═O


embedded image


H
CH2


embedded image







1338


embedded image


C═O


embedded image


H
CH2


embedded image







1339


embedded image


C═O


embedded image


H
CH2


embedded image







1340


embedded image


C═O


embedded image


H
CH2


embedded image







1341


embedded image


C═O


embedded image


H
CH2


embedded image







1342


embedded image


C═O


embedded image


Me
CH2


embedded image







1343


embedded image


C═O


embedded image


H
CH2


embedded image







1344


embedded image


C═O


embedded image


H
CH2


embedded image







1345


embedded image


C═O


embedded image


H
CH2


embedded image







1346


embedded image


C═O


embedded image


H
CH2


embedded image







1347


embedded image


C═O


embedded image


H
CH2


embedded image







1348


embedded image


C═O


embedded image


H
CH2


embedded image







1349


embedded image


C═O


embedded image


H
CH2


embedded image







1350


embedded image


C═O


embedded image


H
CH2


embedded image







1351


embedded image


C═O


embedded image


H
CH2


embedded image







1352


embedded image


C═O


embedded image


H
CH2


embedded image







1353


embedded image


C═O


embedded image


H
CH2


embedded image







1354


embedded image


C═O


embedded image


H
CH2


embedded image







1355


embedded image


C═O


embedded image


H
CH2


embedded image







1356


embedded image


C═O


embedded image


H
CH2


embedded image







1357


embedded image


C═O


embedded image


H
CH2
(S)-CH3





1358


embedded image


C═O


embedded image


H
CH2


embedded image







1359


embedded image


C═O


embedded image


H
CH2


embedded image







1360


embedded image


C═O


embedded image


H
CH2


embedded image







1361


embedded image


C═O


embedded image


H
CH2


embedded image







1362


embedded image


C═O


embedded image


H
CH2


embedded image







1363


embedded image


C═O


embedded image


H
CH2


embedded image







1364


embedded image


C═O


embedded image


Me
CH2


embedded image







1365


embedded image


C═O


embedded image


H
CH2


embedded image







1366


embedded image


C═O


embedded image


H
CH2


embedded image







1367


embedded image


C═O


embedded image


H
CH2


embedded image







1368


embedded image


C═O


embedded image


H
CH2


embedded image







1369


embedded image


C═O


embedded image


H
CH2
(S)-CH3





1370


embedded image


C═O


embedded image


H
CH2


embedded image







1371


embedded image


C═O


embedded image


H
CH2


embedded image







1372


embedded image


C═O


embedded image


H
CH2


embedded image







1373


embedded image


C═O


embedded image


H
CH2


embedded image







1374


embedded image


C═O


embedded image


H
CH2


embedded image







1375


embedded image


C═O


embedded image


H
CH2


embedded image







1376


embedded image


C═O


embedded image


Me
CH2


embedded image







1377


embedded image


C═O


embedded image


H
CH2


embedded image







1378


embedded image


C═O


embedded image


H
CH2


embedded image







1379


embedded image


C═O


embedded image


H
CH2


embedded image







1380


embedded image


C═O


embedded image


H
C═O


embedded image







1381


embedded image


C═O


embedded image


H
CH2
(S)-CH3





1382


embedded image


C═O


embedded image


H
CH2


embedded image







1383


embedded image


C═O


embedded image


H
CH2


embedded image











For all compounds R5 and R6═H, except for compounds 1341 and 1375 in which R5═CH3 and compounds 1343, 1365 and 1377 in which R6═CH3.


For further library diversification, the synthetic scheme presented in Scheme 3 was followed to prepare macrocyclic compounds 1384-1414 on solid support, except for a modification in the attachment of BB4 related to compounds 1399-1400 noted below. The first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D), then, after removal of the Fmoc protection (Method 1F), the oxazole building block (BB2) attached through amide bond formation (Method 1G) or reductive amination (Method 1J). The next amino acid building block (BB3) was coupled (Method 1G) after Fmoc-deprotection (Method 1F) to extend the intermediate chain, then the last building block component (BB4) added using reductive amination (Method 1I or 1J) to complete the cyclization precursor. N-Terminal Fmoc deprotection (Method 1F), macrocyclization (Method 1R) and removal of side chain protecting groups (Method 1S) gave the crude product after evaporation under reduced pressure. The quantities of each macrocycle obtained, their HPLC purity and confirmation of their identity by mass spectrometry (MS) after purification by preparative HPLC (Method 2B) are included in Table 6C. Individual compound structures are provided in Table 6D.


For compounds 1399-1400 only, amide bond formation (Method 1G) was utilized to attach BB4, which results in a carbonyl in the structure rather than a methylene. Also, for compounds 1404 and 1407, BB4 is added via a Mitsunobu reaction using Method 1L. For compound 1392, the N-methyl group on BB2 (add R8 in place of H) is installed prior to the addition of BB3 by the series of reactions described in Method 1P using methanol as the alcohol component. Likewise, for compounds 1406, 1407 and 1409, prior to macrocyclization, the N-methyl group on BB4 (R5) is installed by the series of reactions described in Method 1P using methanol as the alcohol component.
















TABLE 6C










Wt




Cpd
BB1
BB2
BB3
BB4
(mg)1
Purity2
MS (M + H)






















1001
Fmoc-D-Asn(Trt)
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
19.8
100
594


1002
Fmoc-D-Asn(Trt)
Fmoc-D-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
16.9
100
571


1003
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
20.7
88
594


1384
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-Ser(But)
Fmoc-S35
0.8
100
593


1385
Fmoc-D-Tyr(But)
Fmoc-OX-13
Fmoc-D-Lys(Boc)
Fmoc-S30
9.3
100
515


1386
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-Lys(Boc)
Fmoc-S35
3.9
100
592


1387
Fmoc-Trp(Boc)
Fmoc-OX-4
Fmoc-D-Lys(Boc)
Fmoc-S35
1.7
100
592


1388
Fmoc-D-Trp(Boc)
Fmoc-OX-4
Fmoc-D-Lys(Boc)
Fmoc-S35
4.5
100
592


1389
Fmoc-D-Trp(Boc)
Fmoc-OX-4
Fmoc-Lys(Boc)
Fmoc-S35
1.1
100
592


1390
Fmoc-Trp(Boc)
Fmoc-OX-4
Fmoc-Lys(Boc)
Fmoc-S35
3.5
100
592


1391
Fmoc-N-Me-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
na
na
na


1392
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
2.1
100
606


1393
Fmoc-Ala
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
3.1
100
477


1394
Fmoc-Trp(Boc)
Fmoc-OX-19
Fmoc-D-Lys(Boc)
Fmoc-S35
2.4
100
550


1395
Fmoc-Trp(Boc)
Fmoc-OX-20
Fmoc-D-Lys(Boc)
Fmoc-S35
2.1
100
592


1396
Fmoc-Trp(Boc)
Fmoc-OX-21
Fmoc-D-Lys(Boc)
Fmoc-S35
0.9
100
592


1397
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Lys(Boc)
Fmoc-S35
10.2
100
578


1398
Fmoc-Trp(Boc)
Fmoc-OX-16
Fmoc-D-Lys(Boc)
Fmoc-S35
13.8
100
578


1399
Fmoc-Trp(Boc)
Fmoc-OX-13
Fmoc-D-Lys(Boc)
Fmoc-4-Pip*
7.0
100
592


1400
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-4-Pip*
8.5
97
606


1401
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-(S)-SP1**
4.8
100
578


1402
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-(R)-SP1**
6.0
100
578


1403
Fmoc-D-Lys(Boc)
Fmoc-OX-1
Fmoc-Trp(Boc)
Fmoc-S35
2.7
100
592


1404
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S9
19.0
100
582


1405
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S6b***
na
na
566


1406
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S6b***
32.5
100
580


1407
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S9
24.7
100
596


1408
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S33
na
na
552


1409
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S33
na
na
566


1410
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-S35
1.1
55
620


1411
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Orn(Boc)
Fmoc-S35
2.4
100
578


1412
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Dab(Boc)
Fmoc-S35
0.6
na
564


1413
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Gln(Trt)
Fmoc-S35
0.6
100
592


1414
Fmoc-Trp(Boc)
Fmoc-OX-1
Fmoc-D-Arg(Pbf)
Fmoc-S35
0.3
100
620





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.





embedded image


embedded image

Cat. No. 03218)] using Method 1H, while (R)-isomer is synthesized from Fmoc-D-Pro by reduction using the procedure of Example 1J, followed by oxidation using Method 1H].





embedded image















TABLE 6D









embedded image


















Cpd
R1
Q
R2
R3
R5
R7















1384


embedded image


CH2


embedded image




embedded image




embedded image


















1385


embedded image


CH2


embedded image




embedded image


Me


embedded image

















1386


embedded image


C═O


embedded image




embedded image




embedded image







1387


embedded image


C═O


embedded image




embedded image




embedded image







1388


embedded image


C═O


embedded image




embedded image




embedded image







1389


embedded image


C═O


embedded image




embedded image




embedded image







1390


embedded image


C═O


embedded image




embedded image




embedded image







1391


embedded image


C═O


embedded image




embedded image




embedded image







1392


embedded image


C═O


embedded image




embedded image




embedded image







1393
(S)-CH3
C═O


embedded image




embedded image




embedded image







1394


embedded image


C═O
(S)-CH3


embedded image




embedded image







1395


embedded image


C═O


embedded image




embedded image




embedded image







1396


embedded image


C═O


embedded image




embedded image




embedded image







1397


embedded image


CH2


embedded image




embedded image




embedded image







1398


embedded image


CH2


embedded image




embedded image




embedded image







1399


embedded image


CH2


embedded image




embedded image




embedded image







1400


embedded image


C═O


embedded image




embedded image




embedded image







1401


embedded image


C═O


embedded image




embedded image




embedded image







1402


embedded image


C═O


embedded image




embedded image




embedded image







1403
D-Lys
C═O


embedded image




embedded image




embedded image


















1404


embedded image


C═O


embedded image




embedded image


H


embedded image







1405


embedded image


C═O


embedded image




embedded image


H


embedded image







1406


embedded image


C═O


embedded image




embedded image


Me


embedded image







1407


embedded image


C═O


embedded image




embedded image


Me


embedded image







1408


embedded image


C═O


embedded image




embedded image


H


embedded image







1409


embedded image


C═O


embedded image




embedded image


Me


embedded image

















1410


embedded image


C═O


embedded image




embedded image




embedded image







1411


embedded image


C═O


embedded image




embedded image




embedded image







1412


embedded image


C═O


embedded image




embedded image




embedded image







1413


embedded image


C═O


embedded image




embedded image




embedded image







1414


embedded image


C═O


embedded image




embedded image




embedded image











For all compounds, R4, R6 and R8═H, except for compound 1391, where R6═CH3 and compound 1392, where R8═CH3


For the compounds in which BB4 is Fmoc-S35 or Fmoc-Pip, (N)R7 and R5 form part of a six-membered ring, including the nitrogen atom, as shown for the combined R5-R7 in Table 6B. Likewise, for the compounds in which BB4 is Fmoc-(S)-SP1 or Fmoc-(R)-SP1, (N)R7 and R5 form part of a five-membered ring, including the nitrogen atom, as shown for the combined R5-R7 in Table 6D


For compounds 1399-1400, a carbonyl group (C═O) replaces the methylene group (CH2) between NR4 and R7 in the macrocycle structure.


In addition, the synthetic scheme presented in Scheme 4 was followed to prepare macrocyclic compounds 1415-1416 on solid support, except that BB4 was Fmoc-NR7—R6—CHO. The first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D), then, after removal of the Fmoc protection (Method 1F), the second amino acid building block (BB2) attached through amide bond formation (Method 1G). The Fmoc group was cleaved (Method 1F), then the oxazole building block (BB3) attached by reductive amination (Method 1J) or amide coupling (Method 1G) to extend the intermediate chain. After deprotection (Method 1F), the final building block was then added using reductive amination (Method 1I or 1J) to complete the pre-cyclization intermediate. Deprotection of the N-terminal Fmoc group (Method 1F), cleavage from the resin (Method 1Q), macrocyclization (Method 1R) and removal of the side chain protecting groups (Method 1S) followed by evaporation under reduced pressure gave the crude macrocycle. The results after purification by preparative HPLC (Method 2B) are included in Table 6E, including, for each compound, the amounts obtained, the HPLC purity and the confirmation of identity by MS. The macrocyclic structures are provided in Table 6F.
















TABLE 6E












MS


Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
(M + H)







1415
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-(S)-SP1
2.3
100
564


1416
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
Fmoc-(R)-SP1
6.2
100
564






1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.





embedded image

alcohol [L-prolinol (ChemImpex Cat. No. 03218)] using Method 1H, while (R)-isomer is synthesized from Fmoc-D-Pro by reduction using the procedure of Example 1J, followed by oxidation using Method 1H].














TABLE 6F









embedded image


















Cpd
R1
R2
R3
Q
R4
R6-R7





1415


embedded image




embedded image


H
CH2


embedded image




embedded image







1416


embedded image




embedded image


H
CH2


embedded image




embedded image











For both compounds, R6 and (N)R7 form a five-membered ring, including the nitrogen atom, as shown for R6-R7 in Table 6F.


For the addition of still further diverse compounds in the library, the series of synthetic schemes in Schemes 5, 6 and 7 were employed for the solid phase construction of macrocyclic compounds 1417-1440, 1441 and 1442-1465, respectively, except that in Scheme 5, BB3 was Fmoc-NR7—CHR4—CO2H. For all of the compounds, the first amino acid building block amino acid (BB1) was loaded onto the resin (Method 1D). For compounds 1417-1440 and 1442-1465, the second amino acid building block (BB2) was attached through peptide coupling (Method 1G) following Fmoc deprotection (Method 1F). BB2 was added using reductive amination (Method 1I or 1J) for compound 1441. For compounds 1417-1441, the third building block (BB3) was installed after Fmoc deprotection (Method 1F) via amide bond formation (Method 1G), while for 1442-1465, reductive amination (Method 1I or 1J) was employed for BB3. After Fmoc removal ((Method 1F), addition of the oxazole building block (BB4) for all compounds was performed using reductive amination (Method 1J) or amide bond formation (Method 1G). With each scheme, deprotection of the Fmoc moiety (Method 1F), resin cleavage (Method 1Q), macrocycle formation (Method 1R) and removal of the side chain protection (Method 1S) were followed by evaporation in vacuo to yield the crude macrocycle. Upon purification by preparative HPLC (Method 2B), the desired macrocyclic library compounds were obtained. For each macrocycle, the quantities, purity (HPLC) and identity conformation (MS) are presented in Table 6G, with the structures shown in Tables 6H, 6I and 6J.


For compounds 1425-1427, the N-methyl group on BB2 (R3) is installed prior to the addition of BB3 by the series of reactions described in Method 1P using methanol as the alcohol component. Likewise, for compound 1423, prior to macrocyclization, the N-methyl group on BB4 (add R8 in place of H) is installed by the series of reactions described in Method 1P using methanol as the alcohol component
















TABLE 6G





Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
MS (M + H)






















1417
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-16
0.8
80
515


1418
Fmoc-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-16
1.5
100
515


1419
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-16
1.3
100
515


1420
Fmoc-Tyr(But)
Fmoc-S30
Fmoc-Lys(Boc)
Fmoc-OX-16
1.6
100
515


1421
Fmoc-D-N-Me-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.2
100
529


1422
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-N-Me-Lys(Boc)
Fmoc-OX-13
0.6
100
529


1423
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.2
100
529


1424
Fmoc-D-Tyr(But)
Fmoc-S29
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.4
100
501


1425
Fmoc-D-Tyr(But)
Fmoc-S33
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.3
100
529


1426
Fmoc-D-Tyr(But)
Fmoc-(S)-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.0
100
529


1427
Fmoc-D-Tyr(But)
Fmoc-(R)-S31
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.5
100
529


1428
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Orn(Boc)
Fmoc-OX-13
1.2
100
501


1429
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Dab(Boc)
Fmoc-OX-13
1.0
100
487


1430
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Dap(Boc)
Fmoc-OX-13
1.3
100
473


1431
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Asn(Trt)
Fmoc-OX-13
1.4
100
501


1432
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Gln(Trt)
Fmoc-OX-13
na
na
na


1433
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Tyr(But)
Fmoc-OX-13
2.9
91
515


1434
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-33
1.7
100
515


1435
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-31
1.1
100
473


1436
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-32
1.0
100
515


1437
Fmoc-Trp(Boc)
Fmoc-S35
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.3
100
592


1438
Fmoc-Pro
Fmoc-(S)-SP2*
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.1
100
564


1439
Fmoc-Pro
Fmoc-(R)-SP2*
Fmoc-D-Lys(Boc)
Fmoc-OX-13
na
na
na


1440
Fmoc-D-Tyr(But)
Fmoc-S30
Fmoc-D-Lys(Boc)
Fmoc-OX-16
0.5
100
515


1441
Fmoc-Tyr(But)
Fmoc-Arg(Pbf)
Fmoc-S29
Fmoc-OX-13
na
na
na


1442
Fmoc-D-Asn(Trt)
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
2.7
100
595


1443
Fmoc-D-Asn(Trt)
Fmoc-Tyr(But)
Fmoc-Lys(Boc)
Fmoc-OX-13
10.5
98
572


1444
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
10.5
100
578


1445
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
9.0
100
578


1446
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
10.2
100
578


1447
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-13
2.0
100
578


1448
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
3.1
100
578


1449
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-16
9.9
100
578


1450
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
14.0
100
578


1451
Fmoc-Pro
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-16
9.3
100
578


1452
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
8.0
100
578


1453
Fmoc-D-Pro
Fmoc-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-16
10.2
100
578


1454
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-16
2.4
100
578


1455
Fmoc-D-Pro
Fmoc-D-Trp(Boc)
Fmoc-Lys(Boc)
Fmoc-OX-16
2.2
100
578


1456
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-1
na
na
na


1457
Fmoc-N-Me-Ala
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
6.2
100
566


1458
Fmoc-Pro
Fmoc-Ala
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.1
80
463


1459
Fmoc-Pro
Fmoc-Tyr(But)
Fmoc-D-Lys(Boc)
Fmoc-OX-13
2.5
100
555


1460
Fmoc-Pro
Fmoc-Phe
Fmoc-D-Lys(Boc)
Fmoc-OX-13
1.0
100
539


1461
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Om(Boc)
Fmoc-OX-13
2.3
100
564


1462
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Arg(Pbf)
Fmoc-OX-13
2.2
100
606


1463
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-31
1.2
100
536


1464
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-32
1.8
100
578


1465
Fmoc-Pro
Fmoc-Trp(Boc)
Fmoc-D-Lys(Boc)
Fmoc-OX-33
1.5
100
578





na = not available



1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.





embedded image

D-Trp(Boc), by first reduction using the procedure of Example 1J, followed by oxidation using Method 1H].














TABLE 6H









embedded image


















Cpd
R1
R2
R3
R4
Q
R5





1417


embedded image




embedded image


Me


embedded image


CH2


embedded image







1418


embedded image




embedded image


Me


embedded image


CH2


embedded image







1419


embedded image




embedded image


Me


embedded image


CH2


embedded image







1420


embedded image




embedded image


Me


embedded image


CH2


embedded image







1421


embedded image




embedded image


Me


embedded image


CH2


embedded image







1422


embedded image




embedded image


Me


embedded image


CH2


embedded image







1423


embedded image




embedded image


Me


embedded image


CH2


embedded image







1424


embedded image




embedded image


H


embedded image


CH2


embedded image







1425


embedded image




embedded image


Me


embedded image


CH2


embedded image







1426


embedded image




embedded image


Me


embedded image


CH2


embedded image







1427


embedded image




embedded image


Me


embedded image


CH2


embedded image







1428


embedded image




embedded image


Me


embedded image


CH2


embedded image







1429


embedded image




embedded image


Me


embedded image


CH2


embedded image







1430


embedded image




embedded image


Me


embedded image


CH2


embedded image







1431


embedded image




embedded image


Me


embedded image


CH2


embedded image







1432


embedded image




embedded image


Me


embedded image


CH2


embedded image







1433


embedded image




embedded image


Me


embedded image


CH2


embedded image







1434


embedded image




embedded image


Me


embedded image


CH2


embedded image







1435


embedded image




embedded image


Me


embedded image


CH2
(S)-CH3





1436


embedded image




embedded image


Me


embedded image


CH2


embedded image

















1437


embedded image




embedded image




embedded image


C═O


embedded image


















1438


embedded image




embedded image


H


embedded image


CH2


embedded image







1439


embedded image




embedded image


H


embedded image


CH2


embedded image







1440


embedded image




embedded image


CH3


embedded image


CH2


embedded image











For all compounds, R6, R7 and R8═H, except for compound 1421, where R6═CH3, compound 1422, where R7═CH3 and compound 1423, where R8═CH3. In addition, for those compounds (1438-1439) in which Fmoc-Pro is the BB1 component, R1 and (N)R6 form part of a five-membered ring, including the nitrogen atom, as shown for R1 in Table 6H.


For compound 1437, in which BB2 is Fmoc-S35, R2 and (N)R3 form part of a six-membered ring, including the nitrogen atom, as shown for the combined R2-R3 in Table 6H.









TABLE 6I









embedded image


















Cpd
R1
R2
R3
R4
Q
R6





1441


embedded image




embedded image


H


embedded image


CH2


embedded image











In addition for this compound, R5═H.









TABLE 6J









embedded image


















Cpd
R1
R2
R3
R4
Q
R5





1442


embedded image




embedded image


H


embedded image


CH2


embedded image







1443


embedded image




embedded image


H


embedded image


CH2


embedded image







1444


embedded image




embedded image


H


embedded image


CH2


embedded image







1445


embedded image




embedded image


H


embedded image


CH2


embedded image







1446


embedded image




embedded image


H


embedded image


CH2


embedded image







1447


embedded image




embedded image


H


embedded image


CH2


embedded image







1448


embedded image




embedded image


H


embedded image


CH2


embedded image







1449


embedded image




embedded image


H


embedded image


CH2


embedded image







1450


embedded image




embedded image


H


embedded image


CH2


embedded image







1451


embedded image




embedded image


H


embedded image


CH2


embedded image







1452


embedded image




embedded image


H


embedded image


CH2


embedded image







1453


embedded image




embedded image


H


embedded image


CH2


embedded image







1454


embedded image




embedded image


H


embedded image


CH2


embedded image







1455


embedded image




embedded image


H


embedded image


CH2


embedded image







1456


embedded image




embedded image


H


embedded image


CH2


embedded image







1457


embedded image




embedded image


H


embedded image


CH2


embedded image







1458


embedded image


(S)-CH3
H


embedded image


CH2


embedded image







1459


embedded image




embedded image


H


embedded image


CH2


embedded image







1460


embedded image




embedded image


H


embedded image


CH2


embedded image







1461


embedded image




embedded image


H


embedded image


CH2


embedded image







1462


embedded image




embedded image


H


embedded image


CH2


embedded image







1463


embedded image




embedded image


H


embedded image


CH2
(S)-CH3





1464


embedded image




embedded image


H


embedded image


CH2


embedded image







1465


embedded image




embedded image


H


embedded image


CH2


embedded image











For all compounds, R6═H, except for compound 1457, where R6═CH3, and for those compounds in which Fmoc-Pro or Fmoc-D-Pro is the BB1 component, wherein R1 and (N)R6 form part of a five-membered ring, including the nitrogen atom, as shown for R1 in Table 6J.


Lastly, the synthetic scheme presented in Scheme 2 was followed to prepare the macrocyclic compounds 1466-1467 on solid support, except that BB3 was Fmoc-NR5—CHR4—CHO and was attached using different chemistry. The oxazole amino acid (BB1) was loaded onto the resin (Method 1D), then the next two building blocks (BB2, BB3) attached via coupling (Method 1G) and reductive amination (Method 1I or 1J), respectively, each after removal of the Fmoc protection (Method 1F) on the preceding building block. The final building block (BB4) was attached using reductive amination (Method 1I or 1J) followed by selective N-terminal deprotection (Method 1F) and macrocyclization (Method 1R). The side chain protecting groups were then removed (Method 1S) and the resulting crude product purified by preparative HPLC (Method 2B). The amounts of each macrocycle obtained, their HPLC purity and confirmation of their identity by mass spectrometry (MS) are provided in Table 6K. The individual structures of the compounds thus prepared are presented in Table 6L.
















TABLE 6K














MS


Cpd
BB1
BB2
BB3
BB4
Wt (mg)1
Purity2
(M + H)





1466
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
Fmoc-(S)-SP2*
2.0
100
578


1467
Fmoc-OX-1
Fmoc-D-Lys(Boc)
Fmoc-S35
Fmoc-(R)-SP2*
1.6
100
578






1All syntheses were carried out on the solid phase starting from 70-80 mg of 2-chlorotrityl chloride resin (typical loading 1.0 mmol/g).




2Purity is determined by analysis with LC-UV at 220 nm.





embedded image

synthesized from Fmoc-D-Trp(Boc), by first reduction using the procedure of Example 1J, followed by oxidation using Method 1H].














TABLE 6L









embedded image


















Cpd
R1
R2
R3
Q
R4-R5
R6





1466


embedded image




embedded image


H
CH2


embedded image




embedded image







1467


embedded image




embedded image


H
CH2


embedded image




embedded image











For both compounds, R4 and (N)R5 form part of a six-membered ring, including the nitrogen atom, as shown for combined R4-R5 in Table 6L.




embedded image




embedded image




embedded image


embedded image




embedded image


embedded image




embedded image




embedded image




embedded image




embedded image


While the disclosure has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications and this application is intended to cover any variations, uses, or adaptations of the disclosure following, in general, the principles of the disclosure and including such departures from the present disclosure as come within known or customary practice within the art to which the disclosure pertains and as may be applied to the essential features hereinbefore set forth, and as follows in the scope of the appended claims.

Claims
  • 1. A library comprising at least two macrocyclic compounds selected from the group consisting of compounds of formula (Ia), formula (Ib), formula (Ic), formula (Id), formula (Ie) and salts thereof:
  • 2. The library according to claim 1 wherein A, B and D are independently selected from the group consisting of:
  • 3. The library according to claim 1 wherein
  • 4. The library according to claim 1 wherein R1, R2, R4, R5, R6, R7, R9, R10, R11, R13, R14, R15, R16, R17, R18 and R19 are independently selected from the group consisting of:
  • 5. The library according to claim 1 wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12, X13, X14, X15, X16, X17, X18 and X19 are independently selected from the group consisting of NH and NCH3; and wherein X21, X22, X23, X24, X25 and X26 are independently selected from the group consisting of CH2, CH2CH2, O, NH and NCH3.
  • 6. The library according to claim 1 synthesized as discrete macrocyclic compounds.
  • 7. The library according to claim 1 synthesized as mixtures of at least two macrocyclic compounds.
  • 8. The library according to claim 1 wherein the macrocyclic compounds are provided as undissolved solids, syrups or oils.
  • 9. The library according to claim 1 wherein the macrocyclic compounds are provided dissolved in an organic solvent, water or buffer system.
  • 10. The library according to claim 1 wherein the macrocyclic compounds are provided dissolved in DMSO.
  • 11. The library according to claim 1 arrayed in at least one multiple sample holder.
  • 12. The library of claim 11 wherein the at least one multiple sample holder is a microtiter plate containing 96, 384, 1536, 3456, 6144 or 9600 wells or a miniaturized chip.
  • 13. The library of claim 11 wherein the compounds are distributed as individual compounds in each sample of the at least one multiple sample holder.
  • 14. A kit comprising: the library of claim 1; andat least one multiple sample holder.
  • 15. A macrocyclic compound represented by formula (Ia), formula (Ib), formula (Ic), formula (Id), or formula (Ie) as described in claim 1, or salts thereof.
  • 16. A method of using the library according to claim 1, said method comprising contacting said compounds of said library according to claim 1 with a biological target so as to obtain identification of compounds that modulate the biological target.
  • 17. The method of claim 16 wherein the identification is conducted in a high throughput fashion.
  • 18. The method of claim 16 wherein the biological target is an enzyme, a G protein-coupled receptor, a nuclear receptor, an ion channel, a transporter, a transcription factor, a protein-protein interaction or a nucleic acid-protein interaction.
  • 19. The method of claim 16, wherein the modulation is agonism, antagonism, activation, inhibition or inverse agonism.
  • 20. The method of claim 16, wherein said method is carried out in vitro.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a 35 USC 371 national stage entry of PCT/CA2016/000232 filed on Sep. 14, 2016 and which claims priority to U.S. provisional application No. 62/222,995 that was filed on Sep. 24, 2015. These documents are hereby incorporated herein by reference in their entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/CA2016/000232 9/14/2016 WO 00
Publishing Document Publishing Date Country Kind
WO2017/049383 3/30/2017 WO A
US Referenced Citations (1)
Number Name Date Kind
20060161007 Martin et al. Jul 2006 A1
Foreign Referenced Citations (5)
Number Date Country
2284459 Apr 2001 CA
2005012331 Feb 2005 WO
2005012332 Feb 2005 WO
2012062777 May 2012 WO
2017197488 Nov 2017 WO
Non-Patent Literature Citations (6)
Entry
Davis et al. (Tetrahedron, 2012, 68:1029-1051) (Year: 2012).
Di Francesco et al., “Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement”, Journal of Medicinal Chemistry, vol. 52, No. 22, Nov. 26, 2009, pp. 7014-7028.
Bertram et al., “Synthesis of Libraries of Thiazole, Oxazole and Imidazole-Based Cyclic Peptides from Azole-Based Amino Acis. A New Synthetic Approach to Bistratamides and Didmolamides”, Organic & Biomolecular Chemistry, vol. 5, No. 10, Jan. 1, 2007, p. 1541.
Mann et al., “New Oxazole-Based Peptidominetics: Useful Building Blocks for the Synthesis of Orthogonally Protected Macrocyclic Scaffolds”, Organic Letters (Sep. 2, 2003), vol. 5, No. 24 pp. 4567-4570.
Qi et al., “Design and Synthesis of Polyoxazole-based Macrocycles Tethered with a Phosphonate Group”, Chin. J. Chem. (Jun. 13, 2014), 32 pp. 585-591.
Marsault et al., “Efficient parallel synthesis of macrocyclic peptidomimetics”, Bioorganic & Medicinal Chemistry Letter, vol. 18, Issue 16 (Aug. 15, 2008), pp. 4731-4735).
Related Publications (1)
Number Date Country
20180265521 A1 Sep 2018 US
Provisional Applications (1)
Number Date Country
62222995 Sep 2015 US